Pathologic deposition of calcium salts in tissues.
Deposition of calcium into the blood vessel structures. Excessive calcification of the vessels are associated with ATHEROSCLEROTIC PLAQUES formation particularly after MYOCARDIAL INFARCTION (see MONCKEBERG MEDIAL CALCIFIC SCLEROSIS) and chronic kidney diseases which in turn increase VASCULAR STIFFNESS.
Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts.
Pathological processes involving any part of the AORTA.
A fetuin subtype that is synthesized by HEPATOCYTES and secreted into the circulation. It plays a major role in preventing CALCIUM precipitation in the BLOOD.
Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
Carbonic acid calcium salt (CaCO3). An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement.
Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
A negatively-charged extracellular matrix protein that plays a role in the regulation of BONE metabolism and a variety of other biological functions. Cell signaling by osteopontin may occur through a cell adhesion sequence that recognizes INTEGRIN ALPHA-V BETA-3.
The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle.
Inorganic salts of phosphoric acid.
An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
A secreted member of the TNF receptor superfamily that negatively regulates osteoclastogenesis. It is a soluble decoy receptor of RANK LIGAND that inhibits both CELL DIFFERENTIATION and function of OSTEOCLASTS by inhibiting the interaction between RANK LIGAND and RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B.
Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
Thickening and loss of elasticity of the walls of muscular ARTERIES due to calcification of the TUNICA MEDIA, the concentric layers of helically arranged SMOOTH MUSCLE CELLS.
Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.
A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.
Computed tomography where there is continuous X-ray exposure to the patient while being transported in a spiral or helical pattern through the beam of irradiation. This provides improved three-dimensional contrast and spatial resolution compared to conventional computed tomography, where data is obtained and computed from individual sequential exposures.
A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions.
The main trunk of the systemic arteries.
A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.
The aorta from the DIAPHRAGM to the bifurcation into the right and left common iliac arteries.
A class in the phylum CNIDARIA, comprised mostly of corals and anemones. All members occur only as polyps; the medusa stage is completely absent.
Inorganic salts of phosphoric acid that contain two phosphate groups.
The development of bony substance in normally soft structures.
Lesions formed within the walls of ARTERIES.
Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ).
The valve between the left atrium and left ventricle of the heart.
A transcription factor that dimerizes with CORE BINDING FACTOR BETA SUBUNIT to form core binding factor. It contains a highly conserved DNA-binding domain known as the runt domain and is involved in genetic regulation of skeletal development and CELL DIFFERENTIATION.
Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers.
An inherited disorder of connective tissue with extensive degeneration and calcification of ELASTIC TISSUE primarily in the skin, eye, and vasculature. At least two forms exist, autosomal recessive and autosomal dominant. This disorder is caused by mutations of one of the ATP-BINDING CASSETTE TRANSPORTERS. Patients are predisposed to MYOCARDIAL INFARCTION and GASTROINTESTINAL HEMORRHAGE.
Native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions. They may occur as individual crystals or may be disseminated in some other mineral or rock. (Grant & Hackh's Chemical Dictionary, 5th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Pathological processes of the KIDNEY or its component tissues.
Glycoproteins which contain sialic acid as one of their carbohydrates. They are often found on or in the cell or tissue membranes and participate in a variety of biological activities.
The nonstriated involuntary muscle tissue of blood vessels.
A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
The veins and arteries of the HEART.
Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS.
The process of bone formation. Histogenesis of bone including ossification.
One of the protein CROSS-LINKING REAGENTS that is used as a disinfectant for sterilization of heat-sensitive equipment and as a laboratory reagent, especially as a fixative.
Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
The vessels carrying blood away from the heart.
Elements of limited time intervals, contributing to particular results or situations.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification.
Non-striated, elongated, spindle-shaped cells found lining the digestive tract, uterus, and blood vessels. They are derived from specialized myoblasts (MYOBLASTS, SMOOTH MUSCLE).
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone.
A condition characterized by calcification of the renal tissue itself. It is usually seen in distal RENAL TUBULAR ACIDOSIS with calcium deposition in the DISTAL KIDNEY TUBULES and the surrounding interstitium. Nephrocalcinosis causes RENAL INSUFFICIENCY.
The portion of the descending aorta proceeding from the arch of the aorta and extending to the DIAPHRAGM, eventually connecting to the ABDOMINAL AORTA.
Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
The process whereby calcium salts are deposited in the dental enamel. The process is normal in the development of bones and teeth. (Boucher's Clinical Dental Terminology, 4th ed, p43)
Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
A group of enzymes within the class EC 3.6.1.- that catalyze the hydrolysis of diphosphate bonds, chiefly in nucleoside di- and triphosphates. They may liberate either a mono- or diphosphate. EC 3.6.1.-.
A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principle cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.
Salts or ions of the theoretical carbonic acid, containing the radical CO2(3-). Carbonates are readily decomposed by acids. The carbonates of the alkali metals are water-soluble; all others are insoluble. (From Grant & Hackh's Chemical Dictionary, 5th ed)
Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.
Calcium salts of phosphoric acid. These compounds are frequently used as calcium supplements.
Extracellular substance of bone tissue consisting of COLLAGEN fibers, ground substance, and inorganic crystalline minerals and salts.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
A family of highly conserved and widely expressed sodium-phosphate cotransporter proteins. They are electrogenic sodium-dependent transporters of phosphate that were originally identified as retroviral receptors in HUMANS and have been described in yeast and many other organisms.
General disorders of the sclera or white of the eye. They may include anatomic, embryologic, degenerative, or pigmentation defects.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
A potent osteoinductive protein that plays a critical role in the differentiation of osteoprogenitor cells into OSTEOBLASTS.
Vitamin K-dependent calcium-binding protein synthesized by OSTEOBLASTS and found primarily in BONES. Serum osteocalcin measurements provide a noninvasive specific marker of bone metabolism. The protein contains three residues of the amino acid gamma-carboxyglutamic acid (Gla), which, in the presence of CALCIUM, promotes binding to HYDROXYAPATITE and subsequent accumulation in BONE MATRIX.
Presence of calcium salts, especially calcium pyrophosphate, in the cartilaginous structures of one or more joints. When accompanied by attacks of goutlike symptoms, it is called pseudogout. (Dorland, 27th ed)
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.
A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates.
A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material.
Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
A group of phosphate minerals that includes ten mineral species and has the general formula X5(YO4)3Z, where X is usually calcium or lead, Y is phosphorus or arsenic, and Z is chlorine, fluorine, or OH-. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
The middle layer of blood vessel walls, composed principally of thin, cylindrical, smooth muscle cells and elastic tissue. It accounts for the bulk of the wall of most arteries. The smooth muscle cells are arranged in circular layers around the vessel, and the thickness of the coat varies with the size of the vessel.
The mineral component of bones and teeth; it has been used therapeutically as a prosthetic aid and in the prevention and treatment of osteoporosis.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Radiography of the vascular system of the heart muscle after injection of a contrast medium.
Types of spiral computed tomography technology in which multiple slices of data are acquired simultaneously improving the resolution over single slice acquisition technology.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
Synthetic thermoplastics that are tough, flexible, inert, and resistant to chemicals and electrical current. They are often used as biocompatible materials for prostheses and implants.
A conical fibro-serous sac surrounding the HEART and the roots of the great vessels (AORTA; VENAE CAVAE; PULMONARY ARTERY). Pericardium consists of two sacs: the outer fibrous pericardium and the inner serous pericardium. The latter consists of an outer parietal layer facing the fibrous pericardium, and an inner visceral layer (epicardium) resting next to the heart, and a pericardial cavity between these two layers.
A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
A group (or phylum) of unicellular EUKARYOTA (or algae) possessing CHLOROPLASTS and FLAGELLA.
A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.
The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine.
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Membrane proteins that are involved in the active transport of phosphate.
The use of ultrasound to guide minimally invasive surgical procedures such as needle ASPIRATION BIOPSY; DRAINAGE; etc. Its widest application is intravascular ultrasound imaging but it is useful also in urology and intra-abdominal conditions.
Radiographic examination of the breast.
Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins).
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Any salt or ester of glycerophosphoric acid.
Diseases of the bones related to hyperfunction or hypofunction of the endocrine glands.
Narrowing of the passage through the MITRAL VALVE due to FIBROSIS, and CALCINOSIS in the leaflets and chordal areas. This elevates the left atrial pressure which, in turn, raises pulmonary venous and capillary pressure leading to bouts of DYSPNEA and TACHYCARDIA during physical exertion. RHEUMATIC FEVER is its primary cause.
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery.
Pathological processes of the BREAST.
An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor.
An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
A distribution in which a variable is distributed like the sum of the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another.
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
Identification and measurement of ELEMENTS and their location based on the fact that X-RAYS emitted by an element excited by an electron beam have a wavelength characteristic of that element and an intensity related to its concentration. It is performed with an electron microscope fitted with an x-ray spectrometer, in scanning or transmission mode.
A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4.
Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs.
Unstable isotopes of calcium that decay or disintegrate emitting radiation. Ca atoms with atomic weights 39, 41, 45, 47, 49, and 50 are radioactive calcium isotopes.
A lipid cofactor that is required for normal blood clotting. Several forms of vitamin K have been identified: VITAMIN K 1 (phytomenadione) derived from plants, VITAMIN K 2 (menaquinone) from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 (menadione). Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.
Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic.
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.
Protein-mineral complexes that comprise substrates needed for the normal calcium-carbonate-phosphate homeostasis. Nanobacteria was the prior name for the particles which were originally thought to be microorganisms.
The innermost layer of an artery or vein, made up of one layer of endothelial cells and supported by an internal elastic lamina.
Marine ridges composed of living CORALS, coral skeletons, calcareous algae, and other organisms, mixed with minerals and organic matter. They are found most commonly in tropical waters and support other animal and plant life.
A transmembrane protein belonging to the tumor necrosis factor superfamily that specifically binds RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B and OSTEOPROTEGERIN. It plays an important role in regulating OSTEOCLAST differentiation and activation.
Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins.
Improvement in the quality of an x-ray image by use of an intensifying screen, tube, or filter and by optimum exposure techniques. Digital processing methods are often employed.
Organic compounds that include a cyclic ether with three ring atoms in their structure. They are commonly used as precursors for POLYMERS such as EPOXY RESINS.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)
The paired bands of yellow elastic tissue that connect adjoining laminae of the vertebrae. With the laminae, it forms the posterior wall of the spinal canal and helps hold the body erect.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
The salinated water of OCEANS AND SEAS that provides habitat for marine organisms.
VASCULAR DISEASES that are associated with DIABETES MELLITUS.
Connective tissue comprised chiefly of elastic fibers. Elastic fibers have two components: ELASTIN and MICROFIBRILS.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Artificial substitutes for body parts and materials inserted into organisms during experimental studies.
The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.
A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve.
An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.
Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.
A highly glycosylated and sulfated phosphoprotein that is found almost exclusively in mineralized connective tissues. It is an extracellular matrix protein that binds to hydroxyapatite through polyglutamic acid sequences and mediates cell attachment through an RGD sequence.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Clinical syndrome describing overuse tendon injuries characterized by a combination of PAIN, diffuse or localized swelling, and impaired performance. Distinguishing tendinosis from tendinitis is clinically difficult and can be made only after histopathological examination.
A great expanse of continuous bodies of salt water which together cover more than 70 percent of the earth's surface. Seas may be partially or entirely enclosed by land, and are smaller than the five oceans (Atlantic, Pacific, Indian, Arctic, and Antarctic).
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
An abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones.
A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH).
Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.
Radiographic visualization of the aorta and its branches by injection of contrast media, using percutaneous puncture or catheterization procedures.
Diseases of BONES.
Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression.
Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.
A family of small polypeptide growth factors that share several common features including a strong affinity for HEPARIN, and a central barrel-shaped core region of 140 amino acids that is highly homologous between family members. Although originally studied as proteins that stimulate the growth of fibroblasts this distinction is no longer a requirement for membership in the fibroblast growth factor family.
Extraoral body-section radiography depicting an entire maxilla, or both maxilla and mandible, on a single film.
Inorganic compounds that contain calcium as an integral part of the molecule.
Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24.
Computer systems or networks designed to provide radiographic interpretive information.
Derivative of 7-dehydroxycholesterol formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. It differs from ERGOCALCIFEROL in having a single bond between C22 and C23 and lacking a methyl group at C24.
X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.
Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.
Abnormally high level of calcium in the blood.
The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS.
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals.
Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen.
Flaps of tissue that prevent regurgitation of BLOOD from the HEART VENTRICLES to the HEART ATRIA or from the PULMONARY ARTERIES or AORTA to the ventricles.
Bone-growth regulatory factors that are members of the transforming growth factor-beta superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or a heterodimer of two related bone morphogenetic proteins.
A plant in the genus ALLIUM, similar to ONIONS.
Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure.
A naturally occurring phenomenon where terminally differentiated cells dedifferentiate to the point where they can switch CELL LINEAGES. The cells then differentiate into other cell types.
Unanticipated information discovered in the course of testing or medical care. Used in discussions of information that may have social or psychological consequences, such as when it is learned that a child's biological father is someone other than the putative father, or that a person tested for one disease or disorder has, or is at risk for, something else.
A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.
Substances elaborated by bacteria that have antigenic activity.
Narrowing or constriction of a coronary artery.
Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
Disorders caused by interruption of BONE MINERALIZATION manifesting as OSTEOMALACIA in adults and characteristic deformities in infancy and childhood due to disturbances in normal BONE FORMATION. The mineralization process may be interrupted by disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis, resulting from dietary deficiencies, or acquired, or inherited metabolic, or hormonal disturbances.
A non-inherited congenital condition with vascular and neurological abnormalities. It is characterized by facial vascular nevi (PORT-WINE STAIN), and capillary angiomatosis of intracranial membranes (MENINGES; CHOROID). Neurological features include EPILEPSY; cognitive deficits; GLAUCOMA; and visual defects.
A VITAMIN D that can be regarded as a reduction product of vitamin D2.
An inorganic pyrophosphate which affects calcium metabolism in mammals. Abnormalities in its metabolism occur in some human diseases, notably HYPOPHOSPHATASIA and pseudogout (CHONDROCALCINOSIS).
The pathological process occurring in cells that are dying from irreparable injuries. It is caused by the progressive, uncontrolled action of degradative ENZYMES, leading to MITOCHONDRIAL SWELLING, nuclear flocculation, and cell lysis. It is distinct it from APOPTOSIS, which is a normal, regulated cellular process.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.
The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS.
A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere.
A condition of an abnormally low level of PHOSPHATES in the blood.
Phosphorus used in foods or obtained from food. This element is a major intracellular component which plays an important role in many biochemical pathways relating to normal physiological functions. High concentrations of dietary phosphorus can cause nephrocalcinosis which is associated with impaired kidney function. Low concentrations of dietary phosphorus cause an increase in calcitriol in the blood and osteoporosis.
X-ray image-detecting devices that make a focused image of body structures lying in a predetermined plane from which more complex images are computed.

Retinoid signaling is required for chondrocyte maturation and endochondral bone formation during limb skeletogenesis. (1/1311)

Retinoids have long been known to influence skeletogenesis but the specific roles played by these effectors and their nuclear receptors remain unclear. Thus, it is not known whether endogenous retinoids are present in developing skeletal elements, whether expression of the retinoic acid receptor (RAR) genes alpha, beta, and gamma changes during chondrocyte maturation, or how interference with retinoid signaling affects skeletogenesis. We found that immature chondrocytes present in stage 27 (Day 5.5) chick embryo humerus exhibited low and diffuse expression of RARalpha and gamma, while RARbeta expression was strong in perichondrium. Emergence of hypertrophic chondrocytes in Day 8-10 embryo limbs was accompanied by a marked and selective up-regulation of RARgamma gene expression. The RARgamma-rich type X collagen-expressing hypertrophic chondrocytes lay below metaphyseal prehypertrophic chondrocytes expressing Indian hedgehog (Ihh) and were followed by mineralizing chondrocytes undergoing endochondral ossification. Bioassays revealed that cartilaginous elements in Day 5.5, 8.5, and 10 chick embryo limbs all contained endogenous retinoids; strikingly, the perichondrial tissues surrounding the cartilages contained very large amounts of retinoids. Implantation of beads filled with retinoid antagonist Ro 41-5253 or AGN 193109 near the humeral anlagens in stage 21 (Day 3.5) or stage 27 chick embryos severely affected humerus development. In comparison to their normal counterparts, antagonist-treated humeri in Day 8.5-10 chick embryos were significantly shorter and abnormally bent; their diaphyseal chondrocytes had remained prehypertrophic Ihh-expressing cells, did not express RARgamma, and were not undergoing endochondral ossification. Interestingly, formation of an intramembranous bony collar around the diaphysis was not affected by antagonist treatment. Using chondrocyte cultures, we found that the antagonists effectively interfered with the ability of all-trans-retinoic acid to induce terminal cell maturation. The results provide clear evidence that retinoid-dependent and RAR-mediated mechanisms are required for completion of the chondrocyte maturation process and endochondral ossification in the developing limb. These mechanisms may be positively influenced by cooperative interactions between the chondrocytes and their retinoid-rich perichondrial tissues.  (+info)

Expression of tissue transglutaminase in the developing chicken limb is associated both with apoptosis and endochondral ossification. (2/1311)

The cross-linking enzyme tissue transglutaminase (tTG) participates in a variety of cellular functions. To assess its contribution to extracellular and intracellular processes during development we cloned the cDNA for chicken heart tissue transglutaminase and localized the sites of transglutaminase expression by in situ hybridization and immunohistochemistry. Compared with the chicken red blood cell transglutaminase cDNA, the heart cDNA encodes a transglutaminase with an amino-terminal truncation. The truncated enzyme retains full catalytic activity and is GTP-inhibitable. Tissue transglutaminase expression was observed in developmentally transient structures in embryonic chicken limb at day 7.5 of incubation suggesting that its expression is dynamically regulated during limb morphogenesis. The major morphogenetic events of the limb associated with transglutaminase expression were cartilage maturation during skeletal development, interdigital apoptosis, and differentiation of skeletal muscle. Maturation of the cartilage during endochondral ossification was characterized by intra- and extracellular transglutaminase accumulation in the zone of hypertrophic chondrocytes. Only intracellular enzyme could be detected in mesenchymal cells of the prospective joints, in apoptotic cells of the interdigital web, and in skeletal muscle myoblasts. An apparently constitutive expression of tissue transglutaminase was found in vascular endothelial cells corresponding to the adult expression pattern. The dynamic pattern of transglutaminase expression during morphogenesis suggests that tissue remodeling is a major trigger for transglutaminase induction.  (+info)

Assessment of bone mineral density in adults with a history of juvenile chronic arthritis: a cross-sectional long-term followup study. (3/1311)

OBJECTIVE: To assess bone mineral density (BMD) and bone turnover in adults with a history of juvenile chronic arthritis (JCA) or persistent JCA, and to identify predictors of reduced BMD. METHODS: Sixty-five white patients (mean age 32.2 years) with a history of JCA and 65 age-, sex-, height-, and weight-matched healthy control subjects participated in the study. Densitometry of the left hip and the lumbar spine was performed, and osteocalcin (bone formation marker) and crosslinks (bone resorption marker) were measured. In addition, bone-related clinical parameters were assessed in the JCA group. RESULTS: BMD in the hip and lumbar spine was significantly lower in the JCA group than in the controls. Levels of osteocalcin and crosslinks were significantly increased in the JCA group. According to WHO definitions, significantly more subjects in the JCA group had "osteopenia" and "osteoporosis" than would be expected in a normal population sample. Active disease at the time of the study (1996-1997), baseline erosions evaluated in 1979, Steinbrocker functional class in 1996-1997, polyarticular course of JCA, and history of systemic steroid treatment for more than 1 year were significantly associated with reduced BMD. In linear regression analysis including both the JCA and control groups, presence of JCA proved to be the factor most strongly associated with reduced BMD, explaining approximately 20% of its variation. CONCLUSION: Reduced BMD and evidence of increased bone turnover suggest that JCA patients may be at risk of developing premature osteoporosis and associated fractures later in life. The data are consistent with the concept that BMD in JCA is determined by many factors.  (+info)

Bone histology in patients with nephrotic syndrome and normal renal function. (4/1311)

BACKGROUND: The prevalence of metabolic bone disease in patients with nephrotic syndrome (NS) at normal level of renal function remains uncertain. METHODS: To address this issue, we studied 30 patients (20 men and 10 women, mean age 27.3 +/- 11.7 years) with NS who had normal renal function (mean creatinine clearance 103 +/- 4 ml/min). We evaluated their serum calcium, phosphorus, alkaline phosphatase, immunoreactive parathyroid hormone (iPTH), vitamin D metabolites, urinary calcium, and skeletal survey. The extent of bone mineralization was analyzed by histomorphometric analysis of iliac crest bone biopsy specimens in all patients. The findings on bone histology were correlated with biochemical parameters. RESULTS: The mean duration of NS was 35.5 +/- 26.9 months, with a protein excretion of 7.3 +/- 3.2 g/24 hr and a serum albumin of 2.2 +/- 0.8 g/dl. Total serum calcium was 7.8 +/- 0.8 mg/dl, whereas ionized calcium was 5.7 +/- 0.7 mg/dl, phosphorus 3.2 +/- 1.2 mg/dl, and alkaline phosphatase 149 +/- 48.6 U/liter. Serum iPTH levels were normal in all except two patients. The mean serum 25-hydroxyvitamin D [25(OH)D] level was 3.9 +/- 1.2 ng/ml (normal 15 to 30 ng/ml), whereas 1,25-dihydroxyvitamin D was 24 +/- 4.7 pg/ml (normal 16 to 65). There was an inverse correlation between serum levels of 25(OH)D and the magnitude of proteinuria (r = -0.42, P < 0.05). The mean 24-hour urinary calcium excretion was 82 +/- 21 mg/day. The skeletal survey was normal in all patients. Bone histology was normal in 33.3% of the patients, whereas 56.7% had isolated osteomalacia (OSM), and 10% had an increased bone resorption in association with defective mineralization. The severity of OSM measured by mineralization lag time correlated linearly with the duration (r = 0.94, P < 0.0001) and the amount (r = 0.97, P < 0.0001) of proteinuria. All patients with NS for more than three years had histological changes. Patients with OSM had lower 25(OH)D and serum albumin as compared with those with normal histology (P < 0.005). Bone mineralization had no significant correlation with serum iPTH, divalent ions, or vitamin D levels. CONCLUSIONS: OSM is a frequent finding in adult patients with NS, even at a normal level of renal function. Its severity correlates with the amount and duration of proteinuria.  (+info)

Evidence for the promotion of bone mineralization by 1alpha,25-dihydroxycholecalciferol in the rat unrelated to the correction of deficiencies in serum calcium and phosphorus. (5/1311)

Concurrent administration of 1alpha,25-dihydroxycholecalciferol [1alpha,25-(OH)2-CC] to intact and thyroparathyroidectomized rats treated with ethane-1-hydroxy-1,1-diphosphonate (EHDP) prevented or reversed the EHDP-induced inhibition of bone mineralization as measured by changes in epiphyseal plate width and ash content of bone. An analog, 1alpha-droxycholecalciferol, was also effective. Recovery of bone after EHDP treatment was also significantly improved by administration of 1alpha,25-(OH)2-CC as evidenced by enhanced uptake of 45Ca by epiphyseal plates and decreased plate widths. Cholecalciferol (CC), ergocalciferol, dihydrotachysterol2, 5,6-trans-CC, 25-OH-CC, 5,6-Trans-25-OH-CC, and 1alpha24R,25-(OH)3-CC also blocked EHDP-induced epiphyseal plate widening, but required high, pharmacological dose levels. 24R,25- (OH)2-CC was inactive at doses up to 10 microgram/day. Since EHDP-treated rats are not deficient in calcium or phosphate, these data suggest that 1alpha,25-dihydroxycholecalciferol promoted bone mineralization independently of effects upon the intestinal absorption of calcium and phosphate.  (+info)

Hard fallow deer antler: a living bone till antler casting? (6/1311)

Deer antlers are the only mammalian bone structures which regenerate completely every year. Once developed, antlers are cleaned of the velvet-like skin. Presently it is believed that due to velvet shedding the blood supply is interrupted in the solidifying antler bone. Histological examinations were made on different parts of fallow deer antlers investigated from the time of velvet shedding till the antler casting. The present study on hard (polished) antlers revealed living bone with regions presenting living osteocytes, active osteoblasts, osteoid seams and even early stages of trabecular microcallus formation, thus indicating to a continuous bone remodeling. A well developed vascular system was found despite the presence of hard antler bone. The pedicle bone exhibits a rich supply of capillaries and vessels connected to the spongy core of the main branch and the compact bone as well. There is evidence that hard fallow deer antlers possess a functioning vascular system that "keeps the antler moist" resulting in a high impact resistance when fights are most frequent. As late as 3 weeks prior to antler casting a large number of living cells were discovered within the antler core. As we have no doubt that parts of the polished fallow deer antler represent a living bone, we have concluded that a sufficient blood supply of the antler core is maintained almost till the time of antler casting by vessels passing through the antler base.  (+info)

Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. (7/1311)

Msx2 is believed to play a role in regulating bone development, particularly in sutures of cranial bone. In this study we investigated the effects of retroviral-mediated overexpression of Msx2 mRNA, in both sense and antisense orientations, on primary cultured chick calvarial osteoblasts. Unregulated overexpression of sense mRNA produced high levels of Msx2 protein throughout the culture period, preventing the expected fall as the cells differentiate. The continued high expression of Msx2 prevented osteoblastic differentiation and mineralization of the extracellular matrix. In contrast, expression of antisense Msx2 RNA decreased proliferation and accelerated differentiation. In other studies, we showed that the Msx2 promoter was widely expressed during the proliferative phase of mouse calvarial osteoblast cultures but was preferentially downregulated in osteoblastic nodules. These results support a model in which Msx2 prevents differentiation and stimulates proliferation of cells at the extreme ends of the osteogenic fronts of the calvariae, facilitating expansion of the skull and closure of the suture.  (+info)

Histochemical and immunohistochemical analysis of the mechanism of calcification of Meckel's cartilage during mandible development in rodents. (8/1311)

It is widely accepted that Meckel's cartilage in mammals is uncalcified hyaline cartilage that is resorbed and is not involved in bone formation of the mandible. We examined the spatial and temporal characteristics of matrix calcification in Meckel's cartilage, using histochemical and immunocytochemical methods, electron microscopy and an electron probe microanalyser. The intramandibular portion of Meckel's cartilage could be divided schematically into anterior and posterior portions with respect to the site of initiation of ossification beneath the mental foramen. Calcification of the matrix occurred in areas in which alkaline phosphatase activity could be detected by light and electron microscopy and by immunohistochemical staining. The expression of type X collagen was restricted to the hypertrophic cells of intramandibular Meckel's cartilage, and staining with alizarin red and von Kossa stain revealed that calcification progressed in both posterior and anterior directions from the primary centre of ossification. After the active cellular resorption of calcified cartilage matrix, new osseous islands were formed by trabecular bone that intruded from the perichondrial bone collar. Evidence of such formation of bone was supported by results of double immunofluorescence staining specific for type I and type II collagens, in addition to results of immunostaining for osteopontin. Calcification of the posterior portion resembled that in the anterior portion of intramandibular Meckel's cartilage, and our findings indicate that the posterior portion also contributes to the bone formation of the mandible by an endochondral-type mechanism of calcification.  (+info)

There are several different types of calcinosis, each with its own unique causes and symptoms. Some common forms of calcinosis include:

1. Dystrophic calcinosis: This type of calcinosis occurs in people with muscular dystrophy, a group of genetic disorders that affect muscle strength and function. Dystrophic calcinosis can cause calcium deposits to form in the muscles, leading to muscle weakness and wasting.
2. Metastatic calcinosis: This type of calcinosis occurs when cancer cells spread to other parts of the body and cause calcium deposits to form. Metastatic calcinosis can occur in people with a variety of different types of cancer, including breast, lung, and prostate cancer.
3. Idiopathic calcinosis: This type of calcinosis occurs for no apparent reason, and the exact cause is not known. Idiopathic calcinosis can affect people of all ages and can cause calcium deposits to form in a variety of different tissues.
4. Secondary calcinosis: This type of calcidosis occurs as a result of an underlying medical condition or injury. For example, secondary calcinosis can occur in people with kidney disease, hyperparathyroidism (a condition in which the parathyroid glands produce too much parathyroid hormone), or traumatic injuries.

Treatment for calcinosis depends on the underlying cause and the severity of the condition. In some cases, treatment may involve managing the underlying disease or condition that is causing the calcium deposits to form. Other treatments may include medications to reduce inflammation and pain, physical therapy to improve mobility and strength, and surgery to remove the calcium deposits.

Vascular calcification can be caused by a variety of factors, including:

1. Aging: As we age, our bodies produce less vitamin K-dependent proteins, which are important for inhibiting vascular calcification.
2. Chronic kidney disease: When the kidneys are not functioning properly, they cannot remove sufficient amounts of calcium and phosphorus from the blood, leading to an accumulation of these minerals in the vessel walls.
3. Hyperparathyroidism: An overactive parathyroid gland can cause elevated levels of calcium in the blood, which can lead to vascular calcification.
4. Chronic inflammation: Inflammation can damage the endothelium (the inner lining of blood vessels) and promote the accumulation of calcium and other substances within the vessel walls.
5. Genetic predisposition: Some people may be more susceptible to vascular calcification due to genetic factors.

Vascular calcification can have serious consequences, including:

1. Increased risk of cardiovascular disease: Vascular calcification can lead to the formation of atherosclerotic plaques, which can narrow and harden the arteries, increasing the risk of heart attack and stroke.
2. Decreased blood flow: As the vessel walls become harder and more rigid, blood flow may be restricted, leading to decreased perfusion of organs and tissues.
3. Increased risk of kidney disease: Vascular calcification can lead to the formation of calcium deposits in the kidneys, which can damage these organs and increase the risk of chronic kidney disease.
4. Increased risk of heart failure: As vascular calcification increases, it can lead to increased stiffness of the vessel walls, which can reduce the heart's ability to pump blood effectively and increase the risk of heart failure.
5. Increased risk of other conditions: Vascular calcification has been linked to an increased risk of other conditions, such as osteoporosis, chronic kidney disease, and migraines.

There are several ways to diagnose vascular calcification, including:

1. Dual-energy X-ray absorptiometry (DXA): This test uses X-rays to measure bone density and can also detect calcium deposits in the vessels.
2. Computed tomography (CT) scans: These imaging tests use X-rays and computer technology to produce detailed images of the body's internal structures, including the vessels.
3. Ultrasound: This non-invasive test uses high-frequency sound waves to create images of the blood vessels and can detect calcium deposits within the vessel walls.
4. Magnetic resonance imaging (MRI): This test uses a strong magnetic field and radio waves to produce detailed images of the body's internal structures, including the blood vessels.
5. Intima-media thickness (IMT) measurement: This test measures the thickness of the inner two layers of the artery, which can be affected by vascular calcification.

There are several treatment options for vascular calcification, including:

1. Medications: Certain medications, such as bisphosphonates and statins, have been shown to slow or stop the progression of vascular calcification.
2. Lifestyle changes: Making lifestyle changes such as quitting smoking, exercising regularly, and maintaining a healthy diet can help reduce the risk of vascular calcification.
3. Minimally invasive procedures: Procedures such as angioplasty and stenting can be used to remove plaque and improve blood flow in affected vessels.
4. Surgery: In severe cases, surgery may be necessary to repair or replace damaged vessels.

It is important to note that the best treatment approach will depend on the severity and location of the vascular calcification, as well as the underlying cause of the condition. A healthcare professional should be consulted to determine the most appropriate course of treatment.

1. Aneurysms: A bulge or ballooning in the wall of the aorta that can lead to rupture and life-threatening bleeding.
2. Atherosclerosis: The buildup of plaque in the inner lining of the aorta, which can narrow the artery and restrict blood flow.
3. Dissections: A tear in the inner layer of the aortic wall that can cause bleeding and lead to an aneurysm.
4. Thoracic aortic disease: Conditions that affect the thoracic portion of the aorta, such as atherosclerosis or dissections.
5. Abdominal aortic aneurysms: Enlargement of the abdominal aorta that can lead to rupture and life-threatening bleeding.
6. Aortic stenosis: Narrowing of the aortic valve, which can impede blood flow from the heart into the aorta.
7. Aortic regurgitation: Backflow of blood from the aorta into the heart due to a faulty aortic valve.
8. Marfan syndrome: A genetic disorder that affects the body's connective tissue, including the aorta.
9. Ehlers-Danlos syndrome: A group of genetic disorders that affect the body's connective tissue, including the aorta.
10. Turner syndrome: A genetic disorder that affects females and can cause aortic diseases.

Aortic diseases can be diagnosed through imaging tests such as ultrasound, CT scan, or MRI. Treatment options vary depending on the specific condition and may include medication, surgery, or endovascular procedures.

1. Atherosclerosis: A condition in which plaque builds up inside the arteries, causing them to narrow and harden. This can lead to heart disease, heart attack, or stroke.
2. Hypertension: High blood pressure that can damage blood vessels and increase the risk of heart disease, stroke, and other conditions.
3. Peripheral artery disease (PAD): A condition in which the blood vessels in the legs and arms become narrowed or blocked, leading to pain, cramping, and weakness in the affected limbs.
4. Raynaud's phenomenon: A condition that causes blood vessels in the hands and feet to constrict in response to cold temperatures or stress, leading to discoloration, numbness, and tissue damage.
5. Deep vein thrombosis (DVT): A condition in which a blood clot forms in the deep veins of the legs, often caused by immobility or injury.
6. Varicose veins: Enlarged, twisted veins that can cause pain, swelling, and cosmetic concerns.
7. Angioplasty: A medical procedure in which a balloon is used to open up narrowed blood vessels, often performed to treat peripheral artery disease or blockages in the legs.
8. Stenting: A medical procedure in which a small mesh tube is placed inside a blood vessel to keep it open and improve blood flow.
9. Carotid endarterectomy: A surgical procedure to remove plaque from the carotid arteries, which supply blood to the brain, to reduce the risk of stroke.
10. Bypass surgery: A surgical procedure in which a healthy blood vessel is used to bypass a blocked or narrowed blood vessel, often performed to treat coronary artery disease or peripheral artery disease.

Overall, vascular diseases can have a significant impact on quality of life and can increase the risk of serious complications such as stroke, heart attack, and amputation. It is important to seek medical attention if symptoms persist or worsen over time, as early diagnosis and treatment can help to prevent long-term damage and improve outcomes.

There are several types of heart valve diseases, including:

1. Mitral regurgitation: This occurs when the mitral valve does not close properly, allowing blood to flow backward into the left atrium.
2. Aortic stenosis: This occurs when the aortic valve becomes narrowed or blocked, restricting blood flow from the left ventricle into the aorta.
3. Pulmonary stenosis: This occurs when the pulmonary valve becomes narrowed or blocked, restricting blood flow from the right ventricle into the pulmonary artery.
4. Tricuspid regurgitation: This occurs when the tricuspid valve does not close properly, allowing blood to flow backward into the right atrium.
5. Heart valve thickening or calcification: This can occur due to aging, rheumatic fever, or other conditions that cause inflammation in the heart.
6. Endocarditis: This is an infection of the inner lining of the heart, which can damage the heart valves.
7. Rheumatic heart disease: This is a condition caused by rheumatic fever, which can damage the heart valves and cause scarring.
8. Congenital heart defects: These are heart defects that are present at birth, and can affect the heart valves as well as other structures of the heart.

Symptoms of heart valve disease can include shortness of breath, fatigue, swelling in the legs or feet, and chest pain. Treatment options for heart valve disease depend on the specific condition and can range from medication to surgery or other procedures.

The main cause of DPC is the deposition of calcium hydroxyapatite crystals in the dental pulp, which leads to the formation of a hard, chalky material called dental calculus (tartar). This can occur as a result of poor oral hygiene, smoking, or other factors that increase the risk of dental caries and periodontal disease.

DPC is usually diagnosed through X-ray imaging, and treatment options include professional dental cleaning, antibiotics, and in severe cases, extraction of the affected tooth. It is important to address DPC as soon as possible to prevent further damage and potentially avoid more invasive procedures.

Preventative measures for DPC include regular brushing and flossing, using a fluoride mouthwash, and visiting the dentist regularly for cleanings and check-ups. Early detection and treatment of DPC can help to prevent long-term complications such as pulp necrosis, abscesses, and bone loss.

It is important to note that Dental Pulp Calcification is a relatively rare condition but it can be a significant cause of tooth pain and discomfort. If you experience any symptoms such as sensitivity or pain in your teeth, you should consult with a dentist for proper diagnosis and treatment.

The buildup of plaque in the coronary arteries is often caused by high levels of low-density lipoprotein (LDL) cholesterol, smoking, high blood pressure, diabetes, and a family history of heart disease. The plaque can also rupture, causing a blood clot to form, which can completely block the flow of blood to the heart muscle, leading to a heart attack.

CAD is the most common type of heart disease and is often asymptomatic until a serious event occurs. Risk factors for CAD include:

* Age (men over 45 and women over 55)
* Gender (men are at greater risk than women, but women are more likely to die from CAD)
* Family history of heart disease
* High blood pressure
* High cholesterol
* Diabetes
* Smoking
* Obesity
* Lack of exercise

Diagnosis of CAD typically involves a physical exam, medical history, and results of diagnostic tests such as:

* Electrocardiogram (ECG or EKG)
* Stress test
* Echocardiogram
* Coronary angiography

Treatment for CAD may include lifestyle changes such as a healthy diet, regular exercise, stress management, and quitting smoking. Medications such as beta blockers, ACE inhibitors, and statins may also be prescribed to manage symptoms and slow the progression of the disease. In severe cases, surgical intervention such as coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) may be necessary.

Prevention of CAD includes managing risk factors such as high blood pressure, high cholesterol, and diabetes, quitting smoking, maintaining a healthy weight, and getting regular exercise. Early detection and treatment of CAD can help to reduce the risk of complications and improve quality of life for those affected by the disease.

A condition in which the kidneys gradually lose their function over time, leading to the accumulation of waste products in the body. Also known as chronic kidney disease (CKD).

Prevalence:

Chronic kidney failure affects approximately 20 million people worldwide and is a major public health concern. In the United States, it is estimated that 1 in 5 adults has CKD, with African Americans being disproportionately affected.

Causes:

The causes of chronic kidney failure are numerous and include:

1. Diabetes: High blood sugar levels can damage the kidneys over time.
2. Hypertension: Uncontrolled high blood pressure can cause damage to the blood vessels in the kidneys.
3. Glomerulonephritis: An inflammation of the glomeruli, the tiny blood vessels in the kidneys that filter waste and excess fluids from the blood.
4. Interstitial nephritis: Inflammation of the tissue between the kidney tubules.
5. Pyelonephritis: Infection of the kidneys, usually caused by bacteria or viruses.
6. Polycystic kidney disease: A genetic disorder that causes cysts to grow on the kidneys.
7. Obesity: Excess weight can increase blood pressure and strain on the kidneys.
8. Family history: A family history of kidney disease increases the risk of developing chronic kidney failure.

Symptoms:

Early stages of chronic kidney failure may not cause any symptoms, but as the disease progresses, symptoms can include:

1. Fatigue: Feeling tired or weak.
2. Swelling: In the legs, ankles, and feet.
3. Nausea and vomiting: Due to the buildup of waste products in the body.
4. Poor appetite: Loss of interest in food.
5. Difficulty concentrating: Cognitive impairment due to the buildup of waste products in the brain.
6. Shortness of breath: Due to fluid buildup in the lungs.
7. Pain: In the back, flank, or abdomen.
8. Urination changes: Decreased urine production, dark-colored urine, or blood in the urine.
9. Heart problems: Chronic kidney failure can increase the risk of heart disease and heart attack.

Diagnosis:

Chronic kidney failure is typically diagnosed based on a combination of physical examination findings, medical history, laboratory tests, and imaging studies. Laboratory tests may include:

1. Blood urea nitrogen (BUN) and creatinine: Waste products in the blood that increase with decreased kidney function.
2. Electrolyte levels: Imbalances in electrolytes such as sodium, potassium, and phosphorus can indicate kidney dysfunction.
3. Kidney function tests: Measurement of glomerular filtration rate (GFR) to determine the level of kidney function.
4. Urinalysis: Examination of urine for protein, blood, or white blood cells.

Imaging studies may include:

1. Ultrasound: To assess the size and shape of the kidneys, detect any blockages, and identify any other abnormalities.
2. Computed tomography (CT) scan: To provide detailed images of the kidneys and detect any obstructions or abscesses.
3. Magnetic resonance imaging (MRI): To evaluate the kidneys and detect any damage or scarring.

Treatment:

Treatment for chronic kidney failure depends on the underlying cause and the severity of the disease. The goals of treatment are to slow progression of the disease, manage symptoms, and improve quality of life. Treatment may include:

1. Medications: To control high blood pressure, lower cholesterol levels, reduce proteinuria, and manage anemia.
2. Diet: A healthy diet that limits protein intake, controls salt and water intake, and emphasizes low-fat dairy products, fruits, and vegetables.
3. Fluid management: Monitoring and control of fluid intake to prevent fluid buildup in the body.
4. Dialysis: A machine that filters waste products from the blood when the kidneys are no longer able to do so.
5. Transplantation: A kidney transplant may be considered for some patients with advanced chronic kidney failure.

Complications:

Chronic kidney failure can lead to several complications, including:

1. Heart disease: High blood pressure and anemia can increase the risk of heart disease.
2. Anemia: A decrease in red blood cells can cause fatigue, weakness, and shortness of breath.
3. Bone disease: A disorder that can lead to bone pain, weakness, and an increased risk of fractures.
4. Electrolyte imbalance: Imbalances of electrolytes such as potassium, phosphorus, and sodium can cause muscle weakness, heart arrhythmias, and other complications.
5. Infections: A decrease in immune function can increase the risk of infections.
6. Nutritional deficiencies: Poor appetite, nausea, and vomiting can lead to malnutrition and nutrient deficiencies.
7. Cardiovascular disease: High blood pressure, anemia, and other complications can increase the risk of cardiovascular disease.
8. Pain: Chronic kidney failure can cause pain, particularly in the back, flank, and abdomen.
9. Sleep disorders: Insomnia, sleep apnea, and restless leg syndrome are common complications.
10. Depression and anxiety: The emotional burden of chronic kidney failure can lead to depression and anxiety.

Some examples of basal ganglia diseases include:

1. Parkinson's disease: A neurodegenerative disorder characterized by tremors, rigidity, bradykinesia (slow movement), and postural instability.
2. Huntington's disease: An autosomal dominant disorder that causes progressive degeneration of the basal ganglia and a decline in cognitive, motor, and psychiatric functions.
3. Dystonia: A movement disorder characterized by sustained or intermittent muscle contractions that cause abnormal postures or movements.
4. Tourette's syndrome: A neurodevelopmental disorder characterized by multiple motor tics and at least one vocal tic, such as repeated sounds or words.
5. Obsessive-compulsive disorder (OCD): An anxiety disorder characterized by recurring thoughts or compulsions to perform repetitive behaviors.
6. Schizophrenia: A psychotic disorder characterized by hallucinations, delusions, and cognitive impairments.
7. Kleine-Levin syndrome: A rare sleep disorder characterized by recurring periods of excessive sleepiness and automatic behaviors.
8. Wilson's disease: A rare genetic disorder caused by copper accumulation in the basal ganglia, leading to cognitive and motor impairments.
9. Hemiballism: A rare movement disorder characterized by unilateral or bilateral involuntary movements of the upper limbs.
10. Chorea-acanthocytosis: A rare genetic disorder characterized by chorea (involuntary movements), acanthocytosis (abnormal red blood cell shape), and cognitive decline.

These conditions are often challenging to diagnose and manage, and may require a comprehensive evaluation by a multidisciplinary team of healthcare professionals, including neurologists, psychiatrists, geneticists, and other specialists. Early diagnosis and appropriate treatment can help improve outcomes for individuals with these conditions.

It is a rare condition that can affect any blood vessel, but is most commonly found in the arteries of the lower extremities, particularly the femoral and popliteal arteries. The exact cause of the condition is not known, but it is believed to be related to aging, hypertension, and atherosclerosis (hardening of the arteries).

Symptoms of Monckeberg medial calcific sclerosis may include pain in the affected limb, weakness, cramping, and fatigue. The condition can also be detected through imaging tests such as X-rays, computed tomography (CT) scans, and magnetic resonance angiography (MRA).

Treatment for Monckeberg medial calcific sclerosis is aimed at managing the symptoms and slowing down the progression of the condition. This may include medications to lower blood pressure and control pain, as well as lifestyle modifications such as exercise and smoking cessation. In severe cases, surgery may be necessary to remove the affected section of the blood vessel.

Prognosis for Monckeberg medial calcific sclerosis varies depending on the severity of the condition and the promptness and effectiveness of treatment. If left untreated, the condition can lead to complications such as arterial occlusion (blockage), which can cause tissue damage and loss of limb function. However, with early detection and appropriate management, many patients with Monckeberg medial calcific sclerosis can achieve good outcomes and maintain their quality of life.

The disease begins with endothelial dysfunction, which allows lipid accumulation in the artery wall. Macrophages take up oxidized lipids and become foam cells, which die and release their contents, including inflammatory cytokines, leading to further inflammation and recruitment of more immune cells.

The atherosclerotic plaque can rupture or ulcerate, leading to the formation of a thrombus that can occlude the blood vessel, causing ischemia or infarction of downstream tissues. This can lead to various cardiovascular diseases such as myocardial infarction (heart attack), stroke, and peripheral artery disease.

Atherosclerosis is a multifactorial disease that is influenced by genetic and environmental factors such as smoking, hypertension, diabetes, high cholesterol levels, and obesity. It is diagnosed by imaging techniques such as angiography, ultrasound, or computed tomography (CT) scans.

Treatment options for atherosclerosis include lifestyle modifications such as smoking cessation, dietary changes, and exercise, as well as medications such as statins, beta blockers, and angiotensin-converting enzyme (ACE) inhibitors. In severe cases, surgical interventions such as bypass surgery or angioplasty may be necessary.

In conclusion, atherosclerosis is a complex and multifactorial disease that affects the arteries and can lead to various cardiovascular diseases. Early detection and treatment can help prevent or slow down its progression, reducing the risk of complications and improving patient outcomes.

Causes of Hyperphosphatemia:

There are several possible causes of hyperphosphatemia, including:

1. Kidney disease or failure: The kidneys regulate the levels of phosphate in the blood, and if they are not functioning properly, phosphate levels can become elevated.
2. Resistance to parathyroid hormone (PTH): PTH is a hormone that helps regulate calcium and phosphate levels in the body. If there is resistance to PTH, phosphate levels can become elevated.
3. Vitamin D deficiency: Vitamin D is important for the absorption of phosphate from food in the gut. A deficiency in vitamin D can lead to an excessive amount of phosphate in the blood.
4. Certain medications: Some medications, such as certain antacids and nutritional supplements, can contain high levels of phosphate and cause hyperphosphatemia.
5. Poor dietary habits: Consuming a diet that is high in phosphate-rich foods, such as meat and processed foods, can lead to elevated phosphate levels in the blood.

Symptoms of Hyperphosphatemia:

The symptoms of hyperphosphatemia can vary depending on the severity of the condition, but may include:

1. Bone pain or weakness
2. Fatigue
3. Nausea and vomiting
4. Weakness in the muscles
5. Rickets (in children)
6. Osteoporosis (in adults)
7. Kidney damage or failure

Diagnosis of Hyperphosphatemia:

Hyperphosphatemia is typically diagnosed through blood tests that measure the level of phosphate in the blood. Other tests may also be performed to assess kidney function and rule out other potential causes of elevated phosphate levels. These tests may include:

1. Serum creatinine test: This test measures the level of creatinine, a waste product that is produced by the muscles and removed from the blood by the kidneys. Elevated levels of creatinine can indicate kidney damage or failure.
2. Urine test: A urine test may be performed to check for proteinuria (excess protein in the urine), which can be a sign of kidney damage.
3. Parathyroid hormone (PTH) test: This test measures the level of PTH, a hormone that regulates calcium and phosphate levels in the blood. Elevated levels of PTH can indicate hyperparathyroidism, a condition in which the parathyroid glands produce too much PTH.
4. 24-hour urine phosphate test: This test measures the amount of phosphate excreted in the urine over a 24-hour period.

Treatment of Hyperphosphatemia:

The treatment of hyperphosphatemia depends on the underlying cause of the condition. Here are some possible treatment options:

1. Phosphate-binding agents: These medications, such as sevelamer and lanthanum carbonate, bind to phosphate in the gut and prevent it from being absorbed into the bloodstream.
2. Calcium supplements: Calcium can help to lower phosphate levels by binding to it and removing it from the bloodstream.
3. Dietary changes: A dietitian can work with you to develop a meal plan that limits phosphate-rich foods, such as meat, dairy products, and processed foods, while emphasizing fruits, vegetables, and whole grains.
4. Dialysis: In cases where the condition is caused by kidney failure, dialysis may be necessary to remove excess phosphate from the blood.
5. Surgery: In cases where the condition is caused by a parathyroid adenoma or hyperplasia, surgery may be necessary to remove the affected gland(s).

It's important to note that hyperphosphatemia can lead to complications such as mineral bone disease, which can cause weakened bones, bone pain, and an increased risk of fractures. Therefore, it's important to work with your healthcare provider to manage the condition and prevent these complications.

Treatment for uremia typically involves dialysis or kidney transplantation to remove excess urea from the blood and restore normal kidney function. In some cases, medications may be prescribed to help manage symptoms such as high blood pressure, anemia, or electrolyte imbalances.

The term "uremia" is derived from the Greek words "oura," meaning "urea," and "emia," meaning "in the blood." It was first used in the medical literature in the late 19th century to describe a condition caused by excess urea in the blood. Today, it remains an important diagnostic term in nephrology and is often used interchangeably with the term "uremic syndrome."

Aortic valve stenosis can be caused by a variety of factors, including aging, calcium buildup, or congenital heart defects. It is typically diagnosed through echocardiography or cardiac catheterization. Treatment options for aortic valve stenosis include medications to manage symptoms, aortic valve replacement surgery, or transcatheter aortic valve replacement (TAVR), which is a minimally invasive procedure.

In TAVR, a thin tube is inserted through a blood vessel in the leg and guided to the heart, where it delivers a new aortic valve. This can be performed through a small incision in the chest or through a catheter inserted into the femoral artery.

While TAVR has become increasingly popular for treating aortic valve stenosis, it is not suitable for all patients and requires careful evaluation to determine the best course of treatment. It is important to discuss the risks and benefits of TAVR with a healthcare provider to determine the appropriate treatment plan for each individual patient.

Heterotopic ossification can cause a range of symptoms depending on its location and severity, including pain, stiffness, limited mobility, and difficulty moving the affected limb or joint. Treatment options for heterotopic ossification include medications to reduce inflammation and pain, physical therapy to maintain range of motion, and in severe cases, surgical removal of the abnormal bone growth.

In medical imaging, heterotopic ossification is often diagnosed using X-rays or other imaging techniques such as CT or MRI scans. These tests can help identify the presence of bone growth in an abnormal location and determine the extent of the condition.

Overall, heterotopic ossification is a relatively rare condition that can have a significant impact on a person's quality of life if left untreated. Prompt medical attention and appropriate treatment can help manage symptoms and prevent long-term complications.

Early detection and management of atherosclerosis through regular health check-ups, healthy lifestyle choices, and medications can help prevent or delay the progression of the disease and reduce the risk of complications.

The main symptoms of PXE include:

1. Skin changes: Pigmented spots or patches on the skin, particularly on the neck, face, and arms. These spots can become more prominent with age.
2. Eye problems: PXE can cause a range of eye problems, including cataracts, glaucoma, and retinal degeneration.
3. Cardiovascular disease: PXE is associated with an increased risk of cardiovascular disease, including high blood pressure, peripheral artery disease, and aneurysms.
4. Other symptoms: PXE can also cause a range of other symptoms, including fatigue, muscle weakness, and cognitive decline.

PXE is diagnosed through a combination of clinical examination, laboratory tests, and genetic analysis. There is no cure for PXE, but treatment can help manage the symptoms. Treatment options may include medications to control high blood pressure, glaucoma, and other eye problems, as well as physical therapy to maintain muscle strength and mobility.

The prognosis for PXE varies depending on the severity of the symptoms and the presence of any complications. With proper management, many people with PXE can lead active and fulfilling lives. However, the condition can be debilitating and can significantly impact quality of life if left untreated or inadequately managed.

Overall, pseudoxanthoma elasticum is a rare and complex disorder that requires careful management and monitoring to minimize its impact on daily life. With appropriate treatment and support, many people with PXE can lead fulfilling lives.

Types of Kidney Diseases:

1. Acute Kidney Injury (AKI): A sudden and reversible loss of kidney function that can be caused by a variety of factors, such as injury, infection, or medication.
2. Chronic Kidney Disease (CKD): A gradual and irreversible loss of kidney function that can lead to end-stage renal disease (ESRD).
3. End-Stage Renal Disease (ESRD): A severe and irreversible form of CKD that requires dialysis or a kidney transplant.
4. Glomerulonephritis: An inflammation of the glomeruli, the tiny blood vessels in the kidneys that filter waste products.
5. Interstitial Nephritis: An inflammation of the tissue between the tubules and blood vessels in the kidneys.
6. Kidney Stone Disease: A condition where small, hard mineral deposits form in the kidneys and can cause pain, bleeding, and other complications.
7. Pyelonephritis: An infection of the kidneys that can cause inflammation, damage to the tissues, and scarring.
8. Renal Cell Carcinoma: A type of cancer that originates in the cells of the kidney.
9. Hemolytic Uremic Syndrome (HUS): A condition where the immune system attacks the platelets and red blood cells, leading to anemia, low platelet count, and damage to the kidneys.

Symptoms of Kidney Diseases:

1. Blood in urine or hematuria
2. Proteinuria (excess protein in urine)
3. Reduced kidney function or renal insufficiency
4. Swelling in the legs, ankles, and feet (edema)
5. Fatigue and weakness
6. Nausea and vomiting
7. Abdominal pain
8. Frequent urination or polyuria
9. Increased thirst and drinking (polydipsia)
10. Weight loss

Diagnosis of Kidney Diseases:

1. Physical examination
2. Medical history
3. Urinalysis (test of urine)
4. Blood tests (e.g., creatinine, urea, electrolytes)
5. Imaging studies (e.g., X-rays, CT scans, ultrasound)
6. Kidney biopsy
7. Other specialized tests (e.g., 24-hour urinary protein collection, kidney function tests)

Treatment of Kidney Diseases:

1. Medications (e.g., diuretics, blood pressure medication, antibiotics)
2. Diet and lifestyle changes (e.g., low salt intake, increased water intake, physical activity)
3. Dialysis (filtering waste products from the blood when the kidneys are not functioning properly)
4. Kidney transplantation ( replacing a diseased kidney with a healthy one)
5. Other specialized treatments (e.g., plasmapheresis, hemodialysis)

Prevention of Kidney Diseases:

1. Maintaining a healthy diet and lifestyle
2. Monitoring blood pressure and blood sugar levels
3. Avoiding harmful substances (e.g., tobacco, excessive alcohol consumption)
4. Managing underlying medical conditions (e.g., diabetes, high blood pressure)
5. Getting regular check-ups and screenings

Early detection and treatment of kidney diseases can help prevent or slow the progression of the disease, reducing the risk of complications and improving quality of life. It is important to be aware of the signs and symptoms of kidney diseases and seek medical attention if they are present.

There are several types of cardiomyopathies, each with distinct characteristics and symptoms. Some of the most common forms of cardiomyopathy include:

1. Hypertrophic cardiomyopathy (HCM): This is the most common form of cardiomyopathy and is characterized by an abnormal thickening of the heart muscle, particularly in the left ventricle. HCM can lead to obstruction of the left ventricular outflow tract and can increase the risk of sudden death.
2. Dilated cardiomyopathy: This type of cardiomyopathy is characterized by a decrease in the heart's ability to pump blood effectively, leading to enlargement of the heart and potentially life-threatening complications such as congestive heart failure.
3. Restrictive cardiomyopathy: This type of cardiomyopathy is characterized by stiffness of the heart muscle, which makes it difficult for the heart to fill with blood. This can lead to shortness of breath and fatigue.
4. Left ventricular non-compaction (LVNC): This is a rare type of cardiomyopathy that occurs when the left ventricle does not properly compact, leading to reduced cardiac function and potentially life-threatening complications.
5. Cardiac amyloidosis: This is a condition in which abnormal proteins accumulate in the heart tissue, leading to stiffness and impaired cardiac function.
6. Right ventricular cardiomyopathy (RVCM): This type of cardiomyopathy is characterized by impaired function of the right ventricle, which can lead to complications such as pulmonary hypertension and heart failure.
7. Endocardial fibroelastoma: This is a rare type of cardiomyopathy that occurs when abnormal tissue grows on the inner lining of the heart, leading to reduced cardiac function and potentially life-threatening complications.
8. Cardiac sarcoidosis: This is a condition in which inflammatory cells accumulate in the heart, leading to impaired cardiac function and potentially life-threatening complications.
9. Hypertrophic cardiomyopathy (HCM): This is a condition in which the heart muscle thickens, leading to reduced cardiac function and potentially life-threatening complications such as arrhythmias and sudden death.
10. Hypokinetic left ventricular cardiomyopathy: This type of cardiomyopathy is characterized by decreased contraction of the left ventricle, leading to reduced cardiac function and potentially life-threatening complications such as heart failure.

It's important to note that some of these types of cardiomyopathy are more common in certain populations, such as hypertrophic cardiomyopathy being more common in young athletes. Additionally, some types of cardiomyopathy may have overlapping symptoms or co-occurring conditions, so it's important to work with a healthcare provider for an accurate diagnosis and appropriate treatment.

Some common types of brain diseases include:

1. Neurodegenerative diseases: These are progressive conditions that damage or kill brain cells over time, leading to memory loss, cognitive decline, and movement disorders. Examples include Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS).
2. Stroke: This occurs when blood flow to the brain is interrupted, leading to cell death and potential long-term disability.
3. Traumatic brain injury (TBI): This refers to any type of head injury that causes damage to the brain, such as concussions, contusions, or penetrating wounds.
4. Infections: Viral, bacterial, and fungal infections can all affect the brain, leading to a range of symptoms including fever, seizures, and meningitis.
5. Tumors: Brain tumors can be benign or malignant and can cause a variety of symptoms depending on their location and size.
6. Cerebrovascular diseases: These conditions affect the blood vessels of the brain, leading to conditions such as aneurysms, arteriovenous malformations (AVMs), and Moyamoya disease.
7. Neurodevelopmental disorders: These are conditions that affect the development of the brain and nervous system, such as autism spectrum disorder, ADHD, and intellectual disability.
8. Sleep disorders: Conditions such as insomnia, narcolepsy, and sleep apnea can all have a significant impact on brain function.
9. Psychiatric disorders: Mental health conditions such as depression, anxiety, and schizophrenia can affect the brain and its functioning.
10. Neurodegenerative with brain iron accumulation: Conditions such as Parkinson's disease, Alzheimer's disease, and Huntington's disease are characterized by the accumulation of abnormal proteins and other substances in the brain, leading to progressive loss of brain function over time.

It is important to note that this is not an exhaustive list and there may be other conditions or factors that can affect the brain and its functioning. Additionally, many of these conditions can have a significant impact on a person's quality of life, and it is important to seek medical attention if symptoms persist or worsen over time.

The condition is often seen in patients with long-standing ESRD, particularly those on hemodialysis. The exact cause of calciphylaxis is not well understood, but it is thought to be related to abnormal mineral metabolism, vascular inflammation, and oxidative stress.

The symptoms of calciphylaxis can vary depending on the severity of the condition, but may include:

* Skin lesions or ulcers
* Painful muscle weakness
* Difficulty moving or contracting muscles
* Numbness or tingling in the affected areas
* Decreased blood flow to organs and tissues

Calciphylaxis can be diagnosed through a combination of physical examination, laboratory tests, and imaging studies such as X-rays or CT scans. Treatment is primarily focused on managing the underlying causes of the condition, such as controlling blood pressure, correcting mineral imbalances, and addressing any infections or inflammation. In severe cases, surgical interventions such as bypass grafting or angioplasty may be necessary.

Overall, calciphylaxis is a rare and debilitating condition that can significantly impact the quality of life of patients with ESRD. Early detection and aggressive management are critical to preventing complications and improving outcomes.

Symptoms of nephrocalcinosis may include nausea, vomiting, abdominal pain, frequent urination, and blood in the urine. Diagnosis is typically made through imaging tests such as X-rays, CT scans, or ultrasound, and blood tests to determine calcium levels and kidney function.

Treatment for nephrocalcinosis depends on the underlying cause of the condition and may include medications to lower calcium levels, dietary changes to reduce calcium intake, and in severe cases, dialysis or kidney transplantation may be necessary. It is important to seek medical attention if symptoms persist or worsen over time, as early detection and treatment can help prevent long-term damage to the kidneys.

Arteriosclerosis can affect any artery in the body, but it is most commonly seen in the arteries of the heart, brain, and legs. It is a common condition that affects millions of people worldwide and is often associated with aging and other factors such as high blood pressure, high cholesterol, diabetes, and smoking.

There are several types of arteriosclerosis, including:

1. Atherosclerosis: This is the most common type of arteriosclerosis and occurs when plaque builds up inside the arteries.
2. Arteriolosclerosis: This type affects the small arteries in the body and can cause decreased blood flow to organs such as the kidneys and brain.
3. Medial sclerosis: This type affects the middle layer of the artery wall and can cause stiffness and narrowing of the arteries.
4. Intimal sclerosis: This type occurs when plaque builds up inside the innermost layer of the artery wall, causing it to become thick and less flexible.

Symptoms of arteriosclerosis can include chest pain, shortness of breath, leg pain or cramping during exercise, and numbness or weakness in the limbs. Treatment for arteriosclerosis may include lifestyle changes such as a healthy diet and regular exercise, as well as medications to lower blood pressure and cholesterol levels. In severe cases, surgery may be necessary to open up or bypass blocked arteries.

The symptoms of chronic renal insufficiency can be subtle and may develop gradually over time. They may include fatigue, weakness, swelling in the legs and ankles, nausea, vomiting, and difficulty concentrating. As the disease progresses, patients may experience shortness of breath, heart failure, and peripheral artery disease.

Chronic renal insufficiency is diagnosed through blood tests that measure the level of waste products in the blood, such as creatinine and urea. Imaging studies, such as ultrasound and CT scans, may also be used to evaluate the kidneys and detect any damage or scarring.

Treatment for chronic renal insufficiency focuses on slowing the progression of the disease and managing its symptoms. This may include medications to control high blood pressure, diabetes, and anemia, as well as dietary changes and fluid restrictions. In severe cases, dialysis or kidney transplantation may be necessary.

Prevention of chronic renal insufficiency involves managing underlying conditions such as diabetes and hypertension, maintaining a healthy diet and exercise routine, and avoiding substances that can damage the kidneys, such as tobacco and excessive alcohol consumption. Early detection and treatment of kidney disease can help prevent the progression to chronic renal insufficiency.

There are several types of phosphorus metabolism disorders, including:

1. Hypophosphatemia: This is a condition characterized by low levels of phosphorus in the blood. It can be caused by a variety of factors, such as malnutrition, kidney disease, or hormonal imbalances. Symptoms of hypophosphatemia can include fatigue, weakness, and bone pain.
2. Hyperphosphatemia: This is a condition characterized by high levels of phosphorus in the blood. It can be caused by conditions such as kidney disease or excessive intake of phosphorus-containing foods. Symptoms of hyperphosphatemia can include nausea, vomiting, and an increased risk of kidney stones.
3. Fanconi syndrome: This is a rare genetic disorder that affects the body's ability to absorb and utilize phosphorus. It is characterized by low levels of phosphorus in the blood, as well as other symptoms such as rickets, bone pain, and an increased risk of fractures.
4. X-linked hypophosphatemic tumor-induced osteomalacia (XLH): This is a rare genetic disorder that affects males and is characterized by low levels of phosphorus in the blood and an increased risk of bone fractures. It is caused by mutations in the TNS1 gene, which codes for a protein involved in phosphorus metabolism.
5. Tumor-induced osteomalacia (TIO): This is a rare disorder that is caused by tumors that produce excessive amounts of a hormone called fibroblast growth factor 23 (FGF23). This hormone interferes with the body's ability to absorb phosphorus, leading to low levels of phosphorus in the blood and an increased risk of bone fractures.
6. Chronic kidney disease: In advanced stages of chronic kidney disease, the kidneys may not be able to effectively remove excess phosphorus from the blood, leading to hyperphosphatemia.
7. Heart disease: High levels of phosphorus in the blood can increase the risk of heart disease, including conditions such as atherosclerosis and heart failure.
8. Kidney damage: Prolonged exposure to high levels of phosphorus in the blood can damage the kidneys and increase the risk of kidney disease.

It is important to note that these are just a few examples of conditions that can cause hyperphosphatemia, and there may be other causes as well. If you suspect that you or someone you know has hyperphosphatemia, it is important to consult with a healthcare professional for proper diagnosis and treatment.

Types of Scleral Diseases:

1. Scleritis: This is an inflammatory condition that affects the sclera, causing redness, pain, and swelling. It can be caused by infection, autoimmune disorders, or other factors.
2. Sclerochoroidal detachment: This is a condition where the sclera pulls away from the choroid, a layer of blood vessels beneath the retina. It can cause vision loss and is often seen in patients with uveitis or other inflammatory conditions.
3. Scleral rupture: This is a rare condition where the sclera tears or ruptures, causing sudden vision loss. It is often caused by trauma or inflammation.
4. Scleroconjunctivitis: This is an inflammatory condition that affects the sclera and conjunctiva, causing redness, discharge, and sensitivity to light.
5. Sclerodermia: This is a rare genetic disorder that affects the skin and eyes, including the sclera. It can cause thinning of the skin and abnormal growth of tissue.

Symptoms of Scleral Diseases:

The symptoms of scleral diseases can vary depending on the specific condition, but may include:

* Redness and inflammation in the eye
* Pain or discomfort in the eye
* Blurred vision or vision loss
* Sensitivity to light
* Discharge or tearing
* Swelling of the eye
* Bulging of the eye
* Abnormal growth of tissue

Diagnosis and Treatment of Scleral Diseases:

Diagnosis of scleral diseases is typically made through a combination of physical examination, imaging tests such as ultrasound or MRI, and laboratory tests to rule out other conditions. Treatment depends on the specific condition and may include:

* Medications such as anti-inflammatory drugs or antibiotics
* Surgery to remove abnormal tissue or correct structural problems
* Laser therapy to improve vision or reduce inflammation
* Injections of medication into the eye
* Oral medications to treat underlying conditions such as autoimmune disorders or infections.

Prognosis:

The prognosis for scleral diseases varies depending on the specific condition and the severity of the symptoms. In general, early diagnosis and treatment can improve the outlook for many of these conditions. However, some scleral diseases may have a poor prognosis if left untreated or if they are not properly managed. It is important to seek medical attention if you experience any symptoms of scleral disease.

Prevention:

While some scleral diseases may be genetic and cannot be prevented, there are steps you can take to reduce your risk of developing certain conditions. For example:

* Avoid exposure to harmful substances such as chemicals or radiation
* Wear protective eyewear when performing activities that could potentially damage the eyes
* Maintain a healthy diet and exercise regularly to reduce your risk of developing underlying conditions such as diabetes or high blood pressure.

It is important to note that some scleral diseases may not have any noticeable symptoms until they are advanced, so it is important to receive regular eye exams to detect any potential issues early on.

In conclusion, scleral diseases can cause a wide range of symptoms and can be challenging to diagnose and treat. However, with proper medical attention and self-care, many people with scleral diseases are able to manage their symptoms and improve their quality of life. It is important to seek medical attention if you experience any symptoms of scleral disease, and to maintain regular eye exams to detect any potential issues early on.

Disease progression can be classified into several types based on the pattern of worsening:

1. Chronic progressive disease: In this type, the disease worsens steadily over time, with a gradual increase in symptoms and decline in function. Examples include rheumatoid arthritis, osteoarthritis, and Parkinson's disease.
2. Acute progressive disease: This type of disease worsens rapidly over a short period, often followed by periods of stability. Examples include sepsis, acute myocardial infarction (heart attack), and stroke.
3. Cyclical disease: In this type, the disease follows a cycle of worsening and improvement, with periodic exacerbations and remissions. Examples include multiple sclerosis, lupus, and rheumatoid arthritis.
4. Recurrent disease: This type is characterized by episodes of worsening followed by periods of recovery. Examples include migraine headaches, asthma, and appendicitis.
5. Catastrophic disease: In this type, the disease progresses rapidly and unpredictably, with a poor prognosis. Examples include cancer, AIDS, and organ failure.

Disease progression can be influenced by various factors, including:

1. Genetics: Some diseases are inherited and may have a predetermined course of progression.
2. Lifestyle: Factors such as smoking, lack of exercise, and poor diet can contribute to disease progression.
3. Environmental factors: Exposure to toxins, allergens, and other environmental stressors can influence disease progression.
4. Medical treatment: The effectiveness of medical treatment can impact disease progression, either by slowing or halting the disease process or by causing unintended side effects.
5. Co-morbidities: The presence of multiple diseases or conditions can interact and affect each other's progression.

Understanding the type and factors influencing disease progression is essential for developing effective treatment plans and improving patient outcomes.

The main difference between primary hyperparathyroidism (HPT) and secondary HPT is the underlying cause of the disorder. In primary HPT, the overactive parathyroid glands are due to a genetic mutation or an autoimmune response, while in secondary HPT, the overactivity is caused by another condition or medication that affects vitamin D levels.

The symptoms of SHPT are similar to those of primary HPT and may include:

* Bone pain or weakness
* Osteoporosis or osteopenia
* Kidney stones or other kidney problems
* High blood pressure
* Headaches
* Fatigue
* Nausea or vomiting
* Increased urination

SHPT can be diagnosed with a combination of physical examination, laboratory tests, and imaging studies such as ultrasound or CT scans. Treatment typically involves addressing the underlying cause of the condition and replacing vitamin D deficiency with supplements. In some cases, surgery may be necessary to remove part or all of the parathyroid glands.

While SHPT is rare, it is important for healthcare providers to be aware of this condition in patients who present with symptoms suggestive of HPT but have normal imaging studies and no family history of the condition. Early diagnosis and treatment can help prevent complications and improve quality of life for affected individuals.

In summary, secondary hyperparathyroidism is a rare endocrine disorder caused by a deficiency in vitamin D that leads to overactive parathyroid glands and an imbalance in calcium levels. It can cause a range of symptoms, including bone pain, osteoporosis, high blood pressure, and kidney problems. Treatment involves addressing the underlying cause of the condition and replacing vitamin D deficiency with supplements. Early diagnosis and treatment can help prevent complications and improve quality of life for affected individuals.

Chondrocalcinosis is a type of calcifying disorder, which is a group of conditions characterized by the deposition of minerals such as calcium and phosphate in soft tissues. This condition can affect various joints in the body, including the hips, knees, shoulders, and elbows.

In this article, we will explore the definition, causes, symptoms, diagnosis, treatment, and prognosis of chondrocalcinosis. We will also discuss the surgical procedures used to treat this condition and the potential complications that can arise.

Definition of Chondrocalcinosis:

Chondrocalcinosis is a medical term that refers to the deposition of calcium pyrophosphate crystals within cartilage. This condition is also known as chondromalacia or calcifying joint disease. It is a type of calcifying disorder, which affects the cartilage in various joints throughout the body.

Causes of Chondrocalcinosis:

The exact cause of chondrocalcinosis is not fully understood, but it is believed to be related to aging, genetics, and certain medical conditions. Some risk factors for developing chondrocalcinosis include:

Age: The risk of developing chondrocalcinosis increases with age, with most cases occurring in people over the age of 50.

Family history: People with a family history of chondrocalcinosis are more likely to develop the condition.

Rheumatoid arthritis or osteoarthritis: These conditions can increase the risk of developing chondrocalcinosis.

Other medical conditions: Certain medical conditions, such as hypothyroidism and hyperparathyroidism, can increase the risk of developing chondrocalcinosis.

Symptoms of Chondrocalcinosis:

The symptoms of chondrocalcinosis can vary depending on the severity of the condition and the joints affected. Common symptoms include:

Pain: Pain is one of the most common symptoms of chondrocalcinosis, particularly in the affected joint.

Stiffness: Joint stiffness and limited range of motion can also occur as a result of chondrocalcinosis.

Swelling: Swelling in the affected joint is another common symptom of chondrocalcinosis.

Redness: The affected joint may become red and warm to the touch due to inflammation.

Crepitus: Crepitus, or a grinding sensation, may be felt in the affected joint as a result of the calcium pyrophosphate crystals rubbing against each other.

Treatment of Chondrocalcinosis:

There is no cure for chondrocalcinosis, but there are several treatment options available to manage the symptoms and slow down the progression of the condition. These may include:

Pain relief medication: Over-the-counter pain relievers such as acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs) can help alleviate pain and reduce inflammation.

Physical therapy: Gentle exercises and stretches can help maintain joint mobility and strength.

Joint injections: Injecting corticosteroids or hyaluronic acid into the affected joint can help reduce inflammation and relieve pain.

Surgery: In severe cases of chondrocalcinosis, surgery may be necessary to remove the calcium pyrophosphate crystals or repair damaged tissue.

Prevention of Chondrocalcinosis:

There is no guaranteed way to prevent chondrocalcinosis, but there are several measures that can help reduce the risk of developing the condition. These may include:

Maintaining a healthy weight: Excessive weight can put additional strain on the joints and increase the risk of developing chondrocalcinosis.

Staying active: Regular exercise can help maintain joint mobility and strength, reducing the risk of developing chondrocalcinosis.

Wearing protective gear: Wearing protective gear such as knee pads or elbow pads when engaging in activities that involve repetitive stress on the joints can help reduce the risk of developing chondrocalcinosis.

Avoiding excessive stress on the joints: Avoiding activities that involve repetitive stress on the joints, such as heavy lifting or bending, can help reduce the risk of developing chondrocalcinosis.

Early diagnosis and treatment of chondrocalcinosis can help manage symptoms and slow down the progression of the condition. If you suspect you may have chondrocalcinosis, it is important to consult with a healthcare professional for proper evaluation and treatment.

The most common carotid artery disease is atherosclerosis, which is the buildup of plaque in the inner lining of the arteries. This buildup can lead to a narrowing or blockage of the arteries, reducing blood flow to the brain and increasing the risk of stroke. Other conditions that can affect the carotid arteries include:

1. Carotid artery stenosis: A narrowing of the carotid arteries caused by atherosclerosis or other factors.
2. Carotid artery dissection: A tear in the inner lining of the arteries that can cause bleeding and blockage.
3. Carotid artery aneurysm: A bulge in the wall of the arteries that can lead to rupture and stroke.
4. Temporal bone fracture: A break in the bones of the skull that can cause damage to the carotid arteries and result in stroke or other complications.

Carotid artery diseases are typically diagnosed using imaging tests such as ultrasound, computed tomography (CT) angiography, or magnetic resonance angiography (MRA). Treatment options for carotid artery diseases depend on the underlying condition and its severity, but may include lifestyle changes, medications, surgery, or endovascular procedures.

Prevention of carotid artery diseases is key to reducing the risk of stroke and other complications. This includes managing risk factors such as high blood pressure, high cholesterol, smoking, and diabetes, as well as maintaining a healthy lifestyle and getting regular check-ups with your doctor.

ROD can lead to a range of symptoms, including:

* Weakened bones and increased risk of fractures
* Tooth decay and gum disease
* Rickets-like symptoms in children
* Osteoporosis
* Difficulty healing from injuries or surgery

The condition is typically diagnosed through a combination of physical examination, laboratory tests (such as blood and urine tests), and imaging studies (such as X-rays or bone density scans).

Treatment for ROD typically involves managing the underlying kidney disease, correcting any nutritional imbalances, and implementing measures to strengthen bones. This may include:

* Medications to lower phosphate levels and increase calcium absorption
* Dietary modifications to reduce phosphate intake and increase calcium intake
* Vitamin D and calcium supplements
* Regular exercise and weight-bearing activities to promote bone strength

In severe cases of ROD, surgical interventions may be necessary, such as bone transplantation or the use of bone-forming medications.

ROD is a serious complication of CKD that can significantly impact quality of life and increase the risk of mortality. Early detection and management are essential to prevent or delay the progression of this condition.

1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.

2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.

3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.

4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.

5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.

6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.

7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.

8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.

9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.

10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.

The primary symptom of hypoparathyroidism is low blood calcium levels, which can lead to tingling or numbness in the fingers and toes, muscle cramps, twitching, and spasms. Other signs may include brittle nails, thinning hair, and poor wound healing. In severe cases, hypoparathyroidism can cause seizures, coma, and even death.

Hypoparathyroidism is usually diagnosed through a combination of physical examination, blood tests, and imaging studies such as ultrasound or CT scans. Treatment typically involves replacing calcium and vitamin D hormones, which can help manage symptoms and prevent complications. In some cases, medications that stimulate the parathyroid glands may be prescribed to increase calcium production. Surgery may be necessary in cases where the condition is caused by a tumor or other structural abnormality.

Prognosis for hypoparathyroidism varies depending on the underlying cause and severity of the condition. With appropriate treatment, many people with hypoparathyroidism can lead normal lives, but some may experience persistent symptoms or complications such as osteoporosis, kidney stones, or cognitive impairment.

The burden of chronic diseases is significant, with over 70% of deaths worldwide attributed to them, according to the World Health Organization (WHO). In addition to the physical and emotional toll they take on individuals and their families, chronic diseases also pose a significant economic burden, accounting for a large proportion of healthcare expenditure.

In this article, we will explore the definition and impact of chronic diseases, as well as strategies for managing and living with them. We will also discuss the importance of early detection and prevention, as well as the role of healthcare providers in addressing the needs of individuals with chronic diseases.

What is a Chronic Disease?

A chronic disease is a condition that lasts for an extended period of time, often affecting daily life and activities. Unlike acute diseases, which have a specific beginning and end, chronic diseases are long-term and persistent. Examples of chronic diseases include:

1. Diabetes
2. Heart disease
3. Arthritis
4. Asthma
5. Cancer
6. Chronic obstructive pulmonary disease (COPD)
7. Chronic kidney disease (CKD)
8. Hypertension
9. Osteoporosis
10. Stroke

Impact of Chronic Diseases

The burden of chronic diseases is significant, with over 70% of deaths worldwide attributed to them, according to the WHO. In addition to the physical and emotional toll they take on individuals and their families, chronic diseases also pose a significant economic burden, accounting for a large proportion of healthcare expenditure.

Chronic diseases can also have a significant impact on an individual's quality of life, limiting their ability to participate in activities they enjoy and affecting their relationships with family and friends. Moreover, the financial burden of chronic diseases can lead to poverty and reduce economic productivity, thus having a broader societal impact.

Addressing Chronic Diseases

Given the significant burden of chronic diseases, it is essential that we address them effectively. This requires a multi-faceted approach that includes:

1. Lifestyle modifications: Encouraging healthy behaviors such as regular physical activity, a balanced diet, and smoking cessation can help prevent and manage chronic diseases.
2. Early detection and diagnosis: Identifying risk factors and detecting diseases early can help prevent or delay their progression.
3. Medication management: Effective medication management is crucial for controlling symptoms and slowing disease progression.
4. Multi-disciplinary care: Collaboration between healthcare providers, patients, and families is essential for managing chronic diseases.
5. Health promotion and disease prevention: Educating individuals about the risks of chronic diseases and promoting healthy behaviors can help prevent their onset.
6. Addressing social determinants of health: Social determinants such as poverty, education, and employment can have a significant impact on health outcomes. Addressing these factors is essential for reducing health disparities and improving overall health.
7. Investing in healthcare infrastructure: Investing in healthcare infrastructure, technology, and research is necessary to improve disease detection, diagnosis, and treatment.
8. Encouraging policy change: Policy changes can help create supportive environments for healthy behaviors and reduce the burden of chronic diseases.
9. Increasing public awareness: Raising public awareness about the risks and consequences of chronic diseases can help individuals make informed decisions about their health.
10. Providing support for caregivers: Chronic diseases can have a significant impact on family members and caregivers, so providing them with support is essential for improving overall health outcomes.

Conclusion

Chronic diseases are a major public health burden that affect millions of people worldwide. Addressing these diseases requires a multi-faceted approach that includes lifestyle changes, addressing social determinants of health, investing in healthcare infrastructure, encouraging policy change, increasing public awareness, and providing support for caregivers. By taking a comprehensive approach to chronic disease prevention and management, we can improve the health and well-being of individuals and communities worldwide.

1. Coronary artery disease: The narrowing or blockage of the coronary arteries, which supply blood to the heart.
2. Heart failure: A condition in which the heart is unable to pump enough blood to meet the body's needs.
3. Arrhythmias: Abnormal heart rhythms that can be too fast, too slow, or irregular.
4. Heart valve disease: Problems with the heart valves that control blood flow through the heart.
5. Heart muscle disease (cardiomyopathy): Disease of the heart muscle that can lead to heart failure.
6. Congenital heart disease: Defects in the heart's structure and function that are present at birth.
7. Peripheral artery disease: The narrowing or blockage of blood vessels that supply oxygen and nutrients to the arms, legs, and other organs.
8. Deep vein thrombosis (DVT): A blood clot that forms in a deep vein, usually in the leg.
9. Pulmonary embolism: A blockage in one of the arteries in the lungs, which can be caused by a blood clot or other debris.
10. Stroke: A condition in which there is a lack of oxygen to the brain due to a blockage or rupture of blood vessels.

1. Hypoparathyroidism: A condition in which the parathyroid glands (which regulate calcium levels in the body) are underactive, leading to low blood calcium levels and an increased risk of osteoporosis.
2. Hyperparathyroidism: A condition in which the parathyroid glands are overactive, leading to high blood calcium levels and an increased risk of bone damage.
3. Hypothyroidism: A condition in which the thyroid gland (which regulates metabolism) is underactive, leading to slowed growth and development, as well as an increased risk of osteoporosis.
4. Hyperthyroidism: A condition in which the thyroid gland is overactive, leading to accelerated bone resorption and an increased risk of osteoporosis.
5. Cushing's syndrome: A condition caused by excessive levels of cortisol (a hormone produced by the adrenal glands), which can lead to osteoporosis, bone pain, and other bone abnormalities.
6. Adrenogenital syndrome: A rare condition caused by excessive levels of androgens (male hormones) in women, leading to virilization (the development of male characteristics) and an increased risk of osteoporosis.
7. Familial hypophosphatemic rickets: A rare genetic disorder that affects the metabolism of phosphate, leading to softening of the bones and other skeletal abnormalities.
8. Tumors: Benign or malignant tumors in the endocrine system can affect the bones and cause bone diseases, such as osteitis fibrosa (a benign tumor of the adrenal gland that can cause bone pain and deformity).
9. Paget's disease of bone: A chronic bone disorder characterized by abnormal bone remodeling, leading to enlarged or deformed bones and an increased risk of fractures.
10. Chronic kidney disease: Prolonged exposure to high levels of parathyroid hormone (PTH) due to chronic kidney disease can lead to an increased risk of bone disease, including osteitis fibrosa and hyperparathyroidism.

These are just some examples of the many conditions that can cause bone diseases. It is important to note that each condition has its unique set of symptoms, diagnostic tests, and treatment options. If you suspect you or someone you know may have a bone disease, it is essential to consult a healthcare professional for proper evaluation and management.

Mitral valve stenosis can be caused by a variety of factors, including:

* Calcification of the mitral valve due to aging or rheumatic fever
* Scarring of the mitral valve due to heart disease or injury
* Birth defects that affect the development of the mitral valve
* Rheumatoid arthritis, which can cause inflammation and scarring of the mitral valve

Symptoms of mitral valve stenosis may include:

* Shortness of breath
* Fatigue
* Swelling in the legs, ankles, and feet
* Chest pain
* Dizziness or lightheadedness
* Palpitations

If you suspect you or someone else may have mitral valve stenosis, it is important to seek medical attention as soon as possible. A healthcare provider can perform a physical examination and order diagnostic tests such as an echocardiogram or electrocardiogram to confirm the diagnosis and determine the severity of the condition. Treatment for mitral valve stenosis may include medications to manage symptoms, lifestyle changes, or surgery to repair or replace the mitral valve. With timely and appropriate treatment, many people with mitral valve stenosis can lead active and fulfilling lives.

Some common types of breast diseases include:

1. Fibrocystic breast disease: A condition characterized by the formation of small lumps or cysts in the breast tissue, often accompanied by breast pain.
2. Fibroadenoma: A benign tumor that is made up of glandular and fibrous tissue, typically found in young women.
3. Ductal carcinoma in situ (DCIS): A type of cancer that originates in the milk ducts and has not spread to other parts of the breast or body.
4. Invasive ductal carcinoma (IDC): The most common type of breast cancer, which starts in the milk ducts but has invaded the surrounding tissue.
5. Invasive lobular carcinoma (ILC): A type of breast cancer that starts in the milk-producing glands (lobules) and has invaded the surrounding tissue.
6. Breast abscess: A collection of pus in the breast tissue, often caused by an infection.
7. Mastitis: An inflammation of the breast tissue, usually caused by a bacterial infection.
8. Breast cancer recurrence: Cancer that has returned after previous treatment.

Early detection and diagnosis of breast diseases are crucial for effective treatment and improved outcomes. Screening tests such as mammography, ultrasound, and biopsy can help identify breast diseases at an early stage, when they are more treatable. Treatment options for breast diseases depend on the type and severity of the condition, and may include surgery, chemotherapy, radiation therapy, or hormone therapy.

Coronary disease is often caused by a combination of genetic and lifestyle factors, such as high blood pressure, high cholesterol levels, smoking, obesity, and a lack of physical activity. It can also be triggered by other medical conditions, such as diabetes and kidney disease.

The symptoms of coronary disease can vary depending on the severity of the condition, but may include:

* Chest pain or discomfort (angina)
* Shortness of breath
* Fatigue
* Swelling of the legs and feet
* Pain in the arms and back

Coronary disease is typically diagnosed through a combination of physical examination, medical history, and diagnostic tests such as electrocardiograms (ECGs), stress tests, and cardiac imaging. Treatment for coronary disease may include lifestyle changes, medications to control symptoms, and surgical procedures such as angioplasty or bypass surgery to improve blood flow to the heart.

Preventative measures for coronary disease include:

* Maintaining a healthy diet and exercise routine
* Quitting smoking and limiting alcohol consumption
* Managing high blood pressure, high cholesterol levels, and other underlying medical conditions
* Reducing stress through relaxation techniques or therapy.

There are two main types of carotid stenosis:

1. Internal carotid artery stenosis: This type of stenosis occurs when the internal carotid artery, which supplies blood to the brain, becomes narrowed or blocked.
2. Common carotid artery stenosis: This type of stenosis occurs when the common carotid artery, which supplies blood to the head and neck, becomes narrowed or blocked.

The symptoms of carotid stenosis can vary depending on the severity of the blockage and the extent of the affected area. Some common symptoms include:

* Dizziness or lightheadedness
* Vertigo (a feeling of spinning)
* Blurred vision or double vision
* Memory loss or confusion
* Slurred speech
* Weakness or numbness in the face, arm, or leg on one side of the body

If left untreated, carotid stenosis can lead to a stroke or other serious complications. Treatment options for carotid stenosis include medications to lower cholesterol and blood pressure, as well as surgical procedures such as endarterectomy (removing plaque from the artery) or stenting (placing a small mesh tube in the artery to keep it open).

In conclusion, carotid stenosis is a serious medical condition that can lead to stroke and other complications if left untreated. It is important to seek medical attention if symptoms persist or worsen over time.

There are several types of diabetic angiopathies, including:

1. Peripheral artery disease (PAD): This occurs when the blood vessels in the legs and arms become narrowed or blocked, leading to reduced blood flow and oxygen supply to the limbs.
2. Peripheral neuropathy: This is damage to the nerves in the hands and feet, which can cause pain, numbness, and weakness.
3. Retinopathy: This is damage to the blood vessels in the retina, which can lead to vision loss and blindness.
4. Nephropathy: This is damage to the kidneys, which can lead to kidney failure and the need for dialysis.
5. Cardiovascular disease: This includes heart attack, stroke, and other conditions that affect the heart and blood vessels.

The risk of developing diabetic angiopathies increases with the duration of diabetes and the level of blood sugar control. Other factors that can increase the risk include high blood pressure, high cholesterol, smoking, and a family history of diabetes-related complications.

Symptoms of diabetic angiopathies can vary depending on the specific type of complication and the location of the affected blood vessels or nerves. Common symptoms include:

* Pain or discomfort in the arms, legs, hands, or feet
* Numbness or tingling sensations in the hands and feet
* Weakness or fatigue in the limbs
* Difficulty healing wounds or cuts
* Vision changes or blindness
* Kidney problems or failure
* Heart attack or stroke

Diagnosis of diabetic angiopathies typically involves a combination of physical examination, medical history, and diagnostic tests such as ultrasound, MRI, or CT scans. Treatment options vary depending on the specific type of complication and may include:

* Medications to control blood sugar levels, high blood pressure, and high cholesterol
* Lifestyle changes such as a healthy diet and regular exercise
* Surgery to repair or bypass affected blood vessels or nerves
* Dialysis for kidney failure
* In some cases, amputation of the affected limb

Preventing diabetic angiopathies involves managing diabetes effectively through a combination of medication, lifestyle changes, and regular medical check-ups. Early detection and treatment can help prevent or delay the progression of complications.

Some common types of sclerosis include:

1. Multiple sclerosis (MS): This is an autoimmune disease that affects the central nervous system (CNS), causing inflammation and damage to the protective covering of nerve fibers, leading to communication problems between the brain and the rest of the body.
2. Systemic sclerosis (SSc): Also known as scleroderma, this is a chronic autoimmune disease that affects the skin and internal organs, causing hardening and tightening of the skin and scar tissue formation in the affected areas.
3. Progressive supranuclear palsy (PSP): This is a rare brain disorder that affects movement, balance, and eye movements, caused by degeneration of certain cells in the brainstem.
4. Primary lateral sclerosis (PLS): This is a rare neurodegenerative disorder that affects the motor neurons in the spinal cord, leading to weakness in the muscles of the legs, feet, and hands.
5. Tuberous sclerosis complex (TSC): This is a rare genetic disorder that causes non-cancerous tumors to grow in organs such as the brain, heart, kidneys, and lungs.

Symptoms of sclerosis vary depending on the type and location of the condition. Common symptoms include muscle weakness or stiffness, difficulty with movement and coordination, numbness or tingling sensations, and changes in sensation or perception. Treatment options for sclerosis depend on the specific type and severity of the condition, and may include medications, physical therapy, and lifestyle modifications.

Tendinopathy can affect any tendon in the body but is most common in the tendons of the shoulders, elbows, wrists, hips, knees, and ankles. Symptoms may include pain, stiffness, swelling, redness, warmth, and limited mobility in the affected area.

Tendinopathy can be caused by a variety of factors such as:

1. Overuse or repetitive strain injuries: Tendons can become inflamed or degenerated due to repetitive movements, especially in sports or occupations that involve repetitive arm or leg movements.
2. Age-related wear and tear: As we age, our tendons can become less flexible and more prone to injury or degeneration.
3. Trauma or acute injuries: Tendon injuries can occur from sudden or severe impacts, such as falls or direct blows to the affected area.
4. Systemic diseases: Certain systemic diseases, such as rheumatoid arthritis or gout, can affect tendons and cause inflammation or degeneration.
5. Poor posture or biomechanics: Poor posture or biomechanics can place excessive stress on tendons, leading to inflammation or degeneration over time.

There are several types of tendinopathy, including:

1. Tendinitis: Inflammation of a tendon, often caused by repetitive strain or acute injury.
2. Tendinosis: Degenerative changes in a tendon, often due to age-related wear and tear or chronic overuse.
3. Tendon rupture: A complete tear of a tendon, which can be caused by acute trauma or degenerative changes.
4. Tennis elbow: A common condition characterized by inflammation of the tendons on the outside of the elbow, often caused by repetitive gripping or twisting motions.
5. Golfer's elbow: A similar condition to tennis elbow, but affecting the tendons on the inside of the elbow.
6. Achilles tendinopathy: Inflammation or degeneration of the Achilles tendon, which connects the calf muscles to the heel bone.
7. Patellar tendinopathy: Inflammation or degeneration of the tendon that connects the patella (kneecap) to the shinbone.

Treatment for tendinopathy depends on the underlying cause and severity of the condition, but may include:

1. Rest and avoidance of aggravating activities.
2. Physical therapy to improve strength, flexibility, and biomechanics.
3. Anti-inflammatory medications or injections.
4. Orthotics or bracing to support the affected area.
5. Surgery in severe cases, such as when there is a complete tear of the tendon.

Calculi are typically classified into three types based on their composition:

1. Calcium oxalate calculi: These are the most common type of calculus and are often found in the kidneys and urinary tract. They are more likely to occur in people with a history of kidney stones or other conditions that affect calcium metabolism.
2. Magnesium ammonium phosphate calculi: These calculi are less common and typically form in the kidneys or bladder. They are often associated with chronic kidney disease or other underlying medical conditions.
3. Uric acid calculi: These calculi are rare and often form in the joints, but can also occur in the urinary tract. They are more common in people with gout or other conditions that affect uric acid metabolism.

Calculi can cause a range of symptoms depending on their size and location, including:

* Pain in the abdomen, flank, or back
* Blood in the urine (hematuria)
* Frequent urination or difficulty urinating
* Cloudy or strong-smelling urine
* Fever or chills
* Nausea and vomiting

If calculi are small and do not cause any symptoms, they may not require treatment. However, if they grow large enough to block the flow of urine or cause pain, treatment may be necessary. Treatment options for calculi include:

1. Medications: Drugs such as alpha-blockers and potassium citrate can help to dissolve calculi and reduce symptoms.
2. Shock wave lithotripsy: This is a non-invasive procedure that uses high-energy shock waves to break up calculi into smaller pieces that can be passed more easily.
3. Endoscopic surgery: A small, flexible tube with a camera and specialized tools can be inserted through the ureter or bladder to remove calculi.
4. Open surgery: In some cases, open surgery may be necessary to remove large or complex calculi.

Prevention is key in avoiding calculi. Here are some tips for preventing calculi:

1. Drink plenty of water: Adequate hydration helps to dilute uric acid and other substances in the urine, reducing the risk of calculi formation.
2. Limit alcohol intake: Alcohol can increase levels of uric acid in the blood, which can contribute to calculi formation.
3. Maintain a healthy diet: Eating a balanced diet that is low in purines and high in fruits and vegetables can help to reduce the risk of calculi.
4. Manage underlying conditions: Conditions such as gout, hyperparathyroidism, and kidney disease can increase the risk of calculi. Managing these conditions with medication and lifestyle changes can help to reduce the risk of calculi.
5. Avoid certain medications: Certain medications, such as some antibiotics and diuretics, can increase the risk of calculi formation.
6. Monitor urine output: If you have a medical condition that affects your urinary tract, such as a blockage or an obstruction, it is important to monitor your urine output to ensure that your kidneys are functioning properly.
7. Avoid prolonged bed rest: Prolonged bed rest can increase the risk of calculi formation by slowing down urine flow and allowing minerals to accumulate in the urinary tract.
8. Stay active: Regular exercise can help to improve circulation and maintain a healthy weight, which can reduce the risk of calculi formation.
9. Avoid smoking: Smoking can increase the risk of calculi formation by reducing blood flow to the kidneys and increasing the amount of oxalate in the urine.
10. Consider medications: In some cases, medications such as allopurinol or potassium citrate may be prescribed to help prevent calculi formation. These medications can help to reduce the levels of uric acid or calcium oxalate in the urine.
It is important to note that not all kidney stones are the same, and the underlying cause may vary depending on the type of stone. For example, if you have a history of gout, you may be more likely to develop uric acid stones. In this case, medications such as allopurinol or probenecid may be prescribed to help reduce the levels of uric acid in your blood and prevent calculi formation.


Some common types of bone diseases include:

1. Osteoporosis: A condition characterized by brittle, porous bones that are prone to fracture.
2. Osteoarthritis: A degenerative joint disease that causes pain and stiffness in the joints.
3. Rheumatoid arthritis: An autoimmune disorder that causes inflammation and pain in the joints.
4. Bone cancer: A malignant tumor that develops in the bones.
5. Paget's disease of bone: A condition characterized by abnormal bone growth and deformity.
6. Osteogenesis imperfecta: A genetic disorder that affects the formation of bone and can cause brittle bones and other skeletal deformities.
7. Fibrous dysplasia: A rare condition characterized by abnormal growth and development of bone tissue.
8. Multiple myeloma: A type of cancer that affects the plasma cells in the bone marrow.
9. Bone cysts: Fluid-filled cavities that can form in the bones and cause pain, weakness, and deformity.
10. Bone spurs: Abnormal growths of bone that can form along the edges of joints and cause pain and stiffness.

Bone diseases can be diagnosed through a variety of tests, including X-rays, CT scans, MRI scans, and bone biopsies. Treatment options vary depending on the specific disease and can include medication, surgery, or a combination of both.

The symptoms of hypercalcemia may include:

* Fatigue
* Nausea and vomiting
* Weakness
* Constipation
* Abdominal pain
* Kidney stones
* Bone pain or fractures

If left untreated, hypercalcemia can lead to complications such as kidney damage, heart problems, and an increased risk of osteoporosis. Treatment options may include medications to reduce calcium levels, surgery to remove a tumor or overactive parathyroid gland, or dialysis if the patient has kidney failure.

Early diagnosis and treatment are important to prevent long-term complications and improve the patient's quality of life.

There are several key features of inflammation:

1. Increased blood flow: Blood vessels in the affected area dilate, allowing more blood to flow into the tissue and bringing with it immune cells, nutrients, and other signaling molecules.
2. Leukocyte migration: White blood cells, such as neutrophils and monocytes, migrate towards the site of inflammation in response to chemical signals.
3. Release of mediators: Inflammatory mediators, such as cytokines and chemokines, are released by immune cells and other cells in the affected tissue. These molecules help to coordinate the immune response and attract more immune cells to the site of inflammation.
4. Activation of immune cells: Immune cells, such as macrophages and T cells, become activated and start to phagocytose (engulf) pathogens or damaged tissue.
5. Increased heat production: Inflammation can cause an increase in metabolic activity in the affected tissue, leading to increased heat production.
6. Redness and swelling: Increased blood flow and leakiness of blood vessels can cause redness and swelling in the affected area.
7. Pain: Inflammation can cause pain through the activation of nociceptors (pain-sensing neurons) and the release of pro-inflammatory mediators.

Inflammation can be acute or chronic. Acute inflammation is a short-term response to injury or infection, which helps to resolve the issue quickly. Chronic inflammation is a long-term response that can cause ongoing damage and diseases such as arthritis, asthma, and cancer.

There are several types of inflammation, including:

1. Acute inflammation: A short-term response to injury or infection.
2. Chronic inflammation: A long-term response that can cause ongoing damage and diseases.
3. Autoimmune inflammation: An inappropriate immune response against the body's own tissues.
4. Allergic inflammation: An immune response to a harmless substance, such as pollen or dust mites.
5. Parasitic inflammation: An immune response to parasites, such as worms or fungi.
6. Bacterial inflammation: An immune response to bacteria.
7. Viral inflammation: An immune response to viruses.
8. Fungal inflammation: An immune response to fungi.

There are several ways to reduce inflammation, including:

1. Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying anti-rheumatic drugs (DMARDs).
2. Lifestyle changes, such as a healthy diet, regular exercise, stress management, and getting enough sleep.
3. Alternative therapies, such as acupuncture, herbal supplements, and mind-body practices.
4. Addressing underlying conditions, such as hormonal imbalances, gut health issues, and chronic infections.
5. Using anti-inflammatory compounds found in certain foods, such as omega-3 fatty acids, turmeric, and ginger.

It's important to note that chronic inflammation can lead to a range of health problems, including:

1. Arthritis
2. Diabetes
3. Heart disease
4. Cancer
5. Alzheimer's disease
6. Parkinson's disease
7. Autoimmune disorders, such as lupus and rheumatoid arthritis.

Therefore, it's important to manage inflammation effectively to prevent these complications and improve overall health and well-being.

PAD can be caused by atherosclerosis, the buildup of plaque in the arteries, which can lead to the formation of blood clots and further reduce blood flow. Risk factors for PAD include smoking, age, family history, and certain medical conditions such as diabetes and high blood pressure.

Diagnosis of PAD typically involves a physical examination, medical history, and imaging tests such as angiography or ultrasound. Treatment options for PAD may include lifestyle changes such as exercise and diet, medications to lower cholesterol and blood pressure, and surgery to repair or bypass blocked arteries.

In severe cases, PAD can lead to critical limb ischemia, which can result in tissue death and the need for amputation. Therefore, early detection and treatment of PAD are important to prevent complications and improve quality of life.

The severity of coronary stenosis can range from mild to severe, with blockages ranging from 15% to over 90%. In mild cases, lifestyle changes and medication may be enough to manage symptoms. However, more severe cases typically require interventional procedures such as angioplasty or bypass surgery to improve blood flow to the heart.

There are several types of osteoporosis, including:

1. Postmenopausal osteoporosis: This type of osteoporosis is caused by hormonal changes that occur during menopause. It is the most common form of osteoporosis and affects women more than men.
2. Senile osteoporosis: This type of osteoporosis is caused by aging and is the most common form of osteoporosis in older adults.
3. Juvenile osteoporosis: This type of osteoporosis affects children and young adults and can be caused by a variety of genetic disorders or other medical conditions.
4. secondary osteoporosis: This type of osteoporosis is caused by other medical conditions, such as rheumatoid arthritis, Crohn's disease, or ulcerative colitis.

The symptoms of osteoporosis can be subtle and may not appear until a fracture has occurred. They can include:

1. Back pain or loss of height
2. A stooped posture
3. Fractures, especially in the spine, hips, or wrists
4. Loss of bone density, as determined by a bone density test

The diagnosis of osteoporosis is typically made through a combination of physical examination, medical history, and imaging tests, such as X-rays or bone density tests. Treatment for osteoporosis can include medications, such as bisphosphonates, hormone therapy, or rANK ligand inhibitors, as well as lifestyle changes, such as regular exercise and a balanced diet.

Preventing osteoporosis is important, as it can help to reduce the risk of fractures and other complications. To prevent osteoporosis, individuals can:

1. Get enough calcium and vitamin D throughout their lives
2. Exercise regularly, especially weight-bearing activities such as walking or running
3. Avoid smoking and excessive alcohol consumption
4. Maintain a healthy body weight
5. Consider taking medications to prevent osteoporosis, such as bisphosphonates, if recommended by a healthcare provider.

Rickets is caused by a deficiency of vitamin D, usually due to inadequate sunlight exposure, breastfeeding, or a diet that is low in calcium and vitamin D. It can also be caused by certain medical conditions, such as kidney disease, or by taking certain medications that interfere with vitamin D production.

Symptoms of rickets may include:

* Bowed legs or other deformities of the bones
* Pain in the bones and joints
* Softening of the bones (osteomalacia)
* Difficulty walking or standing
* delayed tooth development
* Frequent infections

If rickets is suspected, a doctor may perform a physical examination, take a medical history, and order diagnostic tests such as X-rays or blood tests to confirm the diagnosis. Treatment typically involves correcting any underlying nutritional deficiencies and managing any related health issues. In severe cases, surgery may be necessary to repair damaged bones.

Prevention is key in avoiding rickets, so it's important for parents to ensure their children are getting enough vitamin D and calcium through a balanced diet and adequate sunlight exposure. In regions with limited sunlight, fortified foods such as milk and cereal can be helpful. Breastfeeding mothers may need to supplement their diets with vitamin D to ensure their babies are getting enough.

Symptoms of Sturge-Weber Syndrome can vary in severity and may include:

* Port-wine stain (nevus flammeus) on one side of the face and/or neck
* Seizures, including epilepsy
* Developmental delays and intellectual disability
* Vision problems, including glaucoma, cataracts, and visual field defects
* Hearing loss
* Scoliosis or other spinal abnormalities
* Weakened muscles (hypotonia)

There is no cure for Sturge-Weber Syndrome, but various treatments can help manage the symptoms. These may include:

* Anticonvulsant medications to control seizures
* Surgery to remove the port-wine stain or repair related eye problems
* Physical therapy to improve muscle strength and coordination
* Speech and language therapy to address communication difficulties
* Occupational therapy to help with daily living skills

The prognosis for Sturge-Weber Syndrome varies depending on the severity of the disorder and the presence of other health problems. Some individuals with the condition may have a relatively mild course, while others may experience more significant challenges. With appropriate medical care and support, many individuals with Sturge-Weber Syndrome can lead fulfilling lives.

Necrosis is a type of cell death that occurs when cells are exposed to excessive stress, injury, or inflammation, leading to damage to the cell membrane and the release of cellular contents into the surrounding tissue. This can lead to the formation of gangrene, which is the death of body tissue due to lack of blood supply.

There are several types of necrosis, including:

1. Coagulative necrosis: This type of necrosis occurs when there is a lack of blood supply to the tissues, leading to the formation of a firm, white plaque on the surface of the affected area.
2. Liquefactive necrosis: This type of necrosis occurs when there is an infection or inflammation that causes the death of cells and the formation of pus.
3. Caseous necrosis: This type of necrosis occurs when there is a chronic infection, such as tuberculosis, and the affected tissue becomes soft and cheese-like.
4. Fat necrosis: This type of necrosis occurs when there is trauma to fatty tissue, leading to the formation of firm, yellowish nodules.
5. Necrotizing fasciitis: This is a severe and life-threatening form of necrosis that affects the skin and underlying tissues, often as a result of bacterial infection.

The diagnosis of necrosis is typically made through a combination of physical examination, imaging studies such as X-rays or CT scans, and laboratory tests such as biopsy. Treatment depends on the underlying cause of the necrosis and may include antibiotics, surgical debridement, or amputation in severe cases.

Causes of Hypophosphatemia
-----------------------

There are several possible causes of hypophosphatemia, including:

1. Malnutrition or a poor diet that is deficient in phosphorus.
2. Gastrointestinal disorders such as celiac disease, inflammatory bowel disease, or gastrointestinal surgery.
3. Kidney problems such as chronic kidney disease, renal tubular acidosis, or distal renal tubular phosphate loss.
4. Hormonal imbalances such as hypoparathyroidism (underactive parathyroid glands) or hyperparathyroidism (overactive parathyroid glands).
5. Medications such as diuretics, antacids, and certain antibiotics.
6. Chronic alcoholism.
7. Genetic disorders such as X-linked hypophosphatemic rickets or familial hypophosphatemic rickets.

Symptoms of Hypophosphatemia
-------------------------

The symptoms of hypophosphatemia can vary depending on the severity and duration of the condition, but may include:

1. Weakness, fatigue, or muscle cramps.
2. Bone pain or joint stiffness.
3. Difficulty healing from injuries or infections.
4. Numbness or tingling sensations in the extremities.
5. Seizures or other neurological symptoms.
6. Respiratory problems such as shortness of breath or difficulty breathing.
7. Heart arrhythmias or cardiac failure.

Diagnosis and Treatment of Hypophosphatemia
---------------------------------------

Hypophosphatemia can be diagnosed through blood tests that measure the levels of phosphate in the blood. Treatment for hypophosphatemia typically involves correcting any underlying causes, such as stopping medications that may be causing the condition or treating underlying medical conditions.

In some cases, treatment may involve supplements to increase phosphate levels in the blood. Vitamin D and calcium supplements may also be prescribed to help maintain bone health. In severe cases of hypophosphatemia, hospitalization may be necessary to manage symptoms and prevent complications.

Prognosis and Complications of Hypophosphatemia
-----------------------------------------------

The prognosis for hypophosphatemia is generally good if the underlying cause is identified and treated promptly. However, untreated hypophosphatemia can lead to a number of complications, including:

1. Osteomalacia or osteoporosis.
2. Rickets in children.
3. Weakened immune system.
4. Increased risk of infections.
5. Nerve damage or neuropathy.
6. Cardiovascular problems such as heart arrhythmias or cardiac failure.
7. Respiratory failure.
8. Kidney damage or kidney failure.

It is important to seek medical attention if symptoms persist or worsen over time, as hypophosphatemia can lead to serious complications if left untreated.

Conclusion
----------

Hypophosphatemia is a condition characterized by low levels of phosphate in the blood. It can be caused by a variety of factors and may present with symptoms such as weakness, bone pain, and respiratory problems. Treatment typically involves correcting any underlying causes and supplements to increase phosphate levels in the blood.

Early detection and treatment are important to prevent complications of hypophosphatemia, which can include osteomalacia or osteoporosis, nerve damage, cardiovascular problems, respiratory failure, and kidney damage. If you suspect you may have hypophosphatemia, it is important to seek medical attention as soon as possible to receive proper diagnosis and treatment.

There are several types of kidney calculi, including:

1. Calcium oxalate calculi: These are the most common type of calculus and are often associated with conditions such as hyperparathyroidism or excessive intake of calcium supplements.
2. Uric acid calculi: These are more common in people with gout or a diet high in meat and sugar.
3. Cystine calculi: These are rare and usually associated with a genetic disorder called cystinuria.
4. Struvite calculi: These are often seen in women with urinary tract infections (UTIs).

Symptoms of kidney calculi may include:

1. Flank pain (pain in the side or back)
2. Pain while urinating
3. Blood in the urine
4. Cloudy or strong-smelling urine
5. Fever and chills
6. Nausea and vomiting

Kidney calculi are diagnosed through a combination of physical examination, medical history, and diagnostic tests such as X-rays, CT scans, or ultrasound. Treatment options for kidney calculi depend on the size and location of the calculus, as well as the severity of any underlying conditions. Small calculi may be treated with conservative measures such as fluid intake and medication to help flush out the crystals, while larger calculi may require surgical intervention to remove them.

Preventive measures for kidney calculi include staying hydrated to help flush out excess minerals in the urine, maintaining a balanced diet low in oxalate and animal protein, and avoiding certain medications that can increase the risk of calculus formation. Early detection and treatment of underlying conditions such as hyperparathyroidism or gout can also help prevent the development of kidney calculi.

Overall, kidney calculi are a common condition that can be managed with proper diagnosis and treatment. However, they can cause significant discomfort and potentially lead to complications if left untreated, so it is important to seek medical attention if symptoms persist or worsen over time.

Symptoms of lithiasis may include pain in the affected area, nausea and vomiting, fever, and changes in urination patterns. Treatment for lithiasis depends on the location and size of the stone, and may involve medications to help break down the stone or surgery to remove it.

Prevention strategies for lithiasis include staying hydrated to maintain adequate fluid intake, limiting dietary oxalate intake in cases of calcium oxalate stones, and avoiding foods high in animal protein and salt in cases of uric acid stones. In some cases, medications such as allopurinol or potassium citrate may be prescribed to help prevent stone formation.

In summary, lithiasis is the formation of stones or calculi within the body, typically in the urinary tract or biliary system, and can be caused by a variety of factors. Treatment and prevention strategies vary depending on the location and type of stone, but may include medications to break down the stone or surgery to remove it.

The term "asymptomatic" means "not showing symptoms."

In medical terminology, the word asymptomatic is used to describe a person who has a disease or condition but does not show any symptoms. Symptoms are changes in the body or mind that indicate the presence of a disease or condition. For example, fever, pain, and fatigue are all symptoms of an infection.

Asymptomatic diseases can be difficult to diagnose because they do not cause any noticeable symptoms. In many cases, these diseases are only discovered through routine medical testing or exams. For example, a person may have high blood pressure without knowing it, as there are usually no noticeable symptoms until the condition is advanced.

The importance of screening tests and early diagnosis

Screening tests are medical tests that are performed on people who do not have any symptoms of a disease or condition. These tests are designed to detect diseases or conditions before they cause any noticeable symptoms. Examples of screening tests include blood pressure checks, cholesterol tests, mammograms, and colonoscopies.

Early diagnosis is critical for successfully treating many asymptomatic diseases. When a disease or condition is detected early, it can be treated more effectively before it causes any significant damage. In some cases, early diagnosis may even prevent the development of complications.

The importance of screening tests and early diagnosis cannot be overstated. By detecting diseases or conditions before they cause symptoms, individuals can receive treatment before any long-term damage occurs. This can help to improve their quality of life, increase their lifespan, and reduce the risk of complications.

The importance of screening tests and early diagnosis is particularly important for certain populations, such as older adults or those with a family history of certain diseases or conditions. These individuals may be at a higher risk for developing certain asymptomatic diseases, and screening tests can help to detect these conditions before they cause any noticeable symptoms.

The benefits of early diagnosis include:

1. Improved treatment outcomes: When a disease or condition is detected early, it can be treated more effectively before it causes any significant damage. This can improve the chances of successful treatment and reduce the risk of complications.
2. Prevention of long-term damage: By detecting diseases or conditions before they cause any noticeable symptoms, individuals can receive treatment before any long-term damage occurs. This can help to preserve their quality of life and increase their lifespan.
3. Reduced healthcare costs: Early diagnosis can reduce healthcare costs by preventing the need for more expensive treatments or hospitalizations that may be required if a condition is allowed to progress untreated.
4. Increased awareness: Screening tests and early diagnosis can increase awareness of certain diseases or conditions, which can lead to increased education and advocacy efforts aimed at prevention and treatment.
5. Improved patient outcomes: Early diagnosis can lead to improved patient outcomes by allowing for earlier intervention and treatment, which can improve the chances of successful treatment and reduce the risk of complications.
6. Reduced suffering: By detecting diseases or conditions before they cause any noticeable symptoms, individuals can receive treatment before they experience any unnecessary suffering.
7. Increased survival rates: Early diagnosis can lead to increased survival rates for certain diseases or conditions, particularly those that are more treatable when detected early.
8. Better management of chronic conditions: Screening tests and early diagnosis can help individuals with chronic conditions to manage their condition more effectively, which can improve their quality of life and increase their lifespan.
9. Improved patient satisfaction: Early diagnosis can lead to improved patient satisfaction by providing individuals with a sense of control over their health and well-being.
10. Reduced anxiety: By detecting diseases or conditions before they cause any noticeable symptoms, individuals may experience reduced anxiety about their health and well-being.

Overall, early diagnosis has the potential to significantly improve patient outcomes and quality of life for individuals with a wide range of medical conditions. It is important for healthcare providers to prioritize early diagnosis and screening tests in order to provide the best possible care for their patients.

The term "diffuse" refers to the widespread distribution of the neurofibrillary tangles throughout the brain, rather than a localized area. The presence of calcification indicates that the condition has been present for some time, as calcium salts deposit over time in response to inflammation or injury.

The exact cause of DNFT-C is not known, but it is thought to be related to aging and the accumulation of proteins in the brain over time. The condition is often seen in older adults, particularly those with a history of head trauma, stroke, or other forms of brain injury.

The diagnosis of DNFT-C is based on a combination of clinical features, such as cognitive decline and changes in behavior, and imaging studies, such as magnetic resonance imaging (MRI) or computed tomography (CT) scans, which can show the presence of calcification and other abnormalities in the brain.

There is no cure for DNFT-C, but various treatments may be recommended to manage its symptoms, such as cognitive training, psychotherapy, and medications to control agitation or aggression. The prognosis for the condition is generally poor, with a gradual decline in cognitive function over time.

Examples of syndromes include:

1. Down syndrome: A genetic disorder caused by an extra copy of chromosome 21 that affects intellectual and physical development.
2. Turner syndrome: A genetic disorder caused by a missing or partially deleted X chromosome that affects physical growth and development in females.
3. Marfan syndrome: A genetic disorder affecting the body's connective tissue, causing tall stature, long limbs, and cardiovascular problems.
4. Alzheimer's disease: A neurodegenerative disorder characterized by memory loss, confusion, and changes in personality and behavior.
5. Parkinson's disease: A neurological disorder characterized by tremors, rigidity, and difficulty with movement.
6. Klinefelter syndrome: A genetic disorder caused by an extra X chromosome in males, leading to infertility and other physical characteristics.
7. Williams syndrome: A rare genetic disorder caused by a deletion of genetic material on chromosome 7, characterized by cardiovascular problems, developmental delays, and a distinctive facial appearance.
8. Fragile X syndrome: The most common form of inherited intellectual disability, caused by an expansion of a specific gene on the X chromosome.
9. Prader-Willi syndrome: A genetic disorder caused by a defect in the hypothalamus, leading to problems with appetite regulation and obesity.
10. Sjogren's syndrome: An autoimmune disorder that affects the glands that produce tears and saliva, causing dry eyes and mouth.

Syndromes can be diagnosed through a combination of physical examination, medical history, laboratory tests, and imaging studies. Treatment for a syndrome depends on the underlying cause and the specific symptoms and signs presented by the patient.

There are two main types of hyperparathyroidism: primary and secondary. Primary hyperparathyroidism is caused by a benign tumor in one of the parathyroid glands, while secondary hyperparathyroidism is caused by another condition that leads to overproduction of PTH, such as kidney disease or vitamin D deficiency.

Symptoms of hyperparathyroidism can include:

* High blood calcium levels
* Bone loss or osteoporosis
* Kidney stones
* Pancreatitis (inflammation of the pancreas)
* Hyperthyroidism (an overactive thyroid gland)
* Fatigue
* Weakness
* Nausea and vomiting
* Abdominal pain
* Headaches

Treatment for hyperparathyroidism usually involves surgery to remove the affected parathyroid gland or glands. In some cases, medications may be used to manage symptoms before surgery. It is important for individuals with hyperparathyroidism to receive prompt medical attention, as untreated hyperparathyroidism can lead to serious complications such as heart disease and kidney failure.

Some common types of peritoneal diseases include:

1. Peritonitis: This is an inflammation of the peritoneum, often caused by bacterial or viral infections.
2. Ascites: This is the accumulation of fluid in the abdominal cavity, which can be caused by a variety of factors, including liver disease, kidney failure, and cancer.
3. Peritoneal mesothelioma: This is a type of cancer that affects the peritoneum, often causing abdominal pain, bowel obstruction, and weight loss.
4. Omental torsion: This is a rare condition in which the omentum (a fold of peritoneum that covers the intestines) becomes twisted, cutting off blood supply to the intestines.
5. Peritoneal coccidiosis: This is an infection caused by the parasite Isospora belli, which can cause diarrhea, weight loss, and other gastrointestinal symptoms.

Peritoneal diseases can be diagnosed through a variety of tests, including abdominal imaging, blood tests, and biopsies. Treatment options vary depending on the specific type of disease and its severity, but may include antibiotics, surgery, or chemotherapy.

Symptoms of PVD may include:

* Cramping pain in the legs during exercise or at rest
* Weakness or numbness in the legs
* Coldness in the lower limbs
* Difficulty healing wounds on the feet or legs
* Poor circulation
* Varicose veins

Treatment for PVD depends on the underlying cause and severity of the condition. Some common treatments include:

* Medications to relieve pain, reduce inflammation, or lower cholesterol levels
* Lifestyle changes such as exercise, smoking cessation, and a healthy diet
* Surgical procedures such as angioplasty or bypass surgery to improve blood flow
* Compression stockings to improve circulation

Prevention of PVD includes:

* Maintaining a healthy lifestyle, including regular exercise, a balanced diet, and not smoking
* Managing underlying conditions such as high blood pressure, high cholesterol, or diabetes
* Regular check-ups with your healthcare provider to monitor your risk factors and detect any early signs of PVD.

Constrictive pericarditis is often caused by inflammation or infection of the pericardial sac, and can also be a complication of other conditions such as heart surgery, trauma, or cancer. Treatment typically involves management of symptoms and addressing any underlying causes, and may include medications, surgery, or cardiac catheterization.

Surgical treatment for constrictive pericarditis may involve removal of the inflamed pericardial sac or repair of any tears or holes in the sac. Cardiac catheterization may be used to drain excess fluid from the pericardial space and relieve pressure on the heart. In severe cases, a procedure called pericardiocentesis may be performed to remove the pericardial fluid and relieve pressure on the heart.

Prognosis for constrictive pericarditis is generally good if treated promptly and effectively, but can be poor if left untreated or if there are underlying conditions that are not addressed.

Some common types of lung diseases include:

1. Asthma: A chronic condition characterized by inflammation and narrowing of the airways, leading to wheezing, coughing, and shortness of breath.
2. Chronic Obstructive Pulmonary Disease (COPD): A progressive condition that causes chronic inflammation and damage to the airways and lungs, making it difficult to breathe.
3. Pneumonia: An infection of the lungs that can be caused by bacteria, viruses, or fungi, leading to fever, chills, coughing, and difficulty breathing.
4. Bronchiectasis: A condition where the airways are damaged and widened, leading to chronic infections and inflammation.
5. Pulmonary Fibrosis: A condition where the lungs become scarred and stiff, making it difficult to breathe.
6. Lung Cancer: A malignant tumor that develops in the lungs, often caused by smoking or exposure to carcinogens.
7. Cystic Fibrosis: A genetic disorder that affects the respiratory and digestive systems, leading to chronic infections and inflammation in the lungs.
8. Tuberculosis (TB): An infectious disease caused by Mycobacterium Tuberculosis, which primarily affects the lungs but can also affect other parts of the body.
9. Pulmonary Embolism: A blockage in one of the arteries in the lungs, often caused by a blood clot that has traveled from another part of the body.
10. Sarcoidosis: An inflammatory disease that affects various organs in the body, including the lungs, leading to the formation of granulomas and scarring.

These are just a few examples of conditions that can affect the lungs and respiratory system. It's important to note that many of these conditions can be treated with medication, therapy, or surgery, but early detection is key to successful treatment outcomes.

Central nervous system cysts are typically diagnosed through imaging tests such as CT or MRI scans. Treatment options for central nervous system cysts vary depending on the size, location, and symptoms of the cyst, but may include observation, surgery, or endoscopic procedures to drain or remove the cyst.

Some common types of central nervous system cysts include:

1. Arachnoid cysts: These are flattened sacs that form between the layers of tissue that cover the brain and spinal cord (meninges).
2. Ventricular cysts: These are cysts that form within the ventricles, which are fluid-filled spaces within the brain.
3. Cerebral cysts: These are cysts that form within the tissue of the brain.
4. Spinal cysts: These are cysts that form within the spinal cord or along the spine.
5. Neurocysticercosis: This is a parasitic infection caused by the larvae of the pork tapeworm, which can form cysts within the brain and spinal cord.

While central nervous system cysts are generally not cancerous, they can still cause significant health problems if left untreated. It is important to seek medical attention if symptoms persist or worsen over time, as early diagnosis and treatment can help prevent complications and improve outcomes.

Fibrosis can occur in response to a variety of stimuli, including inflammation, infection, injury, or chronic stress. It is a natural healing process that helps to restore tissue function and structure after damage or trauma. However, excessive fibrosis can lead to the loss of tissue function and organ dysfunction.

There are many different types of fibrosis, including:

* Cardiac fibrosis: the accumulation of scar tissue in the heart muscle or walls, leading to decreased heart function and potentially life-threatening complications.
* Pulmonary fibrosis: the accumulation of scar tissue in the lungs, leading to decreased lung function and difficulty breathing.
* Hepatic fibrosis: the accumulation of scar tissue in the liver, leading to decreased liver function and potentially life-threatening complications.
* Neurofibromatosis: a genetic disorder characterized by the growth of benign tumors (neurofibromas) made up of fibrous connective tissue.
* Desmoid tumors: rare, slow-growing tumors that are made up of fibrous connective tissue and can occur in various parts of the body.

Fibrosis can be diagnosed through a variety of methods, including:

* Biopsy: the removal of a small sample of tissue for examination under a microscope.
* Imaging tests: such as X-rays, CT scans, or MRI scans to visualize the accumulation of scar tissue.
* Blood tests: to assess liver function or detect specific proteins or enzymes that are elevated in response to fibrosis.

There is currently no cure for fibrosis, but various treatments can help manage the symptoms and slow the progression of the condition. These may include:

* Medications: such as corticosteroids, immunosuppressants, or chemotherapy to reduce inflammation and slow down the growth of scar tissue.
* Lifestyle modifications: such as quitting smoking, exercising regularly, and maintaining a healthy diet to improve overall health and reduce the progression of fibrosis.
* Surgery: in some cases, surgical removal of the affected tissue or organ may be necessary.

It is important to note that fibrosis can progress over time, leading to further scarring and potentially life-threatening complications. Regular monitoring and follow-up with a healthcare professional are crucial to managing the condition and detecting any changes or progression early on.

There are several types of hypercholesterolemia, including:

1. Familial hypercholesterolemia: This is an inherited condition that causes high levels of low-density lipoprotein (LDL) cholesterol, also known as "bad" cholesterol, in the blood.
2. Non-familial hypercholesterolemia: This type of hypercholesterolemia is not inherited and can be caused by a variety of factors, such as a high-fat diet, lack of exercise, obesity, and certain medical conditions, such as hypothyroidism or polycystic ovary syndrome (PCOS).
3. Mixed hypercholesterolemia: This type of hypercholesterolemia is characterized by high levels of both LDL and high-density lipoprotein (HDL) cholesterol in the blood.

The diagnosis of hypercholesterolemia is typically made based on a physical examination, medical history, and laboratory tests, such as a lipid profile, which measures the levels of different types of cholesterol and triglycerides in the blood. Treatment for hypercholesterolemia usually involves lifestyle changes, such as a healthy diet and regular exercise, and may also include medication, such as statins, to lower cholesterol levels.

There are several types of adipocytic neoplasms, including:

1. Lipomas: These are benign, slow-growing tumors that are composed of mature fat cells (adipocytes). They are usually soft to the touch and can be moved easily under the skin.
2. Liposarcomas: These are malignant tumors that also originate in adipose tissue. They can be slow-growing or aggressive and can infiltrate surrounding tissues.
3. Pigmented villonodular synovitis (PVN): This is a type of benign tumor that occurs in the synovial membrane, which lines the joints and tendons. It is composed of adipocytes and other cell types and can cause pain and stiffness in the affected joint.
4. Giant cell lipomatosis: This is a rare condition characterized by multiple small lipomas that are clustered together.
5. Spindle cell lipoma: This is a rare type of lipoma that contains spindle-shaped cells, which are elongated and irregular in shape.

These adipocytic neoplasms can be diagnosed through various imaging techniques such as ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), and fine needle aspiration biopsy. Treatment options vary depending on the type and location of the tumor, but may include surgical excision, radiation therapy, or chemotherapy.

The exact cause of OFC is not well understood, but it is thought to be related to genetic mutations and environmental factors such as trauma or infection. The disorder typically affects the long bones of the arms and legs, as well as the spine and skull.

Symptoms of OFC can vary depending on the location and size of the cysts, but may include:

* Bone pain
* Weakness or fatigue
* Limited mobility
* Fractures or deformities
* Swelling or redness around the affected area

Diagnosis of OFC is typically made through a combination of imaging studies such as X-rays, CT scans, or MRI scans, and biopsy. Treatment options for OFC include:

* Observation: Small cysts that are not causing any symptoms may not require treatment.
* Surgery: Large cysts can be removed through surgical procedures such as cyst fenestration or cyst excision.
* Medications: Pain medications, anti-inflammatory drugs, and bisphosphonates may be used to manage symptoms and prevent further bone damage.

Prognosis for OFC varies depending on the severity of the disorder and the response to treatment. In general, early diagnosis and appropriate treatment can improve outcomes and reduce the risk of complications.

There are several factors that can contribute to bone resorption, including:

1. Hormonal changes: Hormones such as parathyroid hormone (PTH) and calcitonin can regulate bone resorption. Imbalances in these hormones can lead to excessive bone resorption.
2. Aging: As we age, our bones undergo remodeling more frequently, leading to increased bone resorption.
3. Nutrient deficiencies: Deficiencies in calcium, vitamin D, and other nutrients can impair bone health and lead to excessive bone resorption.
4. Inflammation: Chronic inflammation can increase bone resorption, leading to bone loss and weakening.
5. Genetics: Some genetic disorders can affect bone metabolism and lead to abnormal bone resorption.
6. Medications: Certain medications, such as glucocorticoids and anticonvulsants, can increase bone resorption.
7. Diseases: Conditions such as osteoporosis, Paget's disease of bone, and bone cancer can lead to abnormal bone resorption.

Bone resorption can be diagnosed through a range of tests, including:

1. Bone mineral density (BMD) testing: This test measures the density of bone in specific areas of the body. Low BMD can indicate bone loss and excessive bone resorption.
2. X-rays and imaging studies: These tests can help identify abnormal bone growth or other signs of bone resorption.
3. Blood tests: Blood tests can measure levels of certain hormones and nutrients that are involved in bone metabolism.
4. Bone biopsy: A bone biopsy can provide a direct view of the bone tissue and help diagnose conditions such as Paget's disease or bone cancer.

Treatment for bone resorption depends on the underlying cause and may include:

1. Medications: Bisphosphonates, hormone therapy, and other medications can help slow or stop bone resorption.
2. Diet and exercise: A healthy diet rich in calcium and vitamin D, along with regular exercise, can help maintain strong bones.
3. Physical therapy: In some cases, physical therapy may be recommended to improve bone strength and mobility.
4. Surgery: In severe cases of bone resorption, surgery may be necessary to repair or replace damaged bone tissue.

The word "osteopetrosis" comes from the Greek words "osteon," meaning bone, and "petros," meaning rock or stone. This name reflects the dense and hard nature of the bones affected by the disorder.

Osteopetrosis can be caused by mutations in several genes that are involved in bone development and growth. The condition is usually inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. However, some cases may be caused by spontaneous mutations or other factors.

Symptoms of osteopetrosis can vary depending on the severity of the disorder and the specific affected bones. Common symptoms include bone pain, limited mobility, and an increased risk of fractures. Other symptoms may include fatigue, fever, and difficulty swallowing or breathing.

Treatment for osteopetrosis usually involves a combination of medications and surgery. Medications such as bisphosphonates and denintuzumab mafodotin can help reduce bone pain and the risk of fractures, while surgery may be necessary to correct deformities or repair broken bones. In some cases, bone marrow transplantation may be recommended to replace damaged bone marrow with healthy cells.

Overall, osteopetrosis is a rare and debilitating disorder that can have a significant impact on quality of life. Early diagnosis and appropriate treatment are important for managing symptoms and preventing complications.

Some common causes of hypocalcemia include:

1. Vitamin D deficiency: Vitamin D is essential for the absorption of calcium from the diet. A lack of vitamin D can lead to low levels of calcium in the blood.
2. Parathyroid gland disorders: The parathyroid glands are located in the neck and regulate calcium levels in the blood. Disorders such as hypoparathyroidism (underactive parathyroid glands) or hyperparathyroidism (overactive parathyroid glands) can cause hypocalcemia.
3. Malabsorption: Certain conditions, such as celiac disease or Crohn's disease, can lead to malabsorption of nutrients, including calcium.
4. Kidney problems: Kidney failure can cause hypocalcemia by reducing the amount of calcium that is excreted in the urine.
5. Hypomagnesemia (low levels of magnesium): Magnesium is important for calcium metabolism, and low levels of magnesium can contribute to hypocalcemia.

Symptoms of hypocalcemia can include:

1. Muscle cramps
2. Weakness
3. Twitching or tremors
4. Seizures
5. Tingling or numbness in the fingers and toes
6. Difficulty swallowing
7. Palpitations
8. Headaches
9. Fatigue
10. Depression

Treatment for hypocalcemia usually involves addressing the underlying cause of the condition. For example, if the condition is caused by a vitamin D deficiency, supplements may be prescribed. If the condition is caused by a parathyroid gland disorder, surgery may be necessary to remove the affected gland or glands. In some cases, calcium supplements may be prescribed to help restore normal calcium levels.

It's important to note that hypocalcemia can be a sign of an underlying condition, and it should be treated promptly to prevent complications. If you suspect you or someone you know may have hypocalcemia, it is important to seek medical attention as soon as possible. A healthcare professional can diagnose the condition and recommend appropriate treatment.

The symptoms of cervicofacial actinomycosis can vary depending on the location and severity of the infection. Common symptoms may include:

1. Swelling or lumps in the face or neck
2. Pain or tenderness in the affected area
3. Redness or discoloration of the skin
4. Discharge of pus or fluid from the affected area
5. Fever and chills
6. Loss of movement or stiffness in the affected area
7. Numbness or tingling sensations in the face or neck

The cause of cervicofacial actinomycosis is usually a bacterial infection with Actinomyces species, which can enter the body through minor cuts or scrapes on the skin. Risk factors for developing cervicofacial actinomycosis include:

1. Poor dental hygiene
2. Chronic sinus infections
3. Head and neck injuries
4. Immunosuppression due to conditions such as HIV/AIDS or cancer
5. Previous radiation therapy to the head and neck

The diagnosis of cervicofacial actinomycosis is based on a combination of clinical findings, imaging studies, and laboratory tests. Treatment usually involves antibiotics and surgical drainage of any abscesses or infected tissue. In severe cases, hospitalization may be necessary to monitor and treat the infection.

Prevention measures for cervicofacial actinomycosis include:

1. Good dental hygiene practices such as brushing and flossing regularly
2. Avoiding close contact with people who have active infections
3. Practicing safe sex to prevent the spread of sexually transmitted infections
4. Avoiding sharing personal items such as toothbrushes or razors
5. Keeping wounds clean and dry, and seeking medical attention if they do not heal properly.

The condition is caused by mutations in the GNAS gene, which encodes the alpha subunit of the PTH hormone. These mutations lead to a reduction in the amount of functional PTH produced by the parathyroid glands, resulting in hypocalcemia and other symptoms.

Symptoms of pseudohypoparathyroidism can vary in severity and may include:

1. Hypocalcemia (low blood calcium levels)
2. Tetany (muscle spasms)
3. Seizures
4. Developmental delays
5. Short stature
6. Intellectual disability
7. Dental abnormalities (such as tooth decay or missing teeth)
8. Bone deformities (such as bowed legs or knock knees)
9. Heart problems (such as atrial fibrillation or bradycardia)

Pseudohypoparathyroidism is diagnosed through a combination of clinical evaluation, laboratory tests, and imaging studies. Laboratory tests may include measurements of PTH and calcium levels in the blood, as well as genetic testing to identify mutations in the GNAS gene. Imaging studies, such as ultrasound or CT scans, may be used to evaluate the parathyroid glands and rule out other conditions that may cause similar symptoms.

Treatment for pseudohypoparathyroidism typically involves replacement therapy with PTH to normalize calcium levels and manage symptoms. In some cases, vitamin D and calcium supplements may also be prescribed to support bone health. Surgery may be recommended in cases where the parathyroid glands are causing problems or are not functioning properly. Regular monitoring of calcium and PTH levels is important to ensure that treatment is effective and to make any necessary adjustments.

In summary, pseudohypoparathyroidism is a rare genetic disorder that affects the parathyroid glands and can cause a range of symptoms related to hypoparathyroidism. Diagnosis is based on clinical evaluation, laboratory tests, and imaging studies, and treatment typically involves replacement therapy with PTH and other supplements as needed. Regular monitoring is important to ensure that treatment is effective and to make any necessary adjustments.

There are two types of hypertension:

1. Primary Hypertension: This type of hypertension has no identifiable cause and is also known as essential hypertension. It accounts for about 90% of all cases of hypertension.
2. Secondary Hypertension: This type of hypertension is caused by an underlying medical condition or medication. It accounts for about 10% of all cases of hypertension.

Some common causes of secondary hypertension include:

* Kidney disease
* Adrenal gland disorders
* Hormonal imbalances
* Certain medications
* Sleep apnea
* Cocaine use

There are also several risk factors for hypertension, including:

* Age (the risk increases with age)
* Family history of hypertension
* Obesity
* Lack of exercise
* High sodium intake
* Low potassium intake
* Stress

Hypertension is often asymptomatic, and it can cause damage to the blood vessels and organs over time. Some potential complications of hypertension include:

* Heart disease (e.g., heart attacks, heart failure)
* Stroke
* Kidney disease (e.g., chronic kidney disease, end-stage renal disease)
* Vision loss (e.g., retinopathy)
* Peripheral artery disease

Hypertension is typically diagnosed through blood pressure readings taken over a period of time. Treatment for hypertension may include lifestyle changes (e.g., diet, exercise, stress management), medications, or a combination of both. The goal of treatment is to reduce the risk of complications and improve quality of life.

Some common types of spinal diseases include:

1. Degenerative disc disease: This is a condition where the discs between the vertebrae in the spine wear down over time, leading to pain and stiffness in the back.
2. Herniated discs: This occurs when the gel-like center of a disc bulges out through a tear in the outer layer, putting pressure on nearby nerves and causing pain.
3. Spinal stenosis: This is a narrowing of the spinal canal, which can put pressure on the spinal cord and nerve roots, causing pain, numbness, and weakness in the legs.
4. Spondylolisthesis: This is a condition where a vertebra slips out of place, either forward or backward, and can cause pressure on nearby nerves and muscles.
5. Scoliosis: This is a curvature of the spine that can be caused by a variety of factors, including genetics, injury, or disease.
6. Spinal infections: These are infections that can affect any part of the spine, including the discs, vertebrae, and soft tissues.
7. Spinal tumors: These are abnormal growths that can occur in the spine, either primary ( originating in the spine) or metastatic (originating elsewhere in the body).
8. Osteoporotic fractures: These are fractures that occur in the spine as a result of weakened bones due to osteoporosis.
9. Spinal cysts: These are fluid-filled sacs that can form in the spine, either as a result of injury or as a congenital condition.
10. Spinal degeneration: This is a general term for any type of wear and tear on the spine, such as arthritis or disc degeneration.

If you are experiencing any of these conditions, it is important to seek medical attention to receive an accurate diagnosis and appropriate treatment.

There are several causes of aortic valve insufficiency, including:

1. Congenital heart defects
2. Rheumatic fever
3. Endocarditis (infection of the inner lining of the heart)
4. Aging and wear and tear on the valve
5. Trauma to the chest
6. Connective tissue disorders such as Marfan syndrome or Ehlers-Danlos syndrome.

Symptoms of aortic valve insufficiency can include fatigue, shortness of breath, swelling in the legs and feet, and chest pain. Diagnosis is typically made through a combination of physical examination, echocardiogram (ultrasound of the heart), electrocardiogram (ECG or EKG), and chest X-ray.

Treatment options for aortic valve insufficiency depend on the severity of the condition and may include:

1. Medications to manage symptoms such as heart failure, high blood pressure, and arrhythmias (abnormal heart rhythms)
2. Lifestyle modifications such as a healthy diet and regular exercise
3. Repair or replacement of the aortic valve through surgery. This may involve replacing the valve with an artificial one, or repairing the existing valve through a procedure called valvuloplasty.
4. In some cases, catheter-based procedures such as balloon valvuloplasty or valve replacement may be used.

It is important to note that aortic valve insufficiency can lead to complications such as heart failure, arrhythmias, and endocarditis, which can be life-threatening if left untreated. Therefore, it is important to seek medical attention if symptoms persist or worsen over time.

There are two main types of Renal Insufficiency:

1. Acute Kidney Injury (AKI): This is a sudden and reversible decrease in kidney function, often caused by injury, sepsis, or medication toxicity. AKI can resolve with appropriate treatment and supportive care.
2. Chronic Renal Insufficiency (CRI): This is a long-standing and irreversible decline in kidney function, often caused by diabetes, high blood pressure, or chronic kidney disease. CRI can lead to ESRD if left untreated.

Signs and symptoms of Renal Insufficiency may include:

* Decreased urine output
* Swelling in the legs and ankles (edema)
* Fatigue
* Nausea and vomiting
* Shortness of breath (dyspnea)
* Pain in the back, flank, or abdomen

Diagnosis of Renal Insufficiency is typically made through a combination of physical examination, medical history, laboratory tests, and imaging studies. Laboratory tests may include urinalysis, blood urea nitrogen (BUN) and creatinine levels, and a 24-hour urine protein collection. Imaging studies, such as ultrasound or CT scans, may be used to evaluate the kidneys and rule out other possible causes of the patient's symptoms.

Treatment of Renal Insufficiency depends on the underlying cause and the severity of the condition. Treatment may include medications to control blood pressure, manage fluid balance, and reduce proteinuria (excess protein in the urine). In some cases, dialysis or a kidney transplant may be necessary.

Prevention of Renal Insufficiency includes managing underlying conditions such as diabetes and hypertension, avoiding nephrotoxic medications and substances, and maintaining a healthy diet and lifestyle. Early detection and treatment of acute kidney injury can also help prevent the development of chronic renal insufficiency.

In conclusion, Renal Insufficiency is a common condition that can have significant consequences if left untreated. It is important for healthcare providers to be aware of the causes, symptoms, and diagnosis of Renal Insufficiency, as well as the treatment and prevention strategies available. With appropriate management, many patients with Renal Insufficiency can recover and maintain their kidney function over time.

Some common types of pleural diseases include:

1. Pleurisy: This is an inflammation of the pleura that can be caused by infection, injury, or cancer. Symptoms include chest pain, fever, and difficulty breathing.
2. Pneumothorax: This is a collection of air or gas between the pleural membranes that can cause the lung to collapse. Symptoms include sudden severe chest pain, shortness of breath, and coughing up blood.
3. Empyema: This is an infection of the pleural space that can cause the accumulation of pus and fluid. Symptoms include fever, chills, and difficulty breathing.
4. Mesothelioma: This is a type of cancer that affects the pleura and can cause symptoms such as chest pain, shortness of breath, and weight loss.
5. Pleural effusion: This is the accumulation of fluid in the pleural space that can be caused by various conditions such as infection, heart failure, or cancer. Symptoms include chest pain, shortness of breath, and coughing up fluid.

Pleural diseases can be diagnosed through various tests such as chest X-rays, CT scans, and pleuroscopy (a minimally invasive procedure that uses a thin tube with a camera and light on the end to examine the pleura). Treatment options vary depending on the underlying cause of the disease and can include antibiotics, surgery, or radiation therapy.

The term "cystadenoma" refers to a benign tumor that grows from glandular tissue, and "serous" indicates that the tumor is derived from the serous (fluid-producing) cells of the ovary. The tumor typically forms a cystic mass filled with a clear or cloudy liquid, and can range in size from small to several centimeters in diameter.

CS usually affects women during their reproductive years, and the peak incidence is between 20 and 40 years of age. Symptoms may include abdominal pain, bloating, and vaginal bleeding, but many cases are asymptomatic and are detected incidentally during pelvic examination or imaging studies.

The exact cause of CS is not known, but it is believed to be related to genetic mutations and hormonal factors. The tumor cells have a characteristic immunophenotype, with expression of markers such as cytokeratin 7 and epidermal growth factor receptor (EGFR).

The diagnosis of CS is based on a combination of imaging studies, such as ultrasound and computed tomography (CT), and histopathological examination of tissue samples obtained through laparoscopy or surgery. Treatment options for CS include watchful waiting, fertility-sparing surgery, and total hysterectomy with bilateral salpingo-oophorectomy (THBSO).

In summary, cystadenoma, serous is a common type of benign ovarian tumor that originates from the serous cells of the ovary. It typically affects women during their reproductive years and can cause symptoms such as abdominal pain and vaginal bleeding. The exact cause is not known, but it is believed to be related to genetic mutations and hormonal factors. Diagnosis is based on a combination of imaging studies and histopathological examination of tissue samples, and treatment options include watchful waiting, fertility-sparing surgery, and total hysterectomy with bilateral salpingo-oophorectomy.

Some common types of bronchial diseases include:

1. Asthma: a chronic condition characterized by inflammation and narrowing of the bronchial tubes, which can cause wheezing, coughing, and shortness of breath.
2. Chronic obstructive pulmonary disease (COPD): a progressive condition that causes inflammation and damage to the lungs, leading to chronic bronchitis and emphysema.
3. Bronchitis: an inflammation of the bronchial tubes, which can be acute or chronic.
4. Cystic fibrosis: a genetic disorder that affects the respiratory, digestive, and reproductive systems, and can cause bronchial disease.
5. Bronchiolitis: an inflammation of the small airways, or bronchioles, which can be caused by viral infections.
6. Pneumonia: an infection of the lungs that can cause inflammation and narrowing of the bronchial tubes.
7. Tuberculosis: a bacterial infection that can affect the bronchial tubes and cause scarring and inflammation.
8. Bronchiectasis: a condition where the bronchial tubes are damaged and widened, leading to chronic infections and inflammation.

These diseases can be caused by a variety of factors, including genetics, environmental exposures, and infections. Diagnosis is typically made through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or pulmonary function tests. Treatment options vary depending on the specific condition and may include medications, respiratory therapy, and lifestyle changes.

There are several types of thyroid nodules, including:

1. Benign nodules: These are the most common type of thyroid nodule and are not cancerous. They can be caused by a variety of factors, such as inflammation, infection, or a benign tumor.
2. Malignant nodules: These are less common than benign nodules and are cancerous. They can grow and spread to other parts of the body if left untreated.
3. Thyroid cancer: This is a type of malignant nodule that is caused by abnormal cell growth within the thyroid gland. There are several types of thyroid cancer, including papillary, follicular, and medullary cancer.

Thyroid nodules can cause a variety of symptoms, including:

1. A lump in the neck
2. Pain in the neck or throat
3. Difficulty swallowing or breathing
4. Hoarseness or changes in voice
5. Enlargement of the thyroid gland (goiter)
6. Weight loss or fatigue

Thyroid nodules can be diagnosed through a variety of tests, including:

1. Physical examination: A healthcare provider will examine the neck and throat to feel for any lumps or abnormalities.
2. Thyroid function tests: These tests measure the levels of thyroid hormones in the blood to determine if the nodule is affecting thyroid function.
3. Imaging tests: Such as ultrasound, CT scan, or MRI scans to visualize the nodule and determine its size and location.
4. Fine needle aspiration biopsy (FNAB): A small sample of the nodule is removed and examined under a microscope to determine if it is benign or malignant.

Treatment for thyroid nodules depends on the type and size of the nodule, as well as the patient's overall health. Some common treatments include:

1. Watchful waiting: Small, non-cancerous nodules may not require immediate treatment and can be monitored with regular check-ups.
2. Thyroid hormone medication: To suppress the growth of the nodule and reduce symptoms.
3. Surgery: To remove the nodule or the entire thyroid gland, depending on the size and location of the nodule.
4. Radioactive iodine ablation: To destroy the nodule with radioactive iodine.
5. Ethanol injection: To shrink the nodule with alcohol injections.

It is important to consult a healthcare provider if you experience any symptoms or lumps in the neck, as thyroid nodules can be cancerous and early detection is key for effective treatment.

There are different types of Breast Neoplasms such as:

1. Fibroadenomas: These are benign tumors that are made up of glandular and fibrous tissues. They are usually small and round, with a smooth surface, and can be moved easily under the skin.

2. Cysts: These are fluid-filled sacs that can develop in both breast tissue and milk ducts. They are usually benign and can disappear on their own or be drained surgically.

3. Ductal Carcinoma In Situ (DCIS): This is a precancerous condition where abnormal cells grow inside the milk ducts. If left untreated, it can progress to invasive breast cancer.

4. Invasive Ductal Carcinoma (IDC): This is the most common type of breast cancer and starts in the milk ducts but grows out of them and invades surrounding tissue.

5. Invasive Lobular Carcinoma (ILC): It originates in the milk-producing glands (lobules) and grows out of them, invading nearby tissue.

Breast Neoplasms can cause various symptoms such as a lump or thickening in the breast or underarm area, skin changes like redness or dimpling, change in size or shape of one or both breasts, discharge from the nipple, and changes in the texture or color of the skin.

Treatment options for Breast Neoplasms may include surgery such as lumpectomy, mastectomy, or breast-conserving surgery, radiation therapy which uses high-energy beams to kill cancer cells, chemotherapy using drugs to kill cancer cells, targeted therapy which uses drugs or other substances to identify and attack cancer cells while minimizing harm to normal cells, hormone therapy, immunotherapy, and clinical trials.

It is important to note that not all Breast Neoplasms are cancerous; some are benign (non-cancerous) tumors that do not spread or grow.

The infection occurs when the parasite migrates through the body and reaches the CNS, where it forms cysticerci, which are fluid-filled structures that can cause inflammation and damage to brain tissue. The symptoms of neurocysticercosis can vary depending on the location and size of the cysts, but they often include seizures, headaches, weakness, and vision problems.

Diagnosis of neurocysticercosis is based on a combination of clinical findings, imaging studies (such as CT or MRI scans), and serological tests to detect antibodies against the parasite. Treatment typically involves antiparasitic drugs to kill the parasites, as well as supportive care to manage symptoms and prevent complications.

Prevention of neurocysticercosis primarily involves controlling the transmission of the parasite, which can be done by improving food hygiene and avoiding consumption of undercooked or raw pork. In areas where the infection is common, mass drug administration programs have also been implemented to reduce the prevalence of the parasite.

In summary, neurocysticercosis is a severe and potentially debilitating parasitic infection that affects the central nervous system, with symptoms ranging from seizures to vision problems. Diagnosis is based on a combination of clinical findings and imaging studies, and treatment involves antiparasitic drugs and supportive care. Prevention primarily involves controlling the transmission of the parasite through improved food hygiene and mass drug administration programs.

Some examples of pathologic constrictions include:

1. Stenosis: A narrowing or constriction of a blood vessel or other tubular structure, often caused by the buildup of plaque or scar tissue.
2. Asthma: A condition characterized by inflammation and constriction of the airways, which can make breathing difficult.
3. Esophageal stricture: A narrowing of the esophagus that can cause difficulty swallowing.
4. Gastric ring constriction: A narrowing of the stomach caused by a band of tissue that forms in the upper part of the stomach.
5. Anal fissure: A tear in the lining of the anus that can cause pain and difficulty passing stools.

Pathologic constrictions can be caused by a variety of factors, including inflammation, infection, injury, or genetic disorders. They can be diagnosed through imaging tests such as X-rays, CT scans, or endoscopies, and may require surgical treatment to relieve symptoms and improve function.

Some common types of testicular diseases include:

1. Testicular torsion: This is a condition where the spermatic cord becomes twisted, cutting off blood flow to the testicle. It is a medical emergency and can cause permanent damage if not treated promptly.
2. Epididymitis: This is an inflammation of the epididymis, a tube that runs along the back of the testicle and helps to store and transport sperm. It can be caused by bacterial infections or viral infections such as chlamydia or gonorrhea.
3. Orchitis: This is an inflammation of the testicles, usually caused by a virus or bacterial infection.
4. Hydrocele: This is a build-up of fluid around the testicle, which can be caused by infection, injury, or other factors.
5. Varicocele: This is a swelling of the veins in the scrotum, which can be caused by a blockage or weakness in the valves that control blood flow.
6. Testicular cancer: This is a type of cancer that affects the testicles, and it is relatively rare but can be aggressive if left untreated.
7. Undescended testicle(s): This is a condition where one or both testicles fail to descend from the abdomen into the scrotum during fetal development.
8. Testicular atrophy: This is a shrinkage of the testicles, which can be caused by a range of factors including aging, injury, or certain medical conditions.
9. Painful ejaculation: This is a condition where ejaculation causes pain in the testicles, and it can be caused by a range of factors such as inflammation or infection.
10. Low testosterone: This is a condition where the levels of testosterone in the body are lower than normal, which can cause a range of symptoms including low sex drive, fatigue, and osteoporosis.

It's important to note that some of these conditions can be caused by other factors as well, so it's always best to consult with a healthcare professional for an accurate diagnosis and treatment plan.

There are two main types of vitamin K deficiency:

1. Hypovitaminosis A (mild deficiency): This type of deficiency is characterized by low levels of vitamin K in the blood, but not low enough to cause bleeding or other serious symptoms. It can be caused by a diet that is low in vitamin K, or by conditions that interfere with vitamin K absorption, such as inflammatory bowel disease or liver disease.
2. Vitamin K deficiency bleeding (VKDB): This type of deficiency is characterized by bleeding that is caused by a lack of vitamin K. It can be caused by a diet that is very low in vitamin K, or by conditions that interfere with vitamin K absorption or clotting factor production.

Symptoms of vitamin K deficiency may include:

* Prolonged bleeding after injuries or surgery
* Nosebleeds
* Bruising easily
* Bleeding gums
* Bloody stools
* Heavy menstrual periods

Causes of vitamin K deficiency may include:

* A diet that is low in vitamin K
* Conditions that interfere with vitamin K absorption, such as inflammatory bowel disease or liver disease
* Certain medications, such as anticoagulants (blood thinners)
* Malabsorption, such as in cases of celiac disease or Crohn's disease
* Vitamin K-dependent diseases, such as osteoporosis or cancer

Diagnosis of vitamin K deficiency is typically made based on a combination of symptoms, medical history, and laboratory tests. Treatment may involve supplementation with vitamin K, changes to the diet to increase vitamin K intake, and addressing any underlying conditions that may be contributing to the deficiency.

It is important to note that vitamin K deficiency can be difficult to diagnose, as symptoms can be subtle and may not always be immediately apparent. If you suspect you or someone you know may have a vitamin K deficiency, it is important to consult with a healthcare professional for proper evaluation and treatment.

Mucinous cystadenocarcinoma is a type of primary ovarian cancer, meaning it originates in the ovary rather than spreading from another part of the body. It accounts for only about 2% to 5% of all ovarian cancers and tends to affect women in their later reproductive years or postmenopausal age.

The exact cause of mucinous cystadenocarcinoma is not known, but it may be related to genetic mutations or hormonal imbalances. Women with a family history of ovarian cancer or those with certain inherited genetic syndromes are at higher risk for developing this type of cancer.

The diagnosis of mucinous cystadenocarcinoma is based on a combination of imaging studies, such as ultrasound and computed tomography (CT) scans, and tissue biopsy. Treatment typically involves surgery to remove the affected ovary and any other involved organs or tissues, followed by chemotherapy or radiation therapy to reduce the risk of recurrence. Prognosis for this type of cancer is generally good if it is detected early and treated appropriately.

In summary, mucinous cystadenocarcinoma is a rare type of ovarian cancer that develops in the mucin-secreting cells of the ovary. It tends to affect older women and may be related to genetic or hormonal factors. Diagnosis is based on imaging studies and tissue biopsy, and treatment typically involves surgery and chemotherapy or radiation therapy. Prognosis is generally good if caught early.

Body weight is an important health indicator, as it can affect an individual's risk for certain medical conditions, such as obesity, diabetes, and cardiovascular disease. Maintaining a healthy body weight is essential for overall health and well-being, and there are many ways to do so, including a balanced diet, regular exercise, and other lifestyle changes.

There are several ways to measure body weight, including:

1. Scale: This is the most common method of measuring body weight, and it involves standing on a scale that displays the individual's weight in kg or lb.
2. Body fat calipers: These are used to measure body fat percentage by pinching the skin at specific points on the body.
3. Skinfold measurements: This method involves measuring the thickness of the skin folds at specific points on the body to estimate body fat percentage.
4. Bioelectrical impedance analysis (BIA): This is a non-invasive method that uses electrical impulses to measure body fat percentage.
5. Dual-energy X-ray absorptiometry (DXA): This is a more accurate method of measuring body composition, including bone density and body fat percentage.

It's important to note that body weight can fluctuate throughout the day due to factors such as water retention, so it's best to measure body weight at the same time each day for the most accurate results. Additionally, it's important to use a reliable scale or measuring tool to ensure accurate measurements.

Symptoms of maxillary sinusitis may include:

* Pain or pressure in the cheekbones or forehead
* Swelling of the eyelids or face
* Yellow or green nasal discharge
* Fever
* Cough
* Headache
* Toothache

Maxillary sinusitis is diagnosed through a combination of physical examination, medical history, and imaging studies such as CT scans or MRI. Treatment typically involves antibiotics to eradicate any underlying infections, along with pain management and drainage of mucus from the sinuses. In severe cases, surgery may be necessary to address any anatomical issues or abscesses that have developed.

It is important to seek medical attention if symptoms persist or worsen over time, as untreated maxillary sinusitis can lead to complications such as meningitis or osteomyelitis (infection of the bone). With prompt and appropriate treatment, however, most cases of maxillary sinusitis can be effectively managed and resolved with minimal long-term consequences.

Some common types of orbital diseases include:

1. Orbital cellulitis: This is an infection of the tissues in the orbit that can be caused by bacteria or viruses. It can cause swelling, redness, and pain in the eye and eyelid.
2. Orbital abscess: This is a collection of pus in the orbit that can be caused by an infection. It can cause swelling, redness, and pain in the eye and eyelid.
3. Dacryostenosis: This is a blockage of the tear ducts that can cause tears to build up in the eye and eyelid.
4. Orbital pseudotumor: This is a condition in which there is inflammation in the orbit without any obvious cause. It can cause pain, swelling, and double vision.
5. Thyroid eye disease: This is a condition that affects the muscles and tissues around the eyes due to an overactive thyroid gland. It can cause double vision, puffy eyelids, and dryness in the eyes.
6. Graves' ophthalmopathy: This is a condition that affects the muscles and tissues around the eyes due to an autoimmune disorder. It can cause double vision, puffy eyelids, and dryness in the eyes.
7. Orbital lymphoid hyperplasia: This is a condition in which there is an abnormal growth of immune cells in the orbit. It can cause pain, swelling, and redness in the eye and eyelid.
8. Orbital sarcoidosis: This is a condition in which there are inflammatory lesions in the orbit due to a systemic autoimmune disorder called sarcoidosis. It can cause pain, swelling, and redness in the eye and eyelid.
9. Orbital pseudotumor: This is a condition that mimics a tumor but is actually caused by inflammation or abnormal blood vessels in the orbit. It can cause pain, swelling, and double vision.
10. Orbital metastasis: This is a condition in which cancer cells from another part of the body spread to the orbit. It can cause pain, swelling, and redness in the eye and eyelid.

It's important to note that this is not an exhaustive list and there may be other causes of orbital inflammation. If you are experiencing symptoms of orbital inflammation, it's important to see an eye doctor or a specialist as soon as possible for proper evaluation and treatment.

Example sentences:

1. The patient was diagnosed with a hamartoma on his skin, which was causing a painful lump on his arm.
2. The doctor recommended removing the hamartoma from the patient's pancreas to alleviate her symptoms of abdominal pain and nausea.
3. After undergoing surgery to remove the hamartoma, the patient experienced significant improvement in their quality of life.

There are several types of diabetes mellitus, including:

1. Type 1 DM: This is an autoimmune condition in which the body's immune system attacks and destroys the cells in the pancreas that produce insulin, resulting in a complete deficiency of insulin production. It typically develops in childhood or adolescence, and patients with this condition require lifelong insulin therapy.
2. Type 2 DM: This is the most common form of diabetes, accounting for around 90% of all cases. It is caused by a combination of insulin resistance (where the body's cells do not respond properly to insulin) and impaired insulin secretion. It is often associated with obesity, physical inactivity, and a diet high in sugar and unhealthy fats.
3. Gestational DM: This type of diabetes develops during pregnancy, usually in the second or third trimester. Hormonal changes and insulin resistance can cause blood sugar levels to rise, putting both the mother and baby at risk.
4. LADA (Latent Autoimmune Diabetes in Adults): This is a form of type 1 DM that develops in adults, typically after the age of 30. It shares features with both type 1 and type 2 DM.
5. MODY (Maturity-Onset Diabetes of the Young): This is a rare form of diabetes caused by genetic mutations that affect insulin production. It typically develops in young adulthood and can be managed with lifestyle changes and/or medication.

The symptoms of diabetes mellitus can vary depending on the severity of the condition, but may include:

1. Increased thirst and urination
2. Fatigue
3. Blurred vision
4. Cuts or bruises that are slow to heal
5. Tingling or numbness in hands and feet
6. Recurring skin, gum, or bladder infections
7. Flu-like symptoms such as weakness, dizziness, and stomach pain
8. Dark, velvety skin patches (acanthosis nigricans)
9. Yellowish color of the skin and eyes (jaundice)
10. Delayed healing of cuts and wounds

If left untreated, diabetes mellitus can lead to a range of complications, including:

1. Heart disease and stroke
2. Kidney damage and failure
3. Nerve damage (neuropathy)
4. Eye damage (retinopathy)
5. Foot damage (neuropathic ulcers)
6. Cognitive impairment and dementia
7. Increased risk of infections and other diseases, such as pneumonia, gum disease, and urinary tract infections.

It is important to note that not all individuals with diabetes will experience these complications, and that proper management of the condition can greatly reduce the risk of developing these complications.

Note: Odontogenic cysts are non-cancerous growths that originate in the tissues of the teeth and jaw. They can be benign or malignant, and their exact nature can only be determined through a biopsy.

Type 2 diabetes can be managed through a combination of diet, exercise, and medication. In some cases, lifestyle changes may be enough to control blood sugar levels, while in other cases, medication or insulin therapy may be necessary. Regular monitoring of blood sugar levels and follow-up with a healthcare provider are important for managing the condition and preventing complications.

Common symptoms of type 2 diabetes include:

* Increased thirst and urination
* Fatigue
* Blurred vision
* Cuts or bruises that are slow to heal
* Tingling or numbness in the hands and feet
* Recurring skin, gum, or bladder infections

If left untreated, type 2 diabetes can lead to a range of complications, including:

* Heart disease and stroke
* Kidney damage and failure
* Nerve damage and pain
* Eye damage and blindness
* Foot damage and amputation

The exact cause of type 2 diabetes is not known, but it is believed to be linked to a combination of genetic and lifestyle factors, such as:

* Obesity and excess body weight
* Lack of physical activity
* Poor diet and nutrition
* Age and family history
* Certain ethnicities (e.g., African American, Hispanic/Latino, Native American)
* History of gestational diabetes or delivering a baby over 9 lbs.

There is no cure for type 2 diabetes, but it can be managed and controlled through a combination of lifestyle changes and medication. With proper treatment and self-care, people with type 2 diabetes can lead long, healthy lives.

There are many different types of cysts that can occur in the body, including:

1. Sebaceous cysts: These are small, usually painless cysts that form in the skin, particularly on the face, neck, or torso. They are filled with a thick, cheesy material and can become inflamed or infected.
2. Ovarian cysts: These are fluid-filled sacs that form on the ovaries. They are common in women of childbearing age and can cause pelvic pain, bloating, and other symptoms.
3. Kidney cysts: These are fluid-filled sacs that form in the kidneys. They are usually benign but can cause problems if they become large or infected.
4. Dermoid cysts: These are small, usually painless cysts that form in the skin or organs. They are filled with skin cells, hair follicles, and other tissue and can become inflamed or infected.
5. Pilar cysts: These are small, usually painless cysts that form on the scalp. They are filled with a thick, cheesy material and can become inflamed or infected.
6. Epidermoid cysts: These are small, usually painless cysts that form just under the skin. They are filled with a thick, cheesy material and can become inflamed or infected.
7. Mucous cysts: These are small, usually painless cysts that form on the fingers or toes. They are filled with a clear, sticky fluid and can become inflamed or infected.
8. Baker's cyst: This is a fluid-filled cyst that forms behind the knee. It can cause swelling and pain in the knee and is more common in women than men.
9. Tarlov cysts: These are small, fluid-filled cysts that form in the spine. They can cause back pain and other symptoms, such as sciatica.
10. ganglion cysts: These are noncancerous lumps that form on the joints or tendons. They are filled with a thick, clear fluid and can cause pain, swelling, and limited mobility.

It's important to note that this is not an exhaustive list and there may be other types of cysts that are not included here. If you suspect that you have a cyst, it's always best to consult with a healthcare professional for proper diagnosis and treatment.

There are several types of Urinary Bladder Calculi, including:

1. Calcium Oxalate Stones: These are the most common type of bladder stone and are formed from a combination of calcium and oxalate. They can occur in people with conditions such as kidney disease, gout, or inflammatory bowel disease.
2. Uric Acid Stones: These stones are formed from uric acid, a waste product that is normally present in the urine. They can occur in people with conditions such as gout, diabetes, or certain types of cancer.
3. Cystine Stones: These stones are formed from cystine, an amino acid that is present in small amounts in the body. They can occur in people with conditions such as cystinuria, a genetic disorder that affects the transport of cystine and other amino acids in the kidneys.
4. Struvite Stones: These stones are formed from a combination of magnesium, ammonium, and phosphate, and can occur in people with urinary tract infections.

The symptoms of Urinary Bladder Calculi can vary depending on the size and location of the stone, but may include:

1. Severe pain in the lower abdomen or back
2. Frequent urination or a strong, persistent urge to urinate
3. Blood in the urine
4. Cloudy or strong-smelling urine
5. Fever and chills
6. Nausea and vomiting

If you suspect that you have Urinary Bladder Calculi, it is important to seek medical attention as soon as possible. Your healthcare provider may perform a physical examination, take a medical history, and order diagnostic tests such as a urinalysis, imaging studies (such as X-rays or CT scans), or a cystoscopy (a procedure that uses a thin, flexible tube with a camera on the end to examine the inside of the bladder) to confirm the diagnosis and determine the appropriate treatment.

Treatment for Urinary Bladder Calculi may include:

1. Drinking plenty of water to help flush out small stones
2. Medications such as alpha-blockers or potassium citrate to help dissolve larger stones
3. Ureteroscopy, a minimally invasive procedure in which a small, flexible scope is used to remove the stone
4. Lithotripsy, a procedure that uses shock waves to break up larger stones into smaller pieces that can be passed more easily
5. Catheterization, a procedure in which a thin tube is placed through the urethra and bladder to drain urine and flush out small stones
6. Surgery, such as open or laparoscopic surgery, to remove larger stones or repair any damage to the urinary tract.

In some cases, Urinary Bladder Calculi may recur, so it is important to follow up with your healthcare provider regularly to monitor for any new stones or complications.

* Osteogenesis imperfecta (OI): A genetic disorder that affects the formation of bone tissue, leading to fragile bones and an increased risk of fractures.
* Rickets: A vitamin D-deficient disease that causes softening of the bones in children.
* Osteomalacia: A condition similar to rickets, but affecting adults and caused by a deficiency of vitamin D or calcium.
* Hyperparathyroidism: A condition in which the parathyroid glands produce too much parathyroid hormone (PTH), leading to an imbalance in bone metabolism and an increase in bone resorption.
* Hypoparathyroidism: A condition in which the parathyroid glands produce too little PTH, leading to low levels of calcium and vitamin D and an increased risk of osteoporosis.

Bone diseases, metabolic are typically diagnosed through a combination of physical examination, imaging studies such as X-rays or CT scans, and laboratory tests to evaluate bone metabolism. Treatment depends on the specific underlying cause of the disease and may include medications, dietary changes, or surgery.

Characteristics:

* Mucinous cystadenomas are typically slow-growing and asymptomatic, but can occasionally cause pelvic pain or discomfort due to their size.
* They are usually unilateral (affecting one ovary), but can rarely occur bilaterally (affecting both ovaries).
* The tumor is composed of mucin-secreting epithelial cells that form glands or cysts within a fibrous stroma.
* Cystadenomas are typically encapsulated, but can rarely become invasive and infiltrate surrounding tissues.
* Mucinous cystadenomas are usually small (less than 5 cm in diameter), but can occasionally be larger.

Diagnosis:

* Imaging studies such as ultrasound or computed tomography (CT) scans may be used to detect the presence of a cystic mass in the ovary, but a definitive diagnosis is usually made through surgical exploration and histopathologic examination of the tumor tissue.
* A preoperative diagnosis of mucinous cystadenoma can be challenging, as the imaging features are not specific and may resemble other ovarian tumors, such as serous cystadenomas or borderline tumors.

Treatment:

* Surgical excision is the primary treatment for mucinous cystadenoma, and the procedure is usually performed through a laparotomy or laparoscopy.
* The surgical approach depends on the size and location of the tumor, as well as the patient's age and fertility status.
* In some cases, the tumor may be removed through a staged approach, with initial cytoreduction followed by chemotherapy or radiation therapy to shrink the remaining tumor burden.

Prognosis:

* Mucinous cystadenoma is generally considered a benign tumor, and the prognosis is excellent for most patients.
* The overall survival rate is high, and the majority of patients can expect to be cured with surgical excision alone.
* However, in rare cases, mucinous cystadenoma can recur or progress to more aggressive types of ovarian cancer, such as serous carcinoma.

Follow-up:

* After surgical excision, patients with mucinous cystadenoma should be followed up with regular pelvic examinations, imaging studies, and serum CA 125 levels to monitor for any signs of recurrence or progression.
* The frequency of follow-up appointments may vary depending on the patient's age, tumor size, and other factors, but annual pelvic examinations and imaging studies are generally recommended for at least 5 years after surgery.

References:

1. Kurman RJ, et al. The origin and pathology of ovarian borderline tumors. International Journal of Gynecological Pathology. 2014;33(2):197-211.
2. Di Cerbo A, et al. Mucinous cystadenoma of the ovary: a review of the literature. Journal of Obstetrics and Gynaecology Canada. 2018;40(6):753-763.
3. Chung H, et al. The clinicopathological features and prognosis of mucinous cystadenoma of the ovary: a systematic review and meta-analysis. Gynecologic Oncology Reports. 2018;20:135-143.

Vitamin D deficiency can occur due to several reasons, including:

1. Limited sun exposure: Vitamin D is produced in the skin when it is exposed to sunlight. People who live in regions with limited sunlight, such as far north or south latitudes, may experience vitamin D deficiency.
2. Poor dietary intake: Vitamin D is found in few foods, such as fatty fish, egg yolks, and fortified dairy products. People who follow a restrictive diet or do not consume enough of these foods may develop vitamin D deficiency.
3. Inability to convert vitamin D: Vitamin D undergoes two stages of conversion in the body before it becomes active. The first stage occurs in the skin, and the second stage occurs in the liver. People who have a genetic disorder or certain medical conditions may experience difficulty converting vitamin D, leading to deficiency.
4. Certain medications: Some medications, such as anticonvulsants and glucocorticoids, can interfere with vitamin D metabolism and lead to deficiency.
5. Increased demand: Vitamin D deficiency can occur in people who have high demands for vitamin D, such as pregnant or lactating women, older adults, and individuals with certain medical conditions like osteomalacia or rickets.

Vitamin D deficiency can cause a range of health problems, including:

1. Osteomalacia (softening of the bones)
2. Rickets (a childhood disease that causes softening of the bones)
3. Increased risk of fractures
4. Muscle weakness and pain
5. Fatigue and malaise
6. Depression and seasonal affective disorder
7. Autoimmune diseases, such as multiple sclerosis, type 1 diabetes, and rheumatoid arthritis
8. Cardiovascular disease
9. Certain types of cancer, such as colorectal, breast, and prostate cancer

If you suspect you may have a vitamin D deficiency, it's important to speak with your healthcare provider, who can diagnose the deficiency through a blood test and recommend appropriate treatment. Treatment for vitamin D deficiency typically involves taking supplements or increasing exposure to sunlight.

There are several types of angiomatosis, including:

1. Capillary angiomatosis: This type of angiomatosis is characterized by the growth of small blood vessels called capillaries. It can cause redness, itching, and swelling in the affected area.
2. Venous angiomatosis: This type of angiomatosis is characterized by the growth of veins, which can lead to varicose veins, bleeding, and swelling.
3. Lymphatic angiomatosis: This type of angiomatosis is characterized by the growth of lymph vessels, which can lead to swelling in the affected limb.
4. Arteriovenous malformation (AVM): This is a congenital condition where there is an abnormal connection between arteries and veins, leading to poor blood flow and oxygenation of tissues.

The symptoms of angiomatosis can vary depending on the location and size of the tumor. Some common symptoms include:

* Painless swelling or lump in the affected area
* Redness, itching, or bruising in the affected area
* Bleeding or discharge from the affected area
* Swelling in the limbs or other areas
* Fatigue or weakness
* Shortness of breath

The diagnosis of angiomatosis is based on a combination of physical examination, medical history, and imaging tests such as ultrasound, computed tomography (CT) scan, or magnetic resonance imaging (MRI). Treatment options for angiomatosis depend on the type and location of the tumor, and may include:

* Observation: Small, asymptomatic tumors may not require treatment and can be monitored with regular check-ups.
* Surgery: Larger tumors may require surgical removal to prevent complications such as bleeding or infection.
* Embolization: This is a minimally invasive procedure where a catheter is inserted through a blood vessel to deliver a substance that blocks the blood flow to the tumor, causing it to shrink.
* Radiation therapy: This may be used to treat tumors that are difficult to remove with surgery or embolization, or to relieve symptoms such as pain or bleeding.
* Medications: Depending on the type of angiomatosis, medications such as anti-inflammatory drugs, anticoagulants, or chemotherapy may be prescribed to manage symptoms and slow the growth of the tumor.

Overall, the prognosis for angiomatosis varies depending on the type and location of the tumor, as well as the promptness and effectiveness of treatment. With early diagnosis and appropriate treatment, many people with angiomatosis can lead normal lives and enjoy a good quality of life. However, in some cases, angiomatosis can be a serious condition that requires ongoing monitoring and treatment to prevent complications and manage symptoms.

Some common types of skin diseases include:

1. Acne: a condition characterized by oil clogged pores, pimples, and other blemishes on the skin.
2. Eczema: a chronic inflammatory skin condition that causes dry, itchy, and scaly patches on the skin.
3. Psoriasis: a chronic autoimmune skin condition characterized by red, scaly patches on the skin.
4. Dermatitis: a term used to describe inflammation of the skin, often caused by allergies or irritants.
5. Skin cancer: a type of cancer that affects the skin cells, often caused by exposure to UV radiation from the sun or tanning beds.
6. Melanoma: the most serious type of skin cancer, characterized by a mole that changes in size, shape, or color.
7. Vitiligo: a condition in which white patches develop on the skin due to the loss of pigment-producing cells.
8. Alopecia: a condition characterized by hair loss, often caused by autoimmune disorders or genetics.
9. Nail diseases: conditions that affect the nails, such as fungal infections, brittleness, and thickening.
10. Mucous membrane diseases: conditions that affect the mucous membranes, such as ulcers, inflammation, and cancer.

Skin diseases can be diagnosed through a combination of physical examination, medical history, and diagnostic tests such as biopsies or blood tests. Treatment options vary depending on the specific condition and may include topical creams or ointments, oral medications, light therapy, or surgery.

Preventive measures to reduce the risk of skin diseases include protecting the skin from UV radiation, using sunscreen, wearing protective clothing, and avoiding exposure to known allergens or irritants. Early detection and treatment can help prevent complications and improve outcomes for many skin conditions.

There are different types of myocardial infarctions, including:

1. ST-segment elevation myocardial infarction (STEMI): This is the most severe type of heart attack, where a large area of the heart muscle is damaged. It is characterized by a specific pattern on an electrocardiogram (ECG) called the ST segment.
2. Non-ST-segment elevation myocardial infarction (NSTEMI): This type of heart attack is less severe than STEMI, and the damage to the heart muscle may not be as extensive. It is characterized by a smaller area of damage or a different pattern on an ECG.
3. Incomplete myocardial infarction: This type of heart attack is when there is some damage to the heart muscle but not a complete blockage of blood flow.
4. Collateral circulation myocardial infarction: This type of heart attack occurs when there are existing collateral vessels that bypass the blocked coronary artery, which reduces the amount of damage to the heart muscle.

Symptoms of a myocardial infarction can include chest pain or discomfort, shortness of breath, lightheadedness, and fatigue. These symptoms may be accompanied by anxiety, fear, and a sense of impending doom. In some cases, there may be no noticeable symptoms at all.

Diagnosis of myocardial infarction is typically made based on a combination of physical examination findings, medical history, and diagnostic tests such as an electrocardiogram (ECG), cardiac enzyme tests, and imaging studies like echocardiography or cardiac magnetic resonance imaging.

Treatment of myocardial infarction usually involves medications to relieve pain, reduce the amount of work the heart has to do, and prevent further damage to the heart muscle. These may include aspirin, beta blockers, ACE inhibitors or angiotensin receptor blockers, and statins. In some cases, a procedure such as angioplasty or coronary artery bypass surgery may be necessary to restore blood flow to the affected area.

Prevention of myocardial infarction involves managing risk factors such as high blood pressure, high cholesterol, smoking, diabetes, and obesity. This can include lifestyle changes such as a healthy diet, regular exercise, and stress reduction, as well as medications to control these conditions. Early detection and treatment of heart disease can help prevent myocardial infarction from occurring in the first place.

There are several types of placenta diseases that can occur during pregnancy, including:

1. Placenta previa: This is a condition in which the placenta partially or completely covers the cervix, which can cause bleeding and other complications.
2. Placental abruption: This is a condition in which the placenta separates from the uterus, which can cause bleeding and can lead to premature delivery.
3. Placental invasion: This is a condition in which the placenta grows into the muscle of the uterus, which can cause complications during delivery.
4. Placental insufficiency: This is a condition in which the placenta does not function properly, which can lead to growth restriction and other complications.
5. Chorioamnionitis: This is an infection of the placenta and amniotic fluid, which can cause fever, chills, and other symptoms.
6. Placental tumors: These are rare growths that can occur on the placenta during pregnancy.
7. Placental blood clots: These are blood clots that can form in the placenta, which can cause complications such as preterm labor and delivery.
8. Preeclampsia: This is a condition that causes high blood pressure and other symptoms during pregnancy, which can lead to complications such as placental abruption and preterm delivery.
9. Gestational diabetes: This is a type of diabetes that occurs during pregnancy, which can increase the risk of placenta diseases.
10. Hypertension: This is high blood pressure during pregnancy, which can increase the risk of placenta diseases such as preeclampsia and placental abruption.
11. Multiple births: Women who are carrying multiple babies (twins, triplets, etc.) may be at higher risk for placenta diseases due to the increased demands on the placenta.
12. Age: Women who are over 35 years old may be at higher risk for placenta diseases due to age-related changes in the placenta and other factors.
13. Obesity: Women who are obese may be at higher risk for placenta diseases due to increased inflammation and other factors.
14. Smoking: Smoking during pregnancy can increase the risk of placenta diseases due to the harmful effects of smoking on the placenta and other organs.
15. Poor prenatal care: Women who do not receive adequate prenatal care may be at higher risk for placenta diseases due to lack of monitoring and treatment.
16. Medical conditions: Certain medical conditions, such as high blood pressure, diabetes, and kidney disease, can increase the risk of placenta diseases.
17. Infections: Women who develop infections during pregnancy, such as group B strep or urinary tract infections, may be at higher risk for placenta diseases.
18. Previous history of placenta problems: Women who have had previous complications with the placenta, such as placenta previa or placental abruption, may be at higher risk for placenta diseases in future pregnancies.

It's important to note that many women who experience one or more of these risk factors will not develop placenta diseases, and some women who do develop placenta diseases may not have any known risk factors. If you have any concerns about your health or your baby's health during pregnancy, it is important to discuss them with your healthcare provider.

1. Infection: Bacterial or viral infections can develop after surgery, potentially leading to sepsis or organ failure.
2. Adhesions: Scar tissue can form during the healing process, which can cause bowel obstruction, chronic pain, or other complications.
3. Wound complications: Incisional hernias, wound dehiscence (separation of the wound edges), and wound infections can occur.
4. Respiratory problems: Pneumonia, respiratory failure, and atelectasis (collapsed lung) can develop after surgery, particularly in older adults or those with pre-existing respiratory conditions.
5. Cardiovascular complications: Myocardial infarction (heart attack), cardiac arrhythmias, and cardiac failure can occur after surgery, especially in high-risk patients.
6. Renal (kidney) problems: Acute kidney injury or chronic kidney disease can develop postoperatively, particularly in patients with pre-existing renal impairment.
7. Neurological complications: Stroke, seizures, and neuropraxia (nerve damage) can occur after surgery, especially in patients with pre-existing neurological conditions.
8. Pulmonary embolism: Blood clots can form in the legs or lungs after surgery, potentially causing pulmonary embolism.
9. Anesthesia-related complications: Respiratory and cardiac complications can occur during anesthesia, including respiratory and cardiac arrest.
10. delayed healing: Wound healing may be delayed or impaired after surgery, particularly in patients with pre-existing medical conditions.

It is important for patients to be aware of these potential complications and to discuss any concerns with their surgeon and healthcare team before undergoing surgery.

Types of Arterial Occlusive Diseases:

1. Atherosclerosis: Atherosclerosis is a condition where plaque builds up inside the arteries, leading to narrowing or blockages that can restrict blood flow to certain areas of the body.
2. Peripheral Artery Disease (PAD): PAD is a condition where the blood vessels in the legs and arms become narrowed or blocked, leading to pain or cramping in the affected limbs.
3. Coronary Artery Disease (CAD): CAD is a condition where the coronary arteries, which supply blood to the heart, become narrowed or blocked, leading to chest pain or a heart attack.
4. Carotid Artery Disease: Carotid artery disease is a condition where the carotid arteries, which supply blood to the brain, become narrowed or blocked, leading to stroke or mini-stroke.
5. Renal Artery Stenosis: Renal artery stenosis is a condition where the blood vessels that supply the kidneys become narrowed or blocked, leading to high blood pressure and decreased kidney function.

Symptoms of Arterial Occlusive Diseases:

1. Pain or cramping in the affected limbs
2. Weakness or fatigue
3. Difficulty walking or standing
4. Chest pain or discomfort
5. Shortness of breath
6. Dizziness or lightheadedness
7. Stroke or mini-stroke

Treatment for Arterial Occlusive Diseases:

1. Medications: Medications such as blood thinners, cholesterol-lowering drugs, and blood pressure medications may be prescribed to treat arterial occlusive diseases.
2. Lifestyle Changes: Lifestyle changes such as quitting smoking, exercising regularly, and eating a healthy diet can help manage symptoms and slow the progression of the disease.
3. Endovascular Procedures: Endovascular procedures such as angioplasty and stenting may be performed to open up narrowed or blocked blood vessels.
4. Surgery: In some cases, surgery may be necessary to treat arterial occlusive diseases, such as bypass surgery or carotid endarterectomy.

Prevention of Arterial Occlusive Diseases:

1. Maintain a healthy diet and lifestyle
2. Quit smoking and avoid exposure to secondhand smoke
3. Exercise regularly
4. Manage high blood pressure, high cholesterol, and diabetes
5. Avoid excessive alcohol consumption
6. Get regular check-ups with your healthcare provider

Early detection and treatment of arterial occlusive diseases can help manage symptoms, slow the progression of the disease, and prevent complications such as heart attack or stroke.

In medicine, cadavers are used for a variety of purposes, such as:

1. Anatomy education: Medical students and residents learn about the human body by studying and dissecting cadavers. This helps them develop a deeper understanding of human anatomy and improves their surgical skills.
2. Research: Cadavers are used in scientific research to study the effects of diseases, injuries, and treatments on the human body. This helps scientists develop new medical techniques and therapies.
3. Forensic analysis: Cadavers can be used to aid in the investigation of crimes and accidents. By examining the body and its injuries, forensic experts can determine cause of death, identify suspects, and reconstruct events.
4. Organ donation: After death, cadavers can be used to harvest organs and tissues for transplantation into living patients. This can improve the quality of life for those with organ failure or other medical conditions.
5. Medical training simulations: Cadavers can be used to simulate real-life medical scenarios, allowing healthcare professionals to practice their skills in a controlled environment.

In summary, the term "cadaver" refers to the body of a deceased person and is used in the medical field for various purposes, including anatomy education, research, forensic analysis, organ donation, and medical training simulations.

1. Stroke: A stroke occurs when the blood supply to the brain is interrupted, either due to a blockage or a rupture of the blood vessels. This can lead to cell death and permanent brain damage.
2. Cerebral vasospasm: Vasospasm is a temporary constriction of the blood vessels in the brain, which can occur after a subarachnoid hemorrhage (bleeding in the space surrounding the brain).
3. Moyamoya disease: This is a rare condition caused by narrowing or blockage of the internal carotid artery and its branches. It can lead to recurrent transient ischemic attacks (TIs) or stroke.
4. Cerebral amyloid angiopathy: This is a condition where abnormal protein deposits accumulate in the blood vessels of the brain, leading to inflammation and bleeding.
5. Cavernous malformations: These are abnormal collections of blood vessels in the brain that can cause seizures, headaches, and other symptoms.
6. Carotid artery disease: Atherosclerosis (hardening) of the carotid arteries can lead to a stroke or TIAs.
7. Vertebrobasilar insufficiency: This is a condition where the blood flow to the brain is reduced due to narrowing or blockage of the vertebral and basilar arteries.
8. Temporal lobe dementia: This is a type of dementia that affects the temporal lobe of the brain, leading to memory loss and other cognitive symptoms.
9. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): This is a rare genetic disorder that affects the blood vessels in the brain, leading to recurrent stroke-like events.
10. Moyamoya disease: This is a rare condition caused by narrowing or blockage of the internal carotid artery and its branches, leading to decreased blood flow to the brain and increased risk of stroke.

It's important to note that this list is not exhaustive and there may be other causes of stroke and TIAs that are not included here. A proper diagnosis can only be made by a qualified medical professional after conducting a thorough examination and reviewing the individual's medical history.

Example sentences:

1. The patient developed a foreign-body reaction after receiving a defective hip implant, resulting in severe pain and swelling.
2. The transplanted liver was rejected by the recipient's immune system, causing a foreign-body reaction that led to its failure.
3. The use of a certain drug was associated with a high risk of foreign-body reactions, leading to its withdrawal from the market.

There are several types of thrombosis, including:

1. Deep vein thrombosis (DVT): A clot forms in the deep veins of the legs, which can cause swelling, pain, and skin discoloration.
2. Pulmonary embolism (PE): A clot breaks loose from another location in the body and travels to the lungs, where it can cause shortness of breath, chest pain, and coughing up blood.
3. Cerebral thrombosis: A clot forms in the brain, which can cause stroke or mini-stroke symptoms such as weakness, numbness, or difficulty speaking.
4. Coronary thrombosis: A clot forms in the coronary arteries, which supply blood to the heart muscle, leading to a heart attack.
5. Renal thrombosis: A clot forms in the kidneys, which can cause kidney damage or failure.

The symptoms of thrombosis can vary depending on the location and size of the clot. Some common symptoms include:

1. Swelling or redness in the affected limb
2. Pain or tenderness in the affected area
3. Warmth or discoloration of the skin
4. Shortness of breath or chest pain if the clot has traveled to the lungs
5. Weakness, numbness, or difficulty speaking if the clot has formed in the brain
6. Rapid heart rate or irregular heartbeat
7. Feeling of anxiety or panic

Treatment for thrombosis usually involves medications to dissolve the clot and prevent new ones from forming. In some cases, surgery may be necessary to remove the clot or repair the damaged blood vessel. Prevention measures include maintaining a healthy weight, exercising regularly, avoiding long periods of immobility, and managing chronic conditions such as high blood pressure and diabetes.

There are several types of hypertrophy, including:

1. Muscle hypertrophy: The enlargement of muscle fibers due to increased protein synthesis and cell growth, often seen in individuals who engage in resistance training exercises.
2. Cardiac hypertrophy: The enlargement of the heart due to an increase in cardiac workload, often seen in individuals with high blood pressure or other cardiovascular conditions.
3. Adipose tissue hypertrophy: The excessive growth of fat cells, often seen in individuals who are obese or have insulin resistance.
4. Neurological hypertrophy: The enlargement of neural structures such as brain or spinal cord due to an increase in the number of neurons or glial cells, often seen in individuals with neurodegenerative diseases such as Alzheimer's or Parkinson's.
5. Hepatic hypertrophy: The enlargement of the liver due to an increase in the number of liver cells, often seen in individuals with liver disease or cirrhosis.
6. Renal hypertrophy: The enlargement of the kidneys due to an increase in blood flow and filtration, often seen in individuals with kidney disease or hypertension.
7. Ovarian hypertrophy: The enlargement of the ovaries due to an increase in the number of follicles or hormonal imbalances, often seen in individuals with polycystic ovary syndrome (PCOS).

Hypertrophy can be diagnosed through various medical tests such as imaging studies (e.g., CT scans, MRI), biopsies, and blood tests. Treatment options for hypertrophy depend on the underlying cause and may include medications, lifestyle changes, and surgery.

In conclusion, hypertrophy is a growth or enlargement of cells, tissues, or organs in response to an excessive stimulus. It can occur in various parts of the body, including the brain, liver, kidneys, heart, muscles, and ovaries. Understanding the underlying causes and diagnosis of hypertrophy is crucial for effective treatment and management of related health conditions.

There are several subtypes of chondrosarcoma, including:

1. Grade 1 (low-grade) chondrosarcoma: This is a slow-growing tumor that is less likely to spread to other parts of the body.
2. Grade 2 (intermediate-grade) chondrosarcoma: This type of tumor grows more quickly than grade 1 and may be more likely to spread.
3. Grade 3 (high-grade) chondrosarcoma: This is an aggressive tumor that can grow quickly and spread to other parts of the body.

The symptoms of chondrosarcoma can vary depending on the location of the tumor, but may include pain in the affected area, swelling, and limited mobility. Treatment for chondrosarcoma typically involves surgery to remove the tumor, followed by radiation therapy and/or chemotherapy to kill any remaining cancer cells. The prognosis for chondrosarcoma varies depending on the grade of the tumor and the effectiveness of treatment.

Sources:

* American Cancer Society. (2020). Chondrosarcoma. Retrieved from
* Mayo Clinic. (2020). Chondrosarcoma. Retrieved from
* National Cancer Institute. (2020). Chondrosarcoma. Retrieved from

Word Origin: From the Greek "alkapton" meaning "darkening" and the suffix "-uria" indicating a condition characterized by excessive urine production.

Some common types of calcium metabolism disorders include:

1. Hypocalcemia (low calcium levels): This can be caused by a deficiency in dietary calcium intake, malabsorption of calcium, or excessive urinary excretion of calcium. Symptoms can include muscle cramps, tremors, and tingling sensations in the fingers and toes.
2. Hypercalcemia (high calcium levels): This can be caused by an overactive parathyroid gland, cancer, or excessive intake of vitamin D. Symptoms can include fatigue, nausea, constipation, and kidney stones.
3. Osteoporosis: This is a condition characterized by weak and brittle bones that can lead to fractures. It is often associated with hormonal imbalances, vitamin D deficiency, or other factors that disrupt calcium metabolism.
4. Hyperparathyroidism (overactive parathyroid gland): This is a condition in which the parathyroid glands produce too much parathyroid hormone (PTH), leading to elevated calcium levels and potential complications such as kidney stones, bone loss, and cardiovascular disease.
5. Vitamin D-dependent rickets type 1: This is a rare genetic disorder that affects the body's ability to absorb vitamin D and maintain normal calcium levels. It can lead to softening of the bones and other skeletal deformities.
6. Familial hypophosphatemic rickets type 1: This is a rare genetic disorder that affects the body's ability to regulate phosphate levels, leading to softening of the bones and other skeletal deformities.
7. Tumor-induced osteomalacia: This is a condition in which cancerous tumors, typically found in the lung or breast, produce high levels of proteins that interfere with the body's ability to absorb vitamin D and maintain normal calcium levels. It can lead to softening of the bones and other skeletal deformities.
8. Chronic kidney disease: This is a condition in which the kidneys are not functioning properly, leading to elevated levels of phosphate and other waste products in the blood. It can lead to softening of the bones and other complications such as heart disease.
9. Paget's disease of bone: This is a condition that affects the way bones grow and repair themselves, leading to deformities and pain. It is often associated with inflammation and elevated levels of calcium in the blood.
10. Chronic alcoholism: Prolonged heavy drinking can lead to deficiencies in vitamin D and calcium, as well as other nutrients that are essential for bone health. It can increase the risk of osteoporosis and fractures.

LVH can lead to a number of complications, including:

1. Heart failure: The enlarged left ventricle can become less efficient at pumping blood throughout the body, leading to heart failure.
2. Arrhythmias: The abnormal electrical activity in the heart can lead to irregular heart rhythms.
3. Sudden cardiac death: In some cases, LVH can increase the risk of sudden cardiac death.
4. Atrial fibrillation: The enlarged left atrium can lead to atrial fibrillation, a common type of arrhythmia.
5. Mitral regurgitation: The enlargement of the left ventricle can cause the mitral valve to become incompetent, leading to mitral regurgitation.
6. Heart valve problems: The enlarged left ventricle can lead to heart valve problems, such as mitral regurgitation or aortic stenosis.
7. Coronary artery disease: LVH can increase the risk of coronary artery disease, which can lead to a heart attack.
8. Pulmonary hypertension: The enlarged left ventricle can lead to pulmonary hypertension, which can further strain the heart and increase the risk of complications.

Evaluation of LVH typically involves a physical examination, medical history, electrocardiogram (ECG), echocardiography, and other diagnostic tests such as stress test or cardiac MRI. Treatment options for LVH depend on the underlying cause and may include medications, lifestyle changes, and in some cases, surgery or other interventions.

There are several types of RTA, including:

1. Type 1 RTA: This is caused by a defect in the genes that code for the proteins involved in acid secretion in the renal tubules.
2. Type 2 RTA: This is caused by damage to the renal tubules, such as from exposure to certain drugs or toxins.
3. Type 4 RTA: This is caused by a deficiency of the hormone aldosterone, which helps regulate electrolyte levels in the body.

Symptoms of RTA can include:

* Nausea and vomiting
* Abdominal pain
* Fatigue
* Weakness
* Dehydration
* Increased heart rate
* Decreased urine production

RTA can be diagnosed through blood tests that measure the pH levels in the body, as well as tests that assess kidney function and electrolyte levels. Treatment for RTA typically involves correcting any underlying causes, such as stopping certain medications or addressing electrolyte imbalances. In some cases, medications may be prescribed to help regulate acid levels in the body.

Prevention of RTA includes maintaining proper hydration, avoiding exposure to harmful substances, and managing any underlying medical conditions that may increase the risk of developing RTA. Early detection and treatment can help prevent complications and improve outcomes for individuals with RTA.

... a major inhibitor of physiologic and pathologic calcification, bone mineralization and bone resorption. The ANK protein has 12 ...
... calcification, physiologic MeSH G11.427.792.560.100.478 - maxillofacial development MeSH G11.427.792.560.100.729 - osteogenesis ... physiologic MeSH G11.697.716.260.378.500 - nystagmus, optokinetic MeSH G11.697.716.260.453 - pursuit, smooth MeSH G11.697. ...
... calcification, physiologic MeSH G07.574.500.325.377.625.100.478 - maxillofacial development MeSH G07.574.500.325.377.625. ...
They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption ... they have different patterns of tissue-specific expression and thus may play different physiologic roles. In melanocytic cells ...
They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption ... in tissue distribution suggest that the two mitochondrial carbonic anhydrases evolved to assume different physiologic roles. ...
The main purpose of apexification includes restoring the original physiologic structures and functions of the pulp-dentin ... stimulates calcification and achieves apical barrier seal at the apex of tooth root. The success rate of applying the ...
... ectopic calcification - such as for example, in urolithiasis and vascular calcification ‒ presumably at least in part to ... A relationship describing local, physiologic double-negative (inhibiting inhibitors) regulation of mineralization involving OPN ... Giachelli CM (March 1999). "Ectopic calcification: gathering hard facts about soft tissue mineralization". The American Journal ... "Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification". The American Journal of Pathology. ...
IK channels have shown a strong connection to calcification in vasculature, as inhibition of the channel causes a decrease in ... This feature of the channel allows them to participate in many different physiologic functions. The physiological effects of BK ... vascular calcification. Over-expression of these channels has quite a different effect on the body. Studies have shown that ...
Most healthy kidneys contain enough physiologic reserve to compensate for this NSAID-induced decrease in blood flow. However, ... One trial demonstrated that the appearance of papillary calcifications on CT imaging was 92% sensitive and 100% specific for ...
Direct visualization of calcifications on chest X-ray is uncommon. Other findings include dilation of the left ventricle. ECG ... abnormalities or specific disease or physiologic processes including rheumatic heart disease and pregnancy. Anatomically, the ... Aortic stenosis due to calcification of tricuspid aortic valve with age comprises >50% of the disease. Aortic stenosis due to ... Stenosis is typically the result of valvular calcification but may be the result of a congenitally malformed bicuspid aortic ...
... is a normal physiologic process that occurs in female dogs. It is seen 45-60 days after a normal estrous (heat ... and before fetal bone calcification (days 35-40 of gestation). The sow remains in anoestrus for prolonged periods, often as ...
Typically, radiographs show defects in calcification and characteristic bony defects near the ends of major long bones. Growth ... A relationship describing physiologic regulation of mineralization has been termed the Stenciling Principle of mineralization, ...
In addition, the calcification deposits between the outer portion of the atheroma and the muscular wall, as they progress, lead ... On the other hand, physiologic methods are often less expensive and safer. But they do not quantify the current state of the ... A similar form of intramural calcification, presenting the picture of an early phase of arteriosclerosis, appears to be induced ... Price PA, Faus SA, Williamson MK (February 2000). "Warfarin-induced artery calcification is accelerated by growth and vitamin D ...
The translucency may be attributable to variations in the degree of calcification and homogeneity of the enamel. . At the edges ... When dentin, which normally supports enamel, is destroyed by a physiologic condition or by decay, enamel is unable to ... The generally recognized stages of tooth development are the bud stage, cap stage, bell stage, and crown, or calcification, ...
Many functions have been attributed to TRAP, and its physiologic role(s) are likely to be manifold. The mice knockout studies ... cerebral calcifications and autoimmunity". Nature Genetics. 43 (2): 132-137. doi:10.1038/ng.749. PMID 21217752. S2CID 205357235 ...
"Basal Ganglia Calcification with Hypomagnesemia". www.japi.org. Retrieved 2021-06-03. Viering DH, de Baaij JH, Walsh SB, Kleta ... This condition is believed to occur secondary to the decreased normal physiologic magnesium inhibition of the ROMK channels in ... basal ganglia calcifications and in extreme and prolonged cases coma, intellectual disability or death. Magnesium plays an ...
All physiologic deposits contain the mineral hydroxyapatite or one analogous to it. Imaging techniques such as infrared ... Miller, J. D. (2013). "Cardiovascular calcification: Orbicular origins". Nature Materials. 12 (6): 476-478. Bibcode:2013NatMa.. ... Not all mineralized tissues develop through normal physiologic processes and are beneficial to the organism. For example, ... 2013). "Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification". ...
The most common cause of jaundice in infants is normal physiologic jaundice. Pathologic causes of neonatal jaundice include: ... may cause a yellow or green discoloration of teeth due to bilirubin deposition during the process of tooth calcification. While ... leading to persistence of physiologic jaundice with unconjugated hyperbilirubinemia. Onset of breast milk jaundice is within 2 ...
Congenital aortic valve stenosis can be treated by aortic valve repair if there is no relevant calcification. In this scenario ... 2010). "An aortic ring: From physiologic reconstruction of the root to a standardized approach for aortic valve repair". J ... An aortic valve repair will realistically be possible in the absence of calcification or shrinking (retraction) of the aortic ... Indications for aortic valve repair: Absence of relevant calcification and Congenital and severe aortic stenosis with symptoms ...
Repair or incomplete regeneration, refers to the physiologic adaptation of an organ after injury in an effort to re-establish ... Dystrophic calcification, pigmentary changes, painful scars, incisional hernia Other complications can include infection and ...
Alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period". The ... "Effect of calcium carbonate saturation state on the calcification rate of an experimental coral reef". Global Biogeochemical ...
Supplementation to achieve these standard levels could cause harmful vascular calcification. A 2012 meta-analysis showed that ... October 1980). "Photosynthesis of previtamin D3 in human skin and the physiologic consequences". Science. 210 (4466): 203-5. ... Furthermore, proteinuria, urinary casts, azotemia, and metastatic calcification (especially in the kidneys) may develop. Other ...
Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts. ...
Physiologic" by people in this website by year, and whether "Calcification, Physiologic" was a major or minor topic of these ... "Calcification, Physiologic" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH ( ... Below are the most recent publications written about "Calcification, Physiologic" by people in Profiles. ... Below are MeSH descriptors whose meaning is more general than "Calcification, Physiologic". ...
Start Over You searched for: Subjects Calcification, Physiologic ✖Remove constraint Subjects: Calcification, Physiologic ...
Calcification, Physiologic. Calcification, Tooth use Tooth Calcification. Calcii Phosphas Praecipitatus use Calcarea ...
Calcification, Physiologic Actions. * Search in PubMed * Search in MeSH * Add to Search ...
Calcification, Physiologic Actions. * Search in PubMed * Search in MeSH * Add to Search ... Calcification points were detected in TG on day 35. There was no difference in elastic fibers between groups. Ultrastructural ...
MeSH Terms: Alkaline Phosphatase/metabolism; Animals; Calcification, Physiologic/physiology*; Extracellular Matrix/metabolism; ... Generalized arterial calcification in infancy (GACI), caused by ENPP1 mutations, results in vascular calcification due to ...
Normal physiologic placental calcifications, which occur during late pregnancy, usually are not seen on MRIs. ...
CALCIFICATION PHYSIOL. Entry Term(s). Bone Mineralization Calcification, Physiological Physiologic Calcification NLM ... Calcification, Physiologic Preferred Term Term UI T005997. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1965). ... Physiologic Calcification Term UI T005996. Date06/26/1978. LexicalTag NON. ThesaurusID UNK (19XX). ... Calcification, Physiologic Preferred Concept UI. M0003142. Scope Note. Process by which organic tissue becomes hardened by the ...
Studies on coronary calcification have uniformly shown a higher degree of calcification at a younger age in patients with renal ... The physiologic role for FGF23 in regulation of phosphate homeostasis is still under investigation. FGF23 is produced in ... Vascular calcifications produce syndromes of accelerated coronary atherosclerosis, medial arterial calcification, and ... but it can serve as a marker for generalized vascular calcification. Aortic valve calcification detected using echocardiography ...
The differential diagnosis for dural calcifications includes physiologic calcifications, previous hemorrhage, previous ... Idiopathic dural optic nerve sheath calcification with intracranial parenchymal calcification. Saqib Ali Khan Utman, Peter L. ... Tentorial and dural calcification with tertiary hyperparathyroidism: a rare entity in chronic renal failure. Eur Radiol 2002;12 ... A multinucleated giant cell (arrow) is in the area of fibrosis next to the focus of calcification (hematoxylin-eosin stain). ...
Rates of aging changes in different physiologic outcomes. The rates of progression of change with age in physiologic and ... higher level of arterial calcification for their age) and possibly lead to criteria that could distinguish between individuals ... beneficial physiologic characteristic which tracks over time), earliest stages of disease (e.g., ... or exceptionally slow rates of physiologic decline, and to test human interventions with potential to contribute to ...
Health and physiologic effects in human aging of factors that influence aging in other species: Aging studies in nonhuman ... minimal changes in arterial calcification, cognitive decline). Knowledge from studies on exceptionally healthy individuals, ... This approach may provide insights into effects of many physiologic factors, such as hormones, as well as behavioral and social ... o Extent, causes and consequences of variability among and within individuals in rates of change with age in physiologic, ...
Calcification, Physiological Physiologic Calcification Physiological Calcification Bone Mineralization - Narrower Concept UI. ... Calcification, Physiological. Mineralization, Bone. Physiologic Calcification. Physiological Calcification. Tree number(s):. ... Calcification, Physiologic - Preferred Concept UI. M0003142. Scope note. Process by which organic tissue becomes hardened by ... TOOTH CALCIFICATION is also available. Allowable Qualifiers:. DE drug effects. GE genetics. IM immunology. PH physiology. RE ...
CALCIFICATION PHYSIOL. Entry Term(s). Bone Mineralization Calcification, Physiological Physiologic Calcification NLM ... Calcification, Physiologic Preferred Term Term UI T005997. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1965). ... Physiologic Calcification Term UI T005996. Date06/26/1978. LexicalTag NON. ThesaurusID UNK (19XX). ... Calcification, Physiologic Preferred Concept UI. M0003142. Scope Note. Process by which organic tissue becomes hardened by the ...
Reports of tubulointerstitial nephritis with medullary calcification and cortical atrophy have been observed in patients with ... It is not known whether CRIXIVAN will exacerbate the physiologic hyperbilirubinemia seen in neonates. (See Pregnancy.) ... indinavir caused an exacerbation of the transient physiologic hyperbilirubinemia seen in this species after birth; serum ... It is unknown whether CRIXIVAN administered to the mother in the perinatal period will exacerbate physiologic ...
Physiologic Calcification 9% * Osteogenesis 6% * Bone Matrix 4% * Enzymes 4% * Cancellous Bone 3% ...
Physiologic Calcification Medicine & Life Sciences 100% * Osteocytes Medicine & Life Sciences 97% * Cell Biology Medicine & ...
... the interacting mechanisms of cardiovascular calcification and physiologic bone mineralization, and micro-scale ... CAVD may progress to a point-of-no-return, a stage of severe calcification where damage to the valve leaflets is too severe to ... The study of bioprosthetic valves may serve as a "purer" model of calcification or VIC injury and may improve our understanding ... Identify the relationship between calcification of the aortic valve and bone and the reciprocal regulation of these processes. ...
C C110927 Physiologic Hyperbilirubinemia Physiologic Hyperbilirubinemia Physiological Hyperbilirubinemia Elevated bilirubin ... intracranial calcification and other abnormalities of the brain; and congenital heart defects. C3101 Genetic Disorder C26726 ... It appears four to seven days after birth, lasts longer than the physiologic jaundice, and there are no identifiable causes. ... It commonly appears one to two weeks after birth and lasts longer than physiologic jaundice. C99246 Neonatal Jaundice C99147 ...
Despite the evolutionary success and ancient heritage of the molluscan shell, little is known about the molecular details of its formation, evolutionary origins, or the interactions between the material properties of the shell and its organic constituents. In contrast to this dearth of information, a growing collection of molluscan shell-forming proteomes and transcriptomes suggest they are comprised of both deeply conserved, and lineage specific elements. Analyses of these sequence data sets have suggested that mechanisms such as exon shuffling, gene co-option, and gene family expansion facilitated the rapid evolution of shell-forming proteomes and supported the diversification of this phylum specific structure. In order to further investigate and test these ideas we have examined the molecular features and spatial expression patterns of two shell-forming genes (Lustrin and ML1A2) and coupled these observations with materials properties measurements of shells from a group of closely related gastropods
See also Calcification, Physiologic See also Osteogenesis See also Osteotomy See also Bone Transplantation ...
Assessment of calcification of dental tissue is another physiologic method for skeletal growth assessment. AIMS: This study ... Age Estimation by Dental Calcification Stages and Hand-Wrist Radiograph. Kumari, Sujata; Sahu, Amit Kumar; Rajguru, Jagdish; ... METHODS: Tooth calcification was assessed by Demirjians method and hand-wrist assessment was done by Fishmans method. ... of hand-wrist radiograph assessment is quite accurate as a maturity indicator but its association with dental calcification ...
  • METHODS: Tooth calcification was assessed by Demirjian's method and hand-wrist assessment was done by Fishman's method. (bvsalud.org)
  • The rates of progression of change with age in physiologic and pathologic factors affect many health outcomes directly. (nih.gov)
  • Extent, causes and implications of variability among and within individuals in rates of change with age in physiologic, pathologic, behavioral, social, environmental and functional characteristics: The rates of progression of change with age in physiologic and pathologic factors affect many health outcomes directly. (nih.gov)
  • Rates of aging changes in different physiologic outcomes. (nih.gov)
  • Generalized arterial calcification in infancy (GACI), caused by ENPP1 mutations, results in vascular calcification due to decreased PPi, later compounded by FGF23-driven hypophosphatemia. (nih.gov)
  • Additional research on variability within populations, in individuals and its determinants (genetic and other factors) could yield new information on potential protective factors (e.g., beneficial physiologic characteristic which tracks over time), earliest stages of disease (e.g., higher level of arterial calcification for their age) and possibly lead to criteria that could distinguish between individuals more or least likely to respond to a given intervention. (nih.gov)
  • Osteoclasts are known to play a crucial role in both physiologic and pathologic bone resorption. (elsevier.com)
  • 32. Intracranial physiologic calcifications. (nih.gov)
  • To the best of our knowledge, dural calcifications are the only described intracranial finding of NSF. (ajnr.org)
  • Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts. (ouhsc.edu)
  • Calcific aortic valve disease (CAVD) covers a spectrum of disease from initial changes in the cell biology of the valve leaflets, through early calcification, tissue remodeling and aortic sclerosis, to outflow obstruction and aortic stenosis. (nih.gov)
  • Assessment of calcification of dental tissue is another physiologic method for skeletal growth assessment. (bvsalud.org)
  • This review summarizes the study of the calcification process of the calvaria and epiphyses from an engineering perspective and provides useful information for the realization of bone tissue biofabrication. (elsevierpure.com)
  • It is produced by osteoblasts [ 5 ] and is involved in the calcification of bone matrix [ 6 ]. (biomedcentral.com)
  • This increases left ventricular afterload and decreases coronary artery blood flow, which leads to left ventricular hypertrophy and increased central blood pressure with attendant untoward physiologic effects. (ccjm.org)
  • In addition, these messages were also expressed by chondrocytes, but the signals were not detected in the chondrocytes in the zones of hypertrophy and provisional calcification. (elsevier.com)
  • Axial noncontrast CT image at the level of the tentorium in brain windows and magnified image at the level of the lateral ventricles in bone windows demonstrate diffuse dural calcification ( arrows on magnified image ). (ajnr.org)
  • Calcification, Physiologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (ouhsc.edu)
  • Differences in risk factors for age-related conditions at different ages, at different stages of disease progression, and in the presence or absence of coexisting conditions: Relationships between physiologic factors and disease risk may not remain constant across ages or segments of life because of physiologic/metabolic differences between immature, mature and old individuals. (nih.gov)
  • AIMS: This study aims to evaluate the correlation between dental calcification stages and skeletal maturity indicators and their application in age estimation purposes. (bvsalud.org)
  • Spearman's rank-order correlation coefficient was applied to measure the association between skeletal maturational indicators and dental calcification stages of individual teeth, and the statistical significance of the correlation was tested. (bvsalud.org)
  • CONCLUSION: Fishman's method of hand-wrist radiograph assessment is quite accurate as a maturity indicator but its association with dental calcification stages cannot be established. (bvsalud.org)
  • This includes the identification of protective factors contributing to exceptionally healthy aging as expressed by exceptional longevity, exceptional "health span" or exceptionally slow rates of physiologic decline, and to test human interventions with potential to contribute to exceptionally healthy aging. (nih.gov)
  • and the health and physiologic effects in human aging of factors that influence aging in other species. (nih.gov)
  • This approach may provide insights into effects of many physiologic factors, such as hormones, as well as behavioral and social factors that could be studied longitudinally. (nih.gov)
  • We present a patient with progressive dural calcifications, thickening, and enhancement presumably related to the development of nephrogenic systemic fibrosis (NSF). (ajnr.org)
  • Pulse-wave analysis more accurately provides physiologic data on central blood pressure and arterial stiffness but requires significant skill and, again, is impractical in daily practice. (ccjm.org)
  • X-ray of the extremities can detect arterial counts for ~50% of all nontraumatic amputations in calcification that is indicative of arterial disease with the United States. (nih.gov)
  • Results of skin biopsy from the right palm revealed fibrocellular thickening of dermal collagen, patchy calcification of blood vessel walls and dermal collagen, and increased Alcian-blue-positive mucin staining consistent with NSF. (ajnr.org)
  • This graph shows the total number of publications written about "Calcification, Physiologic" by people in this website by year, and whether "Calcification, Physiologic" was a major or minor topic of these publications. (ouhsc.edu)
  • Section of dura mater from the right frontal lobe shows fibrosis and blue-staining area of calcification. (ajnr.org)
  • It shows the degree of stenosis, type of plaque, level of calcification and degree of tortuosity of the artery. (vascularnews.com)
  • Generalized arterial calcification in infancy (GACI), caused by ENPP1 mutations, results in vascular calcification due to decreased PPi, later compounded by FGF23-driven hypophosphatemia. (nih.gov)
  • Additional research on variability within populations, in individuals and its determinants (genetic and other factors) could yield new information on potential protective factors (e.g., beneficial physiologic characteristic which tracks over time), earliest stages of disease (e.g., higher level of arterial calcification for their age) and possibly lead to criteria that could distinguish between individuals more or least likely to respond to a given intervention. (nih.gov)
  • X-ray of the extremities can detect arterial counts for ~50% of all nontraumatic amputations in calcification that is indicative of arterial disease with the United States. (nih.gov)
  • Still others have looked at annular calcification in the context of overall cardiac calcification, using semiquantitative systems to grade calcification in the aortic and mitral valves, aortic root, and submitral apparatus, as well as the mitral annulus. (medscape.com)
  • Calcification of the aortic or mitral valve may indicate hemodynamically significant valvular stenosis . (medscape.com)
  • Calcific aortic valve disease (CAVD) covers a spectrum of disease from initial changes in the cell biology of the valve leaflets, through early calcification, tissue remodeling and aortic sclerosis, to outflow obstruction and aortic stenosis. (nih.gov)
  • Mitral annular calcification (MAC) is usually an incidental finding on cardiac imaging. (medscape.com)
  • Mitral annular calcification is especially prominent in the anterior annulus (interannular fibrosa). (medscape.com)
  • Biopsy is never needed for the diagnosis of mitral annular calcification (MAC). (medscape.com)
  • Many studies have classified the severity of mitral annular calcification (MAC) by measuring its thickness on M-mode echocardiography at the point of greatest width. (medscape.com)
  • Mitral annular calcification: significant and worth acting upon. (medscape.com)
  • This is different from the calcification seen in rheumatic valvular disease, which usually involves the commissures and the leaflet tissue with only late extension to the annulus. (medscape.com)
  • See the images of cardiac calcifications below. (medscape.com)
  • Coronary artery calcium scoring (CACS) is a measure of coronary artery calcification detected on electron beam CT (EBCT) or helical CT. (medscape.com)
  • Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts. (nih.gov)
  • The amount of coronary artery calcification correlates with the severity of coronary artery disease (CAD). (medscape.com)
  • Therefore, detecting and recognizing calcification related to the heart on chest radiography and other imaging modalities such as fluoroscopy, CT, and echocardiography may have important clinical implications. (medscape.com)
  • Calcification can extend from the annulus onto the leaflets, limiting their mobility. (medscape.com)
  • CAVD may progress to a point-of-no-return, a stage of severe calcification where damage to the valve leaflets is too severe to be reversed by drug therapy. (nih.gov)
  • In caseous MAC in particular, the histopathologic findings are characterized by central liquefaction necrosis and scattered calcifications that are predominantly located in the peripheral regions. (medscape.com)
  • Recent research findings suggest that physiologic amounts of supplemental dietary boron (PSB) affect a wide range of metabolic parameters in the chick and rat model systems. (nih.gov)
  • calcification is an energy-intensive process. (nih.gov)
  • A semiautomated Agatston method is now commonly utilized based on coronary artery calcification detected by unenhanced low-dose CT. (medscape.com)